date generated: 2022-10-13
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
## x
## 0610009B22Rik 0.19606842
## 0610009E02Rik 2.50381380
## 0610009L18Rik 0.71226654
## 0610010K14Rik -0.06247159
## 0610012G03Rik -0.08438765
## 0610030E20Rik -0.30737084
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 1604 |
| num_genes_in_profile | 17009 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 8305 |
| num_profile_genes_not_in_sets | 8704 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
| Gene sets metrics | |
|---|---|
| num_genesets | 1604 |
| num_genesets_excluded | 440 |
| num_genesets_included | 1164 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO | 10 | 1.96e-03 | 0.566 | 0.05280 |
| TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | 17 | 7.94e-05 | 0.553 | 0.00924 |
| SYNAPTIC ADHESION LIKE MOLECULES | 21 | 3.89e-05 | 0.519 | 0.00503 |
| COMMON PATHWAY OF FIBRIN CLOT FORMATION | 11 | 3.23e-03 | -0.513 | 0.07670 |
| WNT5A DEPENDENT INTERNALIZATION OF FZD4 | 15 | 7.09e-04 | 0.505 | 0.03440 |
| ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES | 10 | 5.92e-03 | -0.503 | 0.12300 |
| CAMK IV MEDIATED PHOSPHORYLATION OF CREB | 10 | 6.73e-03 | 0.495 | 0.12400 |
| CGMP EFFECTS | 15 | 9.40e-04 | 0.493 | 0.03650 |
| DNA METHYLATION | 20 | 4.42e-04 | -0.454 | 0.02450 |
| LGI ADAM INTERACTIONS | 14 | 3.48e-03 | 0.451 | 0.08100 |
| TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX | 12 | 6.92e-03 | 0.450 | 0.12400 |
| SEROTONIN NEUROTRANSMITTER RELEASE CYCLE | 18 | 1.02e-03 | 0.447 | 0.03790 |
| TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | 11 | 1.12e-02 | -0.442 | 0.14300 |
| DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS | 18 | 1.26e-03 | 0.439 | 0.04080 |
| NUCLEOTIDE LIKE PURINERGIC RECEPTORS | 12 | 8.52e-03 | -0.439 | 0.13000 |
| MUCOPOLYSACCHARIDOSES | 11 | 1.20e-02 | 0.437 | 0.14800 |
| TRAFFICKING OF AMPA RECEPTORS | 31 | 2.84e-05 | 0.434 | 0.00456 |
| SHC MEDIATED CASCADE FGFR4 | 11 | 1.52e-02 | -0.423 | 0.17500 |
| SIGNALING BY HIPPO | 20 | 1.24e-03 | -0.417 | 0.04080 |
| INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION | 13 | 1.01e-02 | -0.412 | 0.13700 |
| HSF1 ACTIVATION | 27 | 2.40e-04 | -0.408 | 0.01740 |
| UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION | 21 | 1.31e-03 | 0.405 | 0.04130 |
| SIGNALING BY FGFR3 FUSIONS IN CANCER | 10 | 2.69e-02 | -0.404 | 0.23200 |
| PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING | 11 | 2.13e-02 | 0.401 | 0.20800 |
| NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10 | 11 | 2.18e-02 | -0.399 | 0.21000 |
| CONDENSATION OF PROPHASE CHROMOSOMES | 28 | 2.97e-04 | -0.395 | 0.01820 |
| CROSSLINKING OF COLLAGEN FIBRILS | 14 | 1.12e-02 | 0.391 | 0.14300 |
| NEUROTOXICITY OF CLOSTRIDIUM TOXINS | 10 | 3.24e-02 | 0.391 | 0.24800 |
| CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND | 13 | 1.52e-02 | -0.389 | 0.17500 |
| ATF6 ATF6 ALPHA ACTIVATES CHAPERONES | 12 | 1.99e-02 | -0.388 | 0.20200 |
| RETROGRADE NEUROTROPHIN SIGNALLING | 14 | 1.21e-02 | 0.387 | 0.14800 |
| TRAF6 MEDIATED IRF7 ACTIVATION | 15 | 1.02e-02 | -0.383 | 0.13700 |
| ATTENUATION PHASE | 25 | 9.34e-04 | -0.382 | 0.03650 |
| PI 3K CASCADE FGFR4 | 11 | 3.04e-02 | -0.377 | 0.24200 |
| DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | 23 | 1.82e-03 | 0.376 | 0.05050 |
| DEFECTS IN COBALAMIN B12 METABOLISM | 12 | 2.77e-02 | -0.367 | 0.23500 |
| SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION | 25 | 1.82e-03 | -0.360 | 0.05050 |
| ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 1.02e-02 | 0.360 | 0.13700 |
| CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2 | 11 | 3.88e-02 | -0.360 | 0.27500 |
| RRNA PROCESSING IN THE MITOCHONDRION | 10 | 4.94e-02 | 0.359 | 0.30600 |
| INTERLEUKIN 10 SIGNALING | 19 | 7.48e-03 | -0.354 | 0.12600 |
| INTERACTION BETWEEN L1 AND ANKYRINS | 29 | 1.04e-03 | 0.352 | 0.03790 |
| GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | 14 | 2.27e-02 | -0.352 | 0.21400 |
| FORMATION OF THE CORNIFIED ENVELOPE | 26 | 2.04e-03 | 0.349 | 0.05280 |
| KERATINIZATION | 26 | 2.04e-03 | 0.349 | 0.05280 |
| FRS MEDIATED FGFR4 SIGNALING | 13 | 2.97e-02 | -0.348 | 0.24200 |
| SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | 15 | 1.96e-02 | 0.348 | 0.20200 |
| TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | 13 | 3.12e-02 | -0.345 | 0.24200 |
| PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION | 23 | 4.41e-03 | -0.343 | 0.09680 |
| DSCAM INTERACTIONS | 10 | 6.07e-02 | 0.343 | 0.33400 |
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO | 10 | 1.96e-03 | 0.566000 | 5.28e-02 |
| TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | 17 | 7.94e-05 | 0.553000 | 9.24e-03 |
| SYNAPTIC ADHESION LIKE MOLECULES | 21 | 3.89e-05 | 0.519000 | 5.03e-03 |
| COMMON PATHWAY OF FIBRIN CLOT FORMATION | 11 | 3.23e-03 | -0.513000 | 7.67e-02 |
| WNT5A DEPENDENT INTERNALIZATION OF FZD4 | 15 | 7.09e-04 | 0.505000 | 3.44e-02 |
| ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES | 10 | 5.92e-03 | -0.503000 | 1.23e-01 |
| CAMK IV MEDIATED PHOSPHORYLATION OF CREB | 10 | 6.73e-03 | 0.495000 | 1.24e-01 |
| CGMP EFFECTS | 15 | 9.40e-04 | 0.493000 | 3.65e-02 |
| DNA METHYLATION | 20 | 4.42e-04 | -0.454000 | 2.45e-02 |
| LGI ADAM INTERACTIONS | 14 | 3.48e-03 | 0.451000 | 8.10e-02 |
| TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX | 12 | 6.92e-03 | 0.450000 | 1.24e-01 |
| SEROTONIN NEUROTRANSMITTER RELEASE CYCLE | 18 | 1.02e-03 | 0.447000 | 3.79e-02 |
| TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | 11 | 1.12e-02 | -0.442000 | 1.43e-01 |
| DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS | 18 | 1.26e-03 | 0.439000 | 4.08e-02 |
| NUCLEOTIDE LIKE PURINERGIC RECEPTORS | 12 | 8.52e-03 | -0.439000 | 1.30e-01 |
| MUCOPOLYSACCHARIDOSES | 11 | 1.20e-02 | 0.437000 | 1.48e-01 |
| TRAFFICKING OF AMPA RECEPTORS | 31 | 2.84e-05 | 0.434000 | 4.56e-03 |
| SHC MEDIATED CASCADE FGFR4 | 11 | 1.52e-02 | -0.423000 | 1.75e-01 |
| SIGNALING BY HIPPO | 20 | 1.24e-03 | -0.417000 | 4.08e-02 |
| INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION | 13 | 1.01e-02 | -0.412000 | 1.37e-01 |
| HSF1 ACTIVATION | 27 | 2.40e-04 | -0.408000 | 1.74e-02 |
| UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION | 21 | 1.31e-03 | 0.405000 | 4.13e-02 |
| SIGNALING BY FGFR3 FUSIONS IN CANCER | 10 | 2.69e-02 | -0.404000 | 2.32e-01 |
| PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING | 11 | 2.13e-02 | 0.401000 | 2.08e-01 |
| NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10 | 11 | 2.18e-02 | -0.399000 | 2.10e-01 |
| CONDENSATION OF PROPHASE CHROMOSOMES | 28 | 2.97e-04 | -0.395000 | 1.82e-02 |
| CROSSLINKING OF COLLAGEN FIBRILS | 14 | 1.12e-02 | 0.391000 | 1.43e-01 |
| NEUROTOXICITY OF CLOSTRIDIUM TOXINS | 10 | 3.24e-02 | 0.391000 | 2.48e-01 |
| CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND | 13 | 1.52e-02 | -0.389000 | 1.75e-01 |
| ATF6 ATF6 ALPHA ACTIVATES CHAPERONES | 12 | 1.99e-02 | -0.388000 | 2.02e-01 |
| RETROGRADE NEUROTROPHIN SIGNALLING | 14 | 1.21e-02 | 0.387000 | 1.48e-01 |
| TRAF6 MEDIATED IRF7 ACTIVATION | 15 | 1.02e-02 | -0.383000 | 1.37e-01 |
| ATTENUATION PHASE | 25 | 9.34e-04 | -0.382000 | 3.65e-02 |
| PI 3K CASCADE FGFR4 | 11 | 3.04e-02 | -0.377000 | 2.42e-01 |
| DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | 23 | 1.82e-03 | 0.376000 | 5.05e-02 |
| DEFECTS IN COBALAMIN B12 METABOLISM | 12 | 2.77e-02 | -0.367000 | 2.35e-01 |
| SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION | 25 | 1.82e-03 | -0.360000 | 5.05e-02 |
| ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 1.02e-02 | 0.360000 | 1.37e-01 |
| CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2 | 11 | 3.88e-02 | -0.360000 | 2.75e-01 |
| RRNA PROCESSING IN THE MITOCHONDRION | 10 | 4.94e-02 | 0.359000 | 3.06e-01 |
| INTERLEUKIN 10 SIGNALING | 19 | 7.48e-03 | -0.354000 | 1.26e-01 |
| INTERACTION BETWEEN L1 AND ANKYRINS | 29 | 1.04e-03 | 0.352000 | 3.79e-02 |
| GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | 14 | 2.27e-02 | -0.352000 | 2.14e-01 |
| FORMATION OF THE CORNIFIED ENVELOPE | 26 | 2.04e-03 | 0.349000 | 5.28e-02 |
| KERATINIZATION | 26 | 2.04e-03 | 0.349000 | 5.28e-02 |
| FRS MEDIATED FGFR4 SIGNALING | 13 | 2.97e-02 | -0.348000 | 2.42e-01 |
| SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | 15 | 1.96e-02 | 0.348000 | 2.02e-01 |
| TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | 13 | 3.12e-02 | -0.345000 | 2.42e-01 |
| PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION | 23 | 4.41e-03 | -0.343000 | 9.68e-02 |
| DSCAM INTERACTIONS | 10 | 6.07e-02 | 0.343000 | 3.34e-01 |
| NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION | 21 | 6.61e-03 | 0.342000 | 1.24e-01 |
| NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | 21 | 6.62e-03 | 0.342000 | 1.24e-01 |
| RA BIOSYNTHESIS PATHWAY | 14 | 2.83e-02 | -0.339000 | 2.37e-01 |
| ENDOSOMAL VACUOLAR PATHWAY | 11 | 5.20e-02 | -0.338000 | 3.09e-01 |
| BIOTIN TRANSPORT AND METABOLISM | 11 | 5.24e-02 | 0.338000 | 3.09e-01 |
| ZBP1 DAI MEDIATED INDUCTION OF TYPE I IFNS | 18 | 1.33e-02 | -0.337000 | 1.59e-01 |
| VOLTAGE GATED POTASSIUM CHANNELS | 40 | 2.39e-04 | 0.336000 | 1.74e-02 |
| COMPLEMENT CASCADE | 26 | 3.16e-03 | -0.334000 | 7.67e-02 |
| CELLULAR HEXOSE TRANSPORT | 10 | 7.07e-02 | 0.330000 | 3.55e-01 |
| IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | 10 | 7.17e-02 | 0.329000 | 3.55e-01 |
| ASSEMBLY AND CELL SURFACE PRESENTATION OF NMDA RECEPTORS | 36 | 6.83e-04 | 0.327000 | 3.44e-02 |
| SYNTHESIS OF PE | 13 | 4.15e-02 | -0.327000 | 2.89e-01 |
| SPRY REGULATION OF FGF SIGNALING | 16 | 2.39e-02 | 0.326000 | 2.19e-01 |
| SHC MEDIATED CASCADE FGFR3 | 13 | 4.24e-02 | -0.325000 | 2.89e-01 |
| LONG TERM POTENTIATION | 23 | 7.13e-03 | 0.324000 | 1.24e-01 |
| ENOS ACTIVATION | 11 | 6.57e-02 | -0.321000 | 3.40e-01 |
| TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS | 12 | 5.52e-02 | -0.320000 | 3.15e-01 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR4 | 18 | 2.06e-02 | -0.315000 | 2.05e-01 |
| ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR ANDROGEN RECEPTOR REGULATED GENES KLK2 AND KLK3 | 22 | 1.08e-02 | -0.314000 | 1.42e-01 |
| KSRP KHSRP BINDS AND DESTABILIZES MRNA | 16 | 3.05e-02 | 0.312000 | 2.42e-01 |
| SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | 13 | 5.15e-02 | -0.312000 | 3.09e-01 |
| THE NLRP3 INFLAMMASOME | 15 | 3.72e-02 | -0.311000 | 2.73e-01 |
| ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT | 23 | 1.01e-02 | 0.310000 | 1.37e-01 |
| IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | 21 | 1.57e-02 | -0.304000 | 1.79e-01 |
| TICAM1 RIP1 MEDIATED IKK COMPLEX RECRUITMENT | 18 | 2.60e-02 | -0.303000 | 2.27e-01 |
| FORMATION OF FIBRIN CLOT CLOTTING CASCADE | 21 | 1.72e-02 | -0.300000 | 1.91e-01 |
| ANCHORING FIBRIL FORMATION | 13 | 6.16e-02 | 0.299000 | 3.37e-01 |
| INTERFERON GAMMA SIGNALING | 78 | 5.21e-06 | -0.298000 | 3.03e-03 |
| RIP MEDIATED NFKB ACTIVATION VIA ZBP1 | 15 | 4.56e-02 | -0.298000 | 2.98e-01 |
| REGULATED PROTEOLYSIS OF P75NTR | 12 | 7.38e-02 | -0.298000 | 3.55e-01 |
| MET ACTIVATES RAS SIGNALING | 10 | 1.09e-01 | -0.293000 | 4.37e-01 |
| CELL EXTRACELLULAR MATRIX INTERACTIONS | 18 | 3.20e-02 | -0.292000 | 2.47e-01 |
| IRF3 MEDIATED INDUCTION OF TYPE I IFN | 11 | 9.59e-02 | -0.290000 | 4.13e-01 |
| OLFACTORY SIGNALING PATHWAY | 31 | 5.30e-03 | -0.289000 | 1.12e-01 |
| TRAF6 MEDIATED NF KB ACTIVATION | 22 | 1.92e-02 | -0.288000 | 2.02e-01 |
| MET ACTIVATES RAP1 AND RAC1 | 11 | 9.82e-02 | -0.288000 | 4.19e-01 |
| PI 3K CASCADE FGFR3 | 13 | 7.40e-02 | -0.286000 | 3.55e-01 |
| ERKS ARE INACTIVATED | 13 | 7.45e-02 | 0.286000 | 3.55e-01 |
| STING MEDIATED INDUCTION OF HOST IMMUNE RESPONSES | 14 | 6.51e-02 | -0.285000 | 3.38e-01 |
| INTERLEUKIN 4 AND INTERLEUKIN 13 SIGNALING | 79 | 1.24e-05 | -0.285000 | 3.18e-03 |
| DISEASES OF IMMUNE SYSTEM | 23 | 1.85e-02 | -0.284000 | 1.99e-01 |
| INTERFERON ALPHA BETA SIGNALING | 56 | 2.75e-04 | -0.281000 | 1.78e-02 |
| NEUREXINS AND NEUROLIGINS | 54 | 3.88e-04 | 0.279000 | 2.26e-02 |
| FORMATION OF APOPTOSOME | 10 | 1.27e-01 | -0.278000 | 4.69e-01 |
| CONSTITUTIVE SIGNALING BY EGFRVIII | 15 | 6.36e-02 | -0.277000 | 3.38e-01 |
| FORMATION OF THE EARLY ELONGATION COMPLEX | 33 | 6.01e-03 | 0.276000 | 1.23e-01 |
| DISEASES OF DNA REPAIR | 11 | 1.16e-01 | 0.274000 | 4.54e-01 |
| GLYCOGEN METABOLISM | 25 | 1.79e-02 | -0.274000 | 1.97e-01 |
| FRS MEDIATED FGFR3 SIGNALING | 15 | 6.66e-02 | -0.274000 | 3.42e-01 |
| LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME | 13 | 8.79e-02 | 0.273000 | 3.97e-01 |
| NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 5.12e-02 | 0.273000 | 3.09e-01 |
| REDUCTION OF CYTOSOLIC CA LEVELS | 11 | 1.18e-01 | 0.272000 | 4.55e-01 |
| RHO GTPASES ACTIVATE NADPH OXIDASES | 19 | 4.22e-02 | 0.269000 | 2.89e-01 |
| INITIAL TRIGGERING OF COMPLEMENT | 11 | 1.23e-01 | -0.269000 | 4.67e-01 |
| SIGNALING BY ERBB2 ECD MUTANTS | 16 | 6.29e-02 | -0.269000 | 3.38e-01 |
| SIGNALING BY FGFR4 IN DISEASE | 10 | 1.42e-01 | -0.268000 | 4.88e-01 |
| GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | 23 | 2.65e-02 | 0.267000 | 2.30e-01 |
| COBALAMIN CBL VITAMIN B12 TRANSPORT AND METABOLISM | 13 | 9.56e-02 | -0.267000 | 4.13e-01 |
| TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS | 15 | 7.40e-02 | -0.267000 | 3.55e-01 |
| APOPTOSIS INDUCED DNA FRAGMENTATION | 10 | 1.46e-01 | -0.266000 | 4.91e-01 |
| CA DEPENDENT EVENTS | 36 | 6.22e-03 | 0.264000 | 1.24e-01 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR3 | 20 | 4.21e-02 | -0.263000 | 2.89e-01 |
| ERK MAPK TARGETS | 22 | 3.31e-02 | 0.263000 | 2.51e-01 |
| PROTEIN PROTEIN INTERACTIONS AT SYNAPSES | 85 | 3.14e-05 | 0.261000 | 4.56e-03 |
| SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III | 23 | 3.08e-02 | 0.260000 | 2.42e-01 |
| SIGNALING BY BMP | 25 | 2.47e-02 | -0.259000 | 2.25e-01 |
| TIGHT JUNCTION INTERACTIONS | 16 | 7.36e-02 | -0.258000 | 3.55e-01 |
| RAS ACTIVATION UPON CA2 INFLUX THROUGH NMDA RECEPTOR | 20 | 4.68e-02 | 0.257000 | 2.99e-01 |
| RHO GTPASES ACTIVATE KTN1 | 11 | 1.41e-01 | -0.256000 | 4.88e-01 |
| SCAVENGING BY CLASS A RECEPTORS | 13 | 1.10e-01 | -0.256000 | 4.37e-01 |
| GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION | 12 | 1.25e-01 | 0.256000 | 4.69e-01 |
| SIGNALING BY ERBB2 IN CANCER | 25 | 2.97e-02 | -0.251000 | 2.42e-01 |
| CRMPS IN SEMA3A SIGNALING | 16 | 8.36e-02 | 0.250000 | 3.86e-01 |
| PHASE 0 RAPID DEPOLARISATION | 31 | 1.63e-02 | 0.249000 | 1.84e-01 |
| UNWINDING OF DNA | 12 | 1.35e-01 | 0.249000 | 4.79e-01 |
| EFFECTS OF PIP2 HYDROLYSIS | 27 | 2.50e-02 | 0.249000 | 2.26e-01 |
| RESOLUTION OF ABASIC SITES AP SITES | 38 | 7.88e-03 | 0.249000 | 1.26e-01 |
| ROLE OF SECOND MESSENGERS IN NETRIN 1 SIGNALING | 10 | 1.74e-01 | 0.248000 | 5.31e-01 |
| INFLAMMASOMES | 19 | 6.28e-02 | -0.247000 | 3.38e-01 |
| HEPARAN SULFATE HEPARIN HS GAG METABOLISM | 51 | 2.33e-03 | 0.246000 | 5.90e-02 |
| NCAM SIGNALING FOR NEURITE OUT GROWTH | 57 | 1.35e-03 | 0.245000 | 4.14e-02 |
| PRC2 METHYLATES HISTONES AND DNA | 29 | 2.23e-02 | -0.245000 | 2.13e-01 |
| TRANSCRIPTIONAL REGULATION OF GRANULOPOIESIS | 45 | 4.70e-03 | -0.244000 | 1.01e-01 |
| MEIOTIC RECOMBINATION | 38 | 9.40e-03 | -0.244000 | 1.37e-01 |
| DAG AND IP3 SIGNALING | 40 | 7.99e-03 | 0.242000 | 1.26e-01 |
| PLATELET ADHESION TO EXPOSED COLLAGEN | 12 | 1.46e-01 | -0.242000 | 4.91e-01 |
| HIV TRANSCRIPTION ELONGATION | 42 | 7.02e-03 | 0.240000 | 1.24e-01 |
| OVARIAN TUMOR DOMAIN PROTEASES | 36 | 1.26e-02 | -0.240000 | 1.53e-01 |
| SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL | 10 | 1.89e-01 | 0.240000 | 5.51e-01 |
| COPI MEDIATED ANTEROGRADE TRANSPORT | 90 | 8.82e-05 | 0.239000 | 9.33e-03 |
| VLDLR INTERNALISATION AND DEGRADATION | 12 | 1.53e-01 | 0.238000 | 5.02e-01 |
| DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | 39 | 1.01e-02 | -0.238000 | 1.37e-01 |
| ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | 25 | 4.03e-02 | -0.237000 | 2.84e-01 |
| RHOBTB2 GTPASE CYCLE | 23 | 5.06e-02 | -0.236000 | 3.09e-01 |
| CYTOCHROME C MEDIATED APOPTOTIC RESPONSE | 12 | 1.58e-01 | -0.235000 | 5.07e-01 |
| PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES | 13 | 1.42e-01 | -0.235000 | 4.88e-01 |
| DDX58 IFIH1 MEDIATED INDUCTION OF INTERFERON ALPHA BETA | 64 | 1.23e-03 | -0.234000 | 4.08e-02 |
| ACYL CHAIN REMODELLING OF PS | 14 | 1.31e-01 | 0.233000 | 4.72e-01 |
| AMINE LIGAND BINDING RECEPTORS | 31 | 2.58e-02 | 0.231000 | 2.27e-01 |
| IRAK4 DEFICIENCY TLR2 4 | 12 | 1.67e-01 | -0.230000 | 5.22e-01 |
| ERYTHROPOIETIN ACTIVATES RAS | 13 | 1.51e-01 | -0.230000 | 5.00e-01 |
| FCERI MEDIATED CA 2 MOBILIZATION | 25 | 4.77e-02 | -0.229000 | 2.99e-01 |
| CALNEXIN CALRETICULIN CYCLE | 26 | 4.38e-02 | -0.228000 | 2.94e-01 |
| POTASSIUM CHANNELS | 90 | 1.86e-04 | 0.228000 | 1.67e-02 |
| SUMOYLATION OF TRANSCRIPTION FACTORS | 17 | 1.04e-01 | -0.228000 | 4.27e-01 |
| CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | 12 | 1.74e-01 | 0.226000 | 5.31e-01 |
| SURFACTANT METABOLISM | 16 | 1.17e-01 | -0.226000 | 4.54e-01 |
| TICAM1 DEPENDENT ACTIVATION OF IRF3 IRF7 | 12 | 1.77e-01 | -0.225000 | 5.33e-01 |
| NONHOMOLOGOUS END JOINING NHEJ | 44 | 9.97e-03 | -0.225000 | 1.37e-01 |
| GLUCONEOGENESIS | 27 | 4.40e-02 | 0.224000 | 2.94e-01 |
| WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 | 13 | 1.63e-01 | 0.224000 | 5.15e-01 |
| PROCESSING OF INTRONLESS PRE MRNAS | 19 | 9.23e-02 | 0.223000 | 4.07e-01 |
| GLYCOGEN SYNTHESIS | 14 | 1.49e-01 | -0.223000 | 4.96e-01 |
| METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION | 15 | 1.35e-01 | -0.223000 | 4.79e-01 |
| DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE | 45 | 9.80e-03 | -0.223000 | 1.37e-01 |
| HS GAG BIOSYNTHESIS | 29 | 3.83e-02 | 0.222000 | 2.74e-01 |
| NCAM1 INTERACTIONS | 37 | 1.99e-02 | 0.221000 | 2.02e-01 |
| CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY | 23 | 6.70e-02 | -0.221000 | 3.42e-01 |
| RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 95 | 2.59e-04 | -0.217000 | 1.78e-02 |
| RECYCLING PATHWAY OF L1 | 40 | 1.87e-02 | 0.215000 | 1.99e-01 |
| DARPP 32 EVENTS | 23 | 7.44e-02 | 0.215000 | 3.55e-01 |
| GP1B IX V ACTIVATION SIGNALLING | 11 | 2.17e-01 | 0.215000 | 5.93e-01 |
| REGULATION OF GLYCOLYSIS BY FRUCTOSE 2 6 BISPHOSPHATE METABOLISM | 10 | 2.42e-01 | 0.214000 | 6.30e-01 |
| NETRIN 1 SIGNALING | 48 | 1.06e-02 | 0.213000 | 1.40e-01 |
| AMINO ACIDS REGULATE MTORC1 | 51 | 8.59e-03 | 0.213000 | 1.30e-01 |
| MITOCHONDRIAL FATTY ACID BETA OXIDATION | 33 | 3.46e-02 | -0.213000 | 2.57e-01 |
| ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | 16 | 1.42e-01 | -0.212000 | 4.88e-01 |
| MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS | 18 | 1.19e-01 | 0.212000 | 4.58e-01 |
| RHOBTB3 ATPASE CYCLE | 10 | 2.46e-01 | -0.212000 | 6.35e-01 |
| INACTIVATION OF CSF3 G CSF SIGNALING | 24 | 7.30e-02 | -0.211000 | 3.55e-01 |
| ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS | 84 | 8.13e-04 | 0.211000 | 3.51e-02 |
| SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 107 | 1.62e-04 | -0.211000 | 1.57e-02 |
| EUKARYOTIC TRANSLATION ELONGATION | 88 | 6.66e-04 | -0.210000 | 3.44e-02 |
| NEPHRIN FAMILY INTERACTIONS | 22 | 9.07e-02 | 0.208000 | 4.01e-01 |
| HDR THROUGH MMEJ ALT NHEJ | 10 | 2.55e-01 | 0.208000 | 6.39e-01 |
| AMYLOID FIBER FORMATION | 57 | 6.79e-03 | -0.207000 | 1.24e-01 |
| RHOBTB GTPASE CYCLE | 35 | 3.43e-02 | -0.207000 | 2.56e-01 |
| INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE | 22 | 9.32e-02 | 0.207000 | 4.10e-01 |
| REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS | 14 | 1.82e-01 | -0.206000 | 5.40e-01 |
| HS GAG DEGRADATION | 20 | 1.10e-01 | 0.206000 | 4.37e-01 |
| MTORC1 MEDIATED SIGNALLING | 24 | 8.13e-02 | 0.206000 | 3.80e-01 |
| NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | 22 | 9.53e-02 | 0.205000 | 4.13e-01 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR2 | 23 | 8.88e-02 | -0.205000 | 3.97e-01 |
| CYTOSOLIC SULFONATION OF SMALL MOLECULES | 15 | 1.73e-01 | 0.203000 | 5.31e-01 |
| CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY | 13 | 2.05e-01 | 0.203000 | 5.78e-01 |
| THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION | 14 | 1.90e-01 | -0.202000 | 5.51e-01 |
| RHOBTB1 GTPASE CYCLE | 23 | 9.40e-02 | -0.202000 | 4.10e-01 |
| CONSTITUTIVE SIGNALING BY LIGAND RESPONSIVE EGFR CANCER VARIANTS | 19 | 1.28e-01 | -0.202000 | 4.69e-01 |
| DEACTIVATION OF THE BETA CATENIN TRANSACTIVATING COMPLEX | 41 | 2.57e-02 | -0.201000 | 2.27e-01 |
| SPHINGOLIPID DE NOVO BIOSYNTHESIS | 41 | 2.59e-02 | -0.201000 | 2.27e-01 |
| ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM | 12 | 2.28e-01 | -0.201000 | 6.15e-01 |
| PROCESSING OF CAPPED INTRONLESS PRE MRNA | 28 | 6.65e-02 | 0.200000 | 3.42e-01 |
| RHO GTPASES ACTIVATE WASPS AND WAVES | 36 | 3.80e-02 | 0.200000 | 2.74e-01 |
| RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PURINE | 23 | 9.73e-02 | -0.200000 | 4.17e-01 |
| SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | 11 | 2.53e-01 | 0.199000 | 6.37e-01 |
| PI 3K CASCADE FGFR2 | 16 | 1.68e-01 | -0.199000 | 5.24e-01 |
| HSF1 DEPENDENT TRANSACTIVATION | 35 | 4.17e-02 | -0.199000 | 2.89e-01 |
| ACTIVATION OF AMPK DOWNSTREAM OF NMDARS | 20 | 1.25e-01 | 0.198000 | 4.69e-01 |
| FRS MEDIATED FGFR2 SIGNALING | 18 | 1.45e-01 | -0.198000 | 4.91e-01 |
| CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | 12 | 2.40e-01 | 0.196000 | 6.29e-01 |
| RECEPTOR MEDIATED MITOPHAGY | 11 | 2.60e-01 | 0.196000 | 6.43e-01 |
| ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | 30 | 6.41e-02 | 0.195000 | 3.38e-01 |
| SIGNALING BY PDGFR IN DISEASE | 20 | 1.31e-01 | -0.195000 | 4.72e-01 |
| PLATELET SENSITIZATION BY LDL | 15 | 1.91e-01 | -0.195000 | 5.51e-01 |
| CHONDROITIN SULFATE BIOSYNTHESIS | 19 | 1.42e-01 | 0.194000 | 4.88e-01 |
| HIV ELONGATION ARREST AND RECOVERY | 32 | 5.82e-02 | 0.194000 | 3.28e-01 |
| RESPONSE OF EIF2AK1 HRI TO HEME DEFICIENCY | 14 | 2.13e-01 | -0.192000 | 5.89e-01 |
| REGULATION OF FZD BY UBIQUITINATION | 20 | 1.39e-01 | -0.191000 | 4.88e-01 |
| POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | 59 | 1.14e-02 | 0.190000 | 1.44e-01 |
| PURINE SALVAGE | 12 | 2.54e-01 | 0.190000 | 6.39e-01 |
| POST CHAPERONIN TUBULIN FOLDING PATHWAY | 17 | 1.75e-01 | 0.190000 | 5.31e-01 |
| INSULIN RECEPTOR RECYCLING | 20 | 1.42e-01 | 0.190000 | 4.88e-01 |
| CD209 DC SIGN SIGNALING | 18 | 1.65e-01 | -0.189000 | 5.16e-01 |
| SIGNALING BY CSF3 G CSF | 29 | 7.85e-02 | -0.189000 | 3.69e-01 |
| SIGNALING BY ERBB4 | 57 | 1.38e-02 | -0.189000 | 1.63e-01 |
| DUAL INCISION IN GG NER | 41 | 3.70e-02 | 0.188000 | 2.73e-01 |
| INTERLEUKIN 37 SIGNALING | 19 | 1.57e-01 | -0.188000 | 5.07e-01 |
| HEME BIOSYNTHESIS | 13 | 2.44e-01 | 0.187000 | 6.33e-01 |
| COHESIN LOADING ONTO CHROMATIN | 10 | 3.09e-01 | -0.186000 | 6.89e-01 |
| SHC1 EVENTS IN EGFR SIGNALING | 11 | 2.88e-01 | -0.185000 | 6.70e-01 |
| RUNX3 REGULATES NOTCH SIGNALING | 13 | 2.51e-01 | -0.184000 | 6.35e-01 |
| SEROTONIN RECEPTORS | 10 | 3.15e-01 | 0.183000 | 6.92e-01 |
| TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES | 11 | 2.95e-01 | -0.182000 | 6.77e-01 |
| P38MAPK EVENTS | 12 | 2.76e-01 | -0.182000 | 6.59e-01 |
| N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | 23 | 1.31e-01 | -0.182000 | 4.72e-01 |
| GLYCOSAMINOGLYCAN METABOLISM | 114 | 8.11e-04 | 0.182000 | 3.51e-02 |
| ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS | 10 | 3.20e-01 | 0.181000 | 6.93e-01 |
| PENTOSE PHOSPHATE PATHWAY | 13 | 2.58e-01 | -0.181000 | 6.43e-01 |
| DNA DAMAGE RECOGNITION IN GG NER | 38 | 5.44e-02 | 0.180000 | 3.12e-01 |
| BUDDING AND MATURATION OF HIV VIRION | 27 | 1.05e-01 | 0.180000 | 4.27e-01 |
| SODIUM CALCIUM EXCHANGERS | 10 | 3.24e-01 | 0.180000 | 6.93e-01 |
| NEURONAL SYSTEM | 364 | 3.95e-09 | 0.180000 | 4.60e-06 |
| VXPX CARGO TARGETING TO CILIUM | 19 | 1.78e-01 | 0.179000 | 5.35e-01 |
| RNA POLYMERASE III CHAIN ELONGATION | 18 | 1.91e-01 | 0.178000 | 5.51e-01 |
| MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | 15 | 2.34e-01 | 0.178000 | 6.24e-01 |
| ADENYLATE CYCLASE ACTIVATING PATHWAY | 10 | 3.31e-01 | 0.178000 | 6.94e-01 |
| EARLY PHASE OF HIV LIFE CYCLE | 14 | 2.50e-01 | -0.177000 | 6.35e-01 |
| ACYL CHAIN REMODELLING OF PG | 10 | 3.33e-01 | 0.177000 | 6.95e-01 |
| NEGATIVE REGULATORS OF DDX58 IFIH1 SIGNALING | 34 | 7.43e-02 | -0.177000 | 3.55e-01 |
| L1CAM INTERACTIONS | 109 | 1.44e-03 | 0.177000 | 4.31e-02 |
| CREB1 PHOSPHORYLATION THROUGH NMDA RECEPTOR MEDIATED ACTIVATION OF RAS SIGNALING | 28 | 1.07e-01 | 0.176000 | 4.31e-01 |
| ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | 28 | 1.07e-01 | 0.176000 | 4.31e-01 |
| DEADENYLATION OF MRNA | 25 | 1.28e-01 | 0.176000 | 4.69e-01 |
| TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS | 41 | 5.27e-02 | 0.175000 | 3.09e-01 |
| ERCC6 CSB AND EHMT2 G9A POSITIVELY REGULATE RRNA EXPRESSION | 33 | 8.22e-02 | -0.175000 | 3.83e-01 |
| GLUCOSE METABOLISM | 79 | 7.36e-03 | 0.174000 | 1.26e-01 |
| RNA POLYMERASE I TRANSCRIPTION TERMINATION | 31 | 9.38e-02 | 0.174000 | 4.10e-01 |
| SIGNALING BY FGFR1 IN DISEASE | 32 | 8.95e-02 | -0.173000 | 3.98e-01 |
| DEFECTIVE EXT2 CAUSES EXOSTOSES 2 | 14 | 2.62e-01 | 0.173000 | 6.44e-01 |
| ANTIGEN PROCESSING CROSS PRESENTATION | 95 | 3.66e-03 | -0.173000 | 8.35e-02 |
| E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS | 51 | 3.32e-02 | -0.172000 | 2.51e-01 |
| DERMATAN SULFATE BIOSYNTHESIS | 11 | 3.22e-01 | 0.172000 | 6.93e-01 |
| BUTYRATE RESPONSE FACTOR 1 BRF1 BINDS AND DESTABILIZES MRNA | 16 | 2.35e-01 | 0.172000 | 6.25e-01 |
| REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION | 30 | 1.04e-01 | 0.171000 | 4.27e-01 |
| NEGATIVE REGULATION OF FGFR1 SIGNALING | 26 | 1.30e-01 | 0.171000 | 4.72e-01 |
| VEGFR2 MEDIATED VASCULAR PERMEABILITY | 26 | 1.31e-01 | -0.171000 | 4.72e-01 |
| BLOOD GROUP SYSTEMS BIOSYNTHESIS | 13 | 2.86e-01 | -0.171000 | 6.70e-01 |
| RIPK1 MEDIATED REGULATED NECROSIS | 25 | 1.40e-01 | -0.171000 | 4.88e-01 |
| INCRETIN SYNTHESIS SECRETION AND INACTIVATION | 13 | 2.88e-01 | -0.170000 | 6.70e-01 |
| SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | 20 | 1.87e-01 | -0.170000 | 5.48e-01 |
| NUCLEOTIDE SALVAGE | 21 | 1.80e-01 | 0.169000 | 5.38e-01 |
| PRE NOTCH EXPRESSION AND PROCESSING | 64 | 2.03e-02 | -0.168000 | 2.04e-01 |
| RNA POLYMERASE I TRANSCRIPTION INITIATION | 47 | 4.72e-02 | 0.167000 | 2.99e-01 |
| PURINE CATABOLISM | 16 | 2.48e-01 | 0.167000 | 6.35e-01 |
| P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 3.18e-01 | -0.167000 | 6.92e-01 |
| RHO GTPASES ACTIVATE PKNS | 48 | 4.60e-02 | -0.167000 | 2.98e-01 |
| REGULATION OF IFNG SIGNALING | 13 | 2.99e-01 | -0.166000 | 6.78e-01 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR1 | 25 | 1.51e-01 | -0.166000 | 5.00e-01 |
| MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | 31 | 1.10e-01 | 0.166000 | 4.37e-01 |
| ANTIMICROBIAL PEPTIDES | 16 | 2.51e-01 | -0.166000 | 6.35e-01 |
| SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX | 12 | 3.21e-01 | 0.165000 | 6.93e-01 |
| FORMATION OF RNA POL II ELONGATION COMPLEX | 57 | 3.09e-02 | 0.165000 | 2.42e-01 |
| TBC RABGAPS | 42 | 6.43e-02 | 0.165000 | 3.38e-01 |
| APOPTOTIC FACTOR MEDIATED RESPONSE | 18 | 2.27e-01 | -0.165000 | 6.12e-01 |
| ACYL CHAIN REMODELLING OF PC | 17 | 2.40e-01 | 0.165000 | 6.29e-01 |
| RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | 25 | 1.57e-01 | 0.163000 | 5.07e-01 |
| PI3K EVENTS IN ERBB2 SIGNALING | 15 | 2.73e-01 | -0.163000 | 6.55e-01 |
| ER TO GOLGI ANTEROGRADE TRANSPORT | 140 | 8.54e-04 | 0.163000 | 3.55e-02 |
| BBSOME MEDIATED CARGO TARGETING TO CILIUM | 23 | 1.76e-01 | -0.163000 | 5.31e-01 |
| RECOGNITION OF DNA DAMAGE BY PCNA CONTAINING REPLICATION COMPLEX | 30 | 1.23e-01 | 0.163000 | 4.67e-01 |
| SELENOAMINO ACID METABOLISM | 110 | 3.21e-03 | -0.163000 | 7.67e-02 |
| ER QUALITY CONTROL COMPARTMENT ERQC | 21 | 1.98e-01 | -0.162000 | 5.62e-01 |
| DEREGULATED CDK5 TRIGGERS MULTIPLE NEURODEGENERATIVE PATHWAYS IN ALZHEIMER S DISEASE MODELS | 19 | 2.21e-01 | 0.162000 | 5.99e-01 |
| REGULATION OF RUNX1 EXPRESSION AND ACTIVITY | 17 | 2.47e-01 | -0.162000 | 6.35e-01 |
| ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES | 10 | 3.76e-01 | 0.162000 | 7.29e-01 |
| SARS COV 1 INFECTION | 48 | 5.28e-02 | 0.162000 | 3.09e-01 |
| BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS | 32 | 1.17e-01 | -0.160000 | 4.54e-01 |
| MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS | 13 | 3.18e-01 | -0.160000 | 6.92e-01 |
| ANTIGEN ACTIVATES B CELL RECEPTOR BCR LEADING TO GENERATION OF SECOND MESSENGERS | 26 | 1.60e-01 | -0.159000 | 5.11e-01 |
| CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION | 11 | 3.61e-01 | -0.159000 | 7.24e-01 |
| GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | 18 | 2.44e-01 | 0.159000 | 6.33e-01 |
| SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES | 29 | 1.40e-01 | -0.159000 | 4.88e-01 |
| GLYCOLYSIS | 65 | 2.76e-02 | 0.158000 | 2.35e-01 |
| SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | 14 | 3.07e-01 | 0.158000 | 6.89e-01 |
| NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | 52 | 4.95e-02 | -0.158000 | 3.06e-01 |
| SIGNALING BY EGFR IN CANCER | 22 | 2.02e-01 | -0.157000 | 5.71e-01 |
| JOSEPHIN DOMAIN DUBS | 11 | 3.68e-01 | 0.157000 | 7.28e-01 |
| FORMATION OF THE BETA CATENIN TCF TRANSACTIVATING COMPLEX | 47 | 6.39e-02 | -0.156000 | 3.38e-01 |
| GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 3.52e-01 | -0.155000 | 7.13e-01 |
| FGFR2 LIGAND BINDING AND ACTIVATION | 11 | 3.75e-01 | -0.154000 | 7.29e-01 |
| FORMATION OF TC NER PRE INCISION COMPLEX | 53 | 5.26e-02 | 0.154000 | 3.09e-01 |
| METABOLISM OF PORPHYRINS | 19 | 2.47e-01 | 0.154000 | 6.35e-01 |
| HDACS DEACETYLATE HISTONES | 47 | 6.91e-02 | -0.153000 | 3.50e-01 |
| INTRAFLAGELLAR TRANSPORT | 49 | 6.45e-02 | 0.153000 | 3.38e-01 |
| ACTIVATED NTRK2 SIGNALS THROUGH FRS2 AND FRS3 | 10 | 4.04e-01 | -0.152000 | 7.51e-01 |
| SHC1 EVENTS IN ERBB4 SIGNALING | 13 | 3.42e-01 | -0.152000 | 7.02e-01 |
| PROTEIN UBIQUITINATION | 70 | 2.79e-02 | -0.152000 | 2.35e-01 |
| MRNA SPLICING MINOR PATHWAY | 52 | 5.81e-02 | 0.152000 | 3.28e-01 |
| PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | 15 | 3.09e-01 | -0.152000 | 6.89e-01 |
| TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY DREAM COMPLEX | 18 | 2.65e-01 | -0.152000 | 6.48e-01 |
| FORMATION OF INCISION COMPLEX IN GG NER | 43 | 8.55e-02 | 0.152000 | 3.92e-01 |
| ESTROGEN DEPENDENT GENE EXPRESSION | 102 | 8.28e-03 | -0.151000 | 1.28e-01 |
| ERBB2 REGULATES CELL MOTILITY | 14 | 3.27e-01 | -0.151000 | 6.94e-01 |
| PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR | 21 | 2.31e-01 | 0.151000 | 6.19e-01 |
| N GLYCAN ANTENNAE ELONGATION | 15 | 3.11e-01 | -0.151000 | 6.90e-01 |
| TRNA PROCESSING | 105 | 7.72e-03 | 0.151000 | 1.26e-01 |
| RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | 28 | 1.70e-01 | 0.150000 | 5.26e-01 |
| CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE | 11 | 3.92e-01 | -0.149000 | 7.45e-01 |
| DUAL INCISION IN TC NER | 65 | 3.76e-02 | 0.149000 | 2.74e-01 |
| NUCLEAR ENVELOPE BREAKDOWN | 49 | 7.15e-02 | 0.149000 | 3.55e-01 |
| RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | 78 | 2.31e-02 | 0.149000 | 2.15e-01 |
| ION HOMEOSTASIS | 48 | 7.45e-02 | 0.149000 | 3.55e-01 |
| TRANSCRIPTIONAL REGULATION BY MECP2 | 60 | 4.63e-02 | 0.149000 | 2.98e-01 |
| DAP12 INTERACTIONS | 31 | 1.53e-01 | -0.148000 | 5.02e-01 |
| VIRAL MESSENGER RNA SYNTHESIS | 42 | 9.64e-02 | 0.148000 | 4.14e-01 |
| EGFR DOWNREGULATION | 28 | 1.75e-01 | 0.148000 | 5.31e-01 |
| PKMTS METHYLATE HISTONE LYSINES | 49 | 7.35e-02 | -0.148000 | 3.55e-01 |
| IL 6 TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS | 13 | 3.57e-01 | -0.148000 | 7.21e-01 |
| DISEASES OF PROGRAMMED CELL DEATH | 54 | 6.08e-02 | -0.148000 | 3.34e-01 |
| SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | 62 | 4.47e-02 | 0.147000 | 2.96e-01 |
| TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | 16 | 3.08e-01 | -0.147000 | 6.89e-01 |
| REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA | 13 | 3.58e-01 | -0.147000 | 7.21e-01 |
| A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | 26 | 1.94e-01 | 0.147000 | 5.56e-01 |
| DISEASES ASSOCIATED WITH N GLYCOSYLATION OF PROTEINS | 17 | 2.94e-01 | 0.147000 | 6.77e-01 |
| INTERFERON SIGNALING | 166 | 1.11e-03 | -0.147000 | 3.92e-02 |
| NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION | 177 | 8.02e-04 | 0.146000 | 3.51e-02 |
| INTERLEUKIN 7 SIGNALING | 20 | 2.58e-01 | 0.146000 | 6.43e-01 |
| NUCLEAR ENVELOPE NE REASSEMBLY | 64 | 4.46e-02 | 0.145000 | 2.96e-01 |
| RAP1 SIGNALLING | 15 | 3.32e-01 | 0.145000 | 6.95e-01 |
| SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 | 12 | 3.86e-01 | -0.145000 | 7.42e-01 |
| MTOR SIGNALLING | 40 | 1.14e-01 | 0.144000 | 4.50e-01 |
| RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS | 83 | 2.37e-02 | -0.144000 | 2.19e-01 |
| KERATAN SULFATE DEGRADATION | 11 | 4.09e-01 | 0.144000 | 7.51e-01 |
| INTRA GOLGI TRAFFIC | 43 | 1.04e-01 | 0.143000 | 4.27e-01 |
| IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | 49 | 8.27e-02 | -0.143000 | 3.84e-01 |
| TRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 43 | 1.05e-01 | 0.143000 | 4.27e-01 |
| SHC MEDIATED CASCADE FGFR1 | 15 | 3.40e-01 | -0.142000 | 7.02e-01 |
| METALLOPROTEASE DUBS | 26 | 2.10e-01 | -0.142000 | 5.85e-01 |
| DEADENYLATION DEPENDENT MRNA DECAY | 55 | 6.85e-02 | 0.142000 | 3.48e-01 |
| INTERLEUKIN 6 SIGNALING | 10 | 4.37e-01 | -0.142000 | 7.74e-01 |
| REGULATION OF FOXO TRANSCRIPTIONAL ACTIVITY BY ACETYLATION | 10 | 4.39e-01 | -0.141000 | 7.74e-01 |
| SIGNAL TRANSDUCTION BY L1 | 21 | 2.63e-01 | 0.141000 | 6.47e-01 |
| APC CDC20 MEDIATED DEGRADATION OF NEK2A | 25 | 2.24e-01 | 0.141000 | 6.05e-01 |
| PHASE 2 PLATEAU PHASE | 13 | 3.80e-01 | 0.141000 | 7.34e-01 |
| TRANSMISSION ACROSS CHEMICAL SYNAPSES | 236 | 2.07e-04 | 0.140000 | 1.72e-02 |
| EUKARYOTIC TRANSLATION INITIATION | 115 | 9.38e-03 | -0.140000 | 1.37e-01 |
| TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | 30 | 1.85e-01 | -0.140000 | 5.44e-01 |
| LYSINE CATABOLISM | 11 | 4.22e-01 | -0.140000 | 7.62e-01 |
| ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | 34 | 1.59e-01 | -0.140000 | 5.08e-01 |
| GLYCOGEN STORAGE DISEASES | 12 | 4.03e-01 | -0.140000 | 7.51e-01 |
| ACTIVATION OF BH3 ONLY PROTEINS | 30 | 1.89e-01 | 0.139000 | 5.51e-01 |
| GPVI MEDIATED ACTIVATION CASCADE | 31 | 1.84e-01 | -0.138000 | 5.44e-01 |
| OPIOID SIGNALLING | 85 | 2.89e-02 | 0.137000 | 2.40e-01 |
| REGULATION OF INSULIN SECRETION | 70 | 4.77e-02 | 0.137000 | 2.99e-01 |
| G2 M DNA DAMAGE CHECKPOINT | 67 | 5.33e-02 | -0.137000 | 3.09e-01 |
| G0 AND EARLY G1 | 25 | 2.38e-01 | -0.136000 | 6.28e-01 |
| INTERLEUKIN 6 FAMILY SIGNALING | 19 | 3.04e-01 | -0.136000 | 6.86e-01 |
| NUCLEOTIDE EXCISION REPAIR | 110 | 1.37e-02 | 0.136000 | 1.63e-01 |
| INHIBITION OF DNA RECOMBINATION AT TELOMERE | 36 | 1.58e-01 | -0.136000 | 5.07e-01 |
| REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | 29 | 2.09e-01 | 0.135000 | 5.85e-01 |
| CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | 49 | 1.05e-01 | 0.134000 | 4.27e-01 |
| DEPOLYMERISATION OF THE NUCLEAR LAMINA | 13 | 4.07e-01 | 0.133000 | 7.51e-01 |
| RHOC GTPASE CYCLE | 73 | 5.06e-02 | -0.132000 | 3.09e-01 |
| TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR TC NER | 78 | 4.36e-02 | 0.132000 | 2.94e-01 |
| SHC1 EVENTS IN ERBB2 SIGNALING | 21 | 2.95e-01 | -0.132000 | 6.77e-01 |
| MRNA CAPPING | 29 | 2.19e-01 | 0.132000 | 5.97e-01 |
| DETOXIFICATION OF REACTIVE OXYGEN SPECIES | 31 | 2.07e-01 | -0.131000 | 5.82e-01 |
| RESOLUTION OF D LOOP STRUCTURES THROUGH SYNTHESIS DEPENDENT STRAND ANNEALING SDSA | 25 | 2.57e-01 | -0.131000 | 6.43e-01 |
| PKA ACTIVATION IN GLUCAGON SIGNALLING | 16 | 3.65e-01 | 0.131000 | 7.27e-01 |
| SIGNALING BY NTRK2 TRKB | 24 | 2.70e-01 | 0.130000 | 6.52e-01 |
| PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS | 19 | 3.27e-01 | 0.130000 | 6.94e-01 |
| SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R | 42 | 1.45e-01 | -0.130000 | 4.91e-01 |
| MITOTIC TELOPHASE CYTOKINESIS | 13 | 4.18e-01 | -0.130000 | 7.60e-01 |
| INTEGRIN CELL SURFACE INTERACTIONS | 68 | 6.49e-02 | -0.129000 | 3.38e-01 |
| TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | 13 | 4.19e-01 | -0.129000 | 7.60e-01 |
| REPRESSION OF WNT TARGET GENES | 14 | 4.02e-01 | -0.129000 | 7.51e-01 |
| TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY P107 RBL1 AND P130 RBL2 IN COMPLEX WITH HDAC1 | 15 | 3.87e-01 | -0.129000 | 7.42e-01 |
| GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR GG NER | 84 | 4.14e-02 | 0.129000 | 2.89e-01 |
| GRB2 EVENTS IN ERBB2 SIGNALING | 15 | 3.89e-01 | -0.129000 | 7.42e-01 |
| PROCESSING OF DNA DOUBLE STRAND BREAK ENDS | 73 | 5.95e-02 | -0.128000 | 3.30e-01 |
| NEUTROPHIL DEGRANULATION | 390 | 1.64e-05 | -0.127000 | 3.18e-03 |
| ION TRANSPORT BY P TYPE ATPASES | 47 | 1.31e-01 | 0.127000 | 4.72e-01 |
| N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | 35 | 1.93e-01 | -0.127000 | 5.54e-01 |
| FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | 18 | 3.51e-01 | -0.127000 | 7.13e-01 |
| SENSORY PROCESSING OF SOUND | 61 | 8.87e-02 | 0.126000 | 3.97e-01 |
| NONSENSE MEDIATED DECAY NMD | 110 | 2.28e-02 | -0.126000 | 2.14e-01 |
| TRNA PROCESSING IN THE NUCLEUS | 56 | 1.04e-01 | 0.126000 | 4.27e-01 |
| RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER | 28 | 2.51e-01 | 0.125000 | 6.35e-01 |
| RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | 85 | 4.60e-02 | 0.125000 | 2.98e-01 |
| INTEGRATION OF ENERGY METABOLISM | 96 | 3.42e-02 | 0.125000 | 2.56e-01 |
| TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA | 34 | 2.11e-01 | 0.124000 | 5.85e-01 |
| GENERATION OF SECOND MESSENGER MOLECULES | 18 | 3.62e-01 | -0.124000 | 7.24e-01 |
| REGULATION OF TP53 ACTIVITY THROUGH METHYLATION | 18 | 3.63e-01 | -0.124000 | 7.24e-01 |
| SIGNALING BY PDGFRA TRANSMEMBRANE JUXTAMEMBRANE AND KINASE DOMAIN MUTANTS | 12 | 4.59e-01 | -0.124000 | 7.88e-01 |
| APOPTOTIC EXECUTION PHASE | 45 | 1.52e-01 | -0.124000 | 5.00e-01 |
| REGULATION OF MECP2 EXPRESSION AND ACTIVITY | 30 | 2.42e-01 | 0.123000 | 6.30e-01 |
| SNRNP ASSEMBLY | 51 | 1.27e-01 | 0.123000 | 4.69e-01 |
| TRISTETRAPROLIN TTP ZFP36 BINDS AND DESTABILIZES MRNA | 16 | 3.93e-01 | 0.123000 | 7.47e-01 |
| NOD1 2 SIGNALING PATHWAY | 34 | 2.14e-01 | -0.123000 | 5.90e-01 |
| CHAPERONE MEDIATED AUTOPHAGY | 20 | 3.44e-01 | -0.122000 | 7.04e-01 |
| SIGNALING BY FLT3 FUSION PROTEINS | 18 | 3.70e-01 | -0.122000 | 7.29e-01 |
| ERBB2 ACTIVATES PTK6 SIGNALING | 11 | 4.83e-01 | -0.122000 | 7.96e-01 |
| IRAK1 RECRUITS IKK COMPLEX | 14 | 4.29e-01 | -0.122000 | 7.70e-01 |
| THE ROLE OF NEF IN HIV 1 REPLICATION AND DISEASE PATHOGENESIS | 28 | 2.65e-01 | 0.122000 | 6.48e-01 |
| RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION | 51 | 1.33e-01 | -0.122000 | 4.75e-01 |
| RETROGRADE TRANSPORT AT THE TRANS GOLGI NETWORK | 48 | 1.46e-01 | 0.121000 | 4.91e-01 |
| NEGATIVE REGULATION OF MAPK PATHWAY | 43 | 1.70e-01 | 0.121000 | 5.26e-01 |
| TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | 79 | 6.40e-02 | 0.121000 | 3.38e-01 |
| RND1 GTPASE CYCLE | 38 | 1.99e-01 | -0.121000 | 5.64e-01 |
| FGFR1 MUTANT RECEPTOR ACTIVATION | 25 | 2.98e-01 | -0.120000 | 6.78e-01 |
| ADRENALINE NORADRENALINE INHIBITS INSULIN SECRETION | 26 | 2.89e-01 | 0.120000 | 6.70e-01 |
| CARDIAC CONDUCTION | 108 | 3.10e-02 | 0.120000 | 2.42e-01 |
| STRIATED MUSCLE CONTRACTION | 24 | 3.08e-01 | 0.120000 | 6.89e-01 |
| CS DS DEGRADATION | 14 | 4.37e-01 | 0.120000 | 7.74e-01 |
| FCGR3A MEDIATED IL10 SYNTHESIS | 33 | 2.34e-01 | -0.120000 | 6.24e-01 |
| SEMA4D IN SEMAPHORIN SIGNALING | 24 | 3.11e-01 | -0.120000 | 6.90e-01 |
| SENESCENCE ASSOCIATED SECRETORY PHENOTYPE SASP | 64 | 9.86e-02 | -0.119000 | 4.19e-01 |
| INFECTION WITH MYCOBACTERIUM TUBERCULOSIS | 25 | 3.05e-01 | -0.119000 | 6.88e-01 |
| FRS MEDIATED FGFR1 SIGNALING | 17 | 3.99e-01 | -0.118000 | 7.51e-01 |
| GAB1 SIGNALOSOME | 14 | 4.44e-01 | -0.118000 | 7.76e-01 |
| MEIOTIC SYNAPSIS | 41 | 1.95e-01 | -0.117000 | 5.57e-01 |
| INITIATION OF NUCLEAR ENVELOPE NE REFORMATION | 17 | 4.04e-01 | 0.117000 | 7.51e-01 |
| HEME SIGNALING | 44 | 1.80e-01 | 0.117000 | 5.38e-01 |
| SIGNALING BY RETINOIC ACID | 34 | 2.41e-01 | -0.116000 | 6.29e-01 |
| ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION | 14 | 4.52e-01 | -0.116000 | 7.83e-01 |
| SIGNALING BY NTRK3 TRKC | 17 | 4.07e-01 | 0.116000 | 7.51e-01 |
| DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | 23 | 3.37e-01 | 0.116000 | 6.99e-01 |
| VEGFR2 MEDIATED CELL PROLIFERATION | 19 | 3.85e-01 | -0.115000 | 7.42e-01 |
| INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | 20 | 3.73e-01 | 0.115000 | 7.29e-01 |
| G PROTEIN MEDIATED EVENTS | 51 | 1.57e-01 | 0.115000 | 5.07e-01 |
| BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | 76 | 8.46e-02 | 0.114000 | 3.89e-01 |
| METABOLISM OF CARBOHYDRATES | 257 | 1.63e-03 | 0.114000 | 4.76e-02 |
| SUPPRESSION OF PHAGOSOMAL MATURATION | 13 | 4.76e-01 | -0.114000 | 7.90e-01 |
| EPH EPHRIN MEDIATED REPULSION OF CELLS | 49 | 1.69e-01 | 0.114000 | 5.26e-01 |
| DNA DAMAGE BYPASS | 48 | 1.74e-01 | 0.113000 | 5.31e-01 |
| TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | 168 | 1.16e-02 | 0.113000 | 1.46e-01 |
| DAP12 SIGNALING | 24 | 3.39e-01 | -0.113000 | 7.01e-01 |
| CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER | 62 | 1.26e-01 | -0.112000 | 4.69e-01 |
| PHASE 4 RESTING MEMBRANE POTENTIAL | 14 | 4.66e-01 | 0.112000 | 7.88e-01 |
| SIGNALING BY NUCLEAR RECEPTORS | 224 | 3.83e-03 | -0.112000 | 8.57e-02 |
| REGULATION OF HSF1 MEDIATED HEAT SHOCK RESPONSE | 77 | 8.86e-02 | -0.112000 | 3.97e-01 |
| CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | 92 | 6.34e-02 | -0.112000 | 3.38e-01 |
| INFLUENZA INFECTION | 146 | 1.98e-02 | -0.112000 | 2.02e-01 |
| ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | 59 | 1.39e-01 | -0.111000 | 4.88e-01 |
| PROLACTIN RECEPTOR SIGNALING | 12 | 5.05e-01 | -0.111000 | 8.07e-01 |
| CYTOKINE SIGNALING IN IMMUNE SYSTEM | 547 | 9.74e-06 | -0.111000 | 3.18e-03 |
| VITAMIN B5 PANTOTHENATE METABOLISM | 15 | 4.61e-01 | -0.110000 | 7.88e-01 |
| CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN | 34 | 2.67e-01 | 0.110000 | 6.51e-01 |
| RNA POLYMERASE II TRANSCRIPTION TERMINATION | 65 | 1.28e-01 | 0.109000 | 4.69e-01 |
| COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 44 | 2.10e-01 | 0.109000 | 5.85e-01 |
| NUCLEOBASE CATABOLISM | 31 | 2.95e-01 | 0.109000 | 6.77e-01 |
| SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX | 13 | 4.98e-01 | -0.109000 | 8.06e-01 |
| PI 3K CASCADE FGFR1 | 15 | 4.67e-01 | -0.109000 | 7.88e-01 |
| MEIOSIS | 64 | 1.34e-01 | -0.108000 | 4.76e-01 |
| LATE ENDOSOMAL MICROAUTOPHAGY | 31 | 2.97e-01 | 0.108000 | 6.78e-01 |
| TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES | 61 | 1.44e-01 | 0.108000 | 4.91e-01 |
| ESR MEDIATED SIGNALING | 165 | 1.72e-02 | -0.108000 | 1.91e-01 |
| NEGATIVE REGULATION OF FGFR2 SIGNALING | 27 | 3.35e-01 | 0.107000 | 6.97e-01 |
| AUTOPHAGY | 138 | 3.01e-02 | 0.107000 | 2.42e-01 |
| COPI DEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 86 | 8.65e-02 | 0.107000 | 3.95e-01 |
| PLATELET CALCIUM HOMEOSTASIS | 25 | 3.55e-01 | 0.107000 | 7.19e-01 |
| DOWNREGULATION OF ERBB2 SIGNALING | 28 | 3.31e-01 | -0.106000 | 6.94e-01 |
| CELL JUNCTION ORGANIZATION | 73 | 1.17e-01 | -0.106000 | 4.54e-01 |
| NEDDYLATION | 217 | 7.74e-03 | 0.105000 | 1.26e-01 |
| LAMININ INTERACTIONS | 27 | 3.46e-01 | -0.105000 | 7.06e-01 |
| FATTY ACID METABOLISM | 144 | 3.02e-02 | -0.105000 | 2.42e-01 |
| INWARDLY RECTIFYING K CHANNELS | 31 | 3.15e-01 | 0.104000 | 6.92e-01 |
| SIGNALING BY TGFB FAMILY MEMBERS | 97 | 7.69e-02 | -0.104000 | 3.65e-01 |
| INTERLEUKIN 20 FAMILY SIGNALING | 14 | 5.01e-01 | 0.104000 | 8.06e-01 |
| EXTRA NUCLEAR ESTROGEN SIGNALING | 67 | 1.42e-01 | -0.104000 | 4.88e-01 |
| RHOQ GTPASE CYCLE | 58 | 1.73e-01 | -0.103000 | 5.31e-01 |
| PEXOPHAGY | 11 | 5.54e-01 | 0.103000 | 8.32e-01 |
| B WICH COMPLEX POSITIVELY REGULATES RRNA EXPRESSION | 48 | 2.18e-01 | -0.103000 | 5.93e-01 |
| P75NTR SIGNALS VIA NF KB | 16 | 4.76e-01 | -0.103000 | 7.90e-01 |
| TRANSLESION SYNTHESIS BY POLH | 19 | 4.38e-01 | 0.103000 | 7.74e-01 |
| TOLL LIKE RECEPTOR CASCADES | 137 | 3.83e-02 | -0.103000 | 2.74e-01 |
| TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX | 15 | 4.92e-01 | -0.102000 | 8.01e-01 |
| SARS COV 2 INFECTION | 65 | 1.55e-01 | 0.102000 | 5.05e-01 |
| MITOPHAGY | 29 | 3.44e-01 | 0.102000 | 7.04e-01 |
| SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | 20 | 4.32e-01 | -0.101000 | 7.74e-01 |
| TCF DEPENDENT SIGNALING IN RESPONSE TO WNT | 179 | 1.94e-02 | -0.101000 | 2.02e-01 |
| NUCLEAR PORE COMPLEX NPC DISASSEMBLY | 32 | 3.21e-01 | 0.101000 | 6.93e-01 |
| DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE | 27 | 3.64e-01 | 0.101000 | 7.26e-01 |
| NS1 MEDIATED EFFECTS ON HOST PATHWAYS | 37 | 2.89e-01 | 0.101000 | 6.70e-01 |
| MITOCHONDRIAL TRNA AMINOACYLATION | 21 | 4.25e-01 | 0.101000 | 7.66e-01 |
| REGULATED NECROSIS | 46 | 2.39e-01 | -0.100000 | 6.29e-01 |
| GOLGI TO ER RETROGRADE TRANSPORT | 119 | 5.86e-02 | 0.100000 | 3.28e-01 |
| PYRIMIDINE CATABOLISM | 10 | 5.84e-01 | 0.100000 | 8.41e-01 |
| NRAGE SIGNALS DEATH THROUGH JNK | 56 | 1.95e-01 | 0.100000 | 5.57e-01 |
| SIGNALING BY SCF KIT | 41 | 2.69e-01 | -0.099900 | 6.51e-01 |
| HYALURONAN METABOLISM | 15 | 5.04e-01 | 0.099500 | 8.07e-01 |
| SUMOYLATION OF RNA BINDING PROTEINS | 45 | 2.49e-01 | 0.099400 | 6.35e-01 |
| LYSOSOME VESICLE BIOGENESIS | 33 | 3.25e-01 | 0.099100 | 6.94e-01 |
| SULFUR AMINO ACID METABOLISM | 23 | 4.11e-01 | -0.099000 | 7.52e-01 |
| IRS MEDIATED SIGNALLING | 37 | 2.99e-01 | -0.098800 | 6.78e-01 |
| NEGATIVE REGULATION OF FGFR3 SIGNALING | 24 | 4.04e-01 | 0.098400 | 7.51e-01 |
| SIGNALING BY NTRKS | 130 | 5.32e-02 | 0.098300 | 3.09e-01 |
| ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | 23 | 4.15e-01 | -0.098200 | 7.55e-01 |
| RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES | 20 | 4.47e-01 | 0.098200 | 7.79e-01 |
| ION CHANNEL TRANSPORT | 139 | 4.60e-02 | 0.098100 | 2.98e-01 |
| AGGREPHAGY | 35 | 3.17e-01 | 0.097800 | 6.92e-01 |
| AURKA ACTIVATION BY TPX2 | 71 | 1.56e-01 | 0.097500 | 5.06e-01 |
| SIGNALING BY ACTIVIN | 12 | 5.60e-01 | -0.097100 | 8.34e-01 |
| REPRODUCTION | 74 | 1.49e-01 | -0.097100 | 4.96e-01 |
| RHOF GTPASE CYCLE | 40 | 2.88e-01 | -0.097000 | 6.70e-01 |
| PARASITE INFECTION | 56 | 2.10e-01 | 0.096900 | 5.85e-01 |
| DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE | 20 | 4.54e-01 | 0.096800 | 7.84e-01 |
| CLATHRIN MEDIATED ENDOCYTOSIS | 134 | 5.33e-02 | 0.096700 | 3.09e-01 |
| REGULATION OF TLR BY ENDOGENOUS LIGAND | 11 | 5.79e-01 | -0.096700 | 8.41e-01 |
| RHOG GTPASE CYCLE | 73 | 1.55e-01 | -0.096400 | 5.05e-01 |
| E2F MEDIATED REGULATION OF DNA REPLICATION | 19 | 4.68e-01 | -0.096200 | 7.88e-01 |
| HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE | 41 | 2.87e-01 | -0.096000 | 6.70e-01 |
| METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES | 21 | 4.48e-01 | -0.095700 | 7.79e-01 |
| DISEASES OF CARBOHYDRATE METABOLISM | 29 | 3.73e-01 | 0.095700 | 7.29e-01 |
| SUMOYLATION OF SUMOYLATION PROTEINS | 33 | 3.42e-01 | 0.095600 | 7.02e-01 |
| BASIGIN INTERACTIONS | 22 | 4.38e-01 | -0.095500 | 7.74e-01 |
| EPH EPHRIN SIGNALING | 90 | 1.21e-01 | 0.094700 | 4.61e-01 |
| NR1H2 AND NR1H3 MEDIATED SIGNALING | 39 | 3.07e-01 | -0.094500 | 6.89e-01 |
| ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | 285 | 6.40e-03 | 0.094000 | 1.24e-01 |
| PEROXISOMAL PROTEIN IMPORT | 58 | 2.16e-01 | -0.094000 | 5.91e-01 |
| RET SIGNALING | 37 | 3.24e-01 | 0.093700 | 6.93e-01 |
| RHO GTPASES ACTIVATE IQGAPS | 23 | 4.39e-01 | 0.093200 | 7.74e-01 |
| G ALPHA S SIGNALLING EVENTS | 104 | 1.01e-01 | 0.093000 | 4.26e-01 |
| SUMOYLATION OF UBIQUITINYLATION PROTEINS | 37 | 3.28e-01 | 0.092900 | 6.94e-01 |
| ZINC TRANSPORTERS | 15 | 5.34e-01 | 0.092800 | 8.23e-01 |
| GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | 30 | 3.79e-01 | 0.092800 | 7.33e-01 |
| INTERLEUKIN 12 FAMILY SIGNALING | 43 | 2.94e-01 | -0.092500 | 6.77e-01 |
| CARNITINE METABOLISM | 14 | 5.49e-01 | -0.092500 | 8.30e-01 |
| PHOSPHORYLATION OF THE APC C | 17 | 5.09e-01 | 0.092400 | 8.09e-01 |
| INNATE IMMUNE SYSTEM | 781 | 1.37e-05 | -0.092000 | 3.18e-03 |
| PLATELET HOMEOSTASIS | 77 | 1.64e-01 | 0.091800 | 5.16e-01 |
| INTEGRIN SIGNALING | 24 | 4.37e-01 | -0.091600 | 7.74e-01 |
| REGULATION OF IFNA SIGNALING | 12 | 5.83e-01 | -0.091600 | 8.41e-01 |
| DCC MEDIATED ATTRACTIVE SIGNALING | 14 | 5.53e-01 | 0.091500 | 8.32e-01 |
| NUCLEAR IMPORT OF REV PROTEIN | 32 | 3.72e-01 | 0.091200 | 7.29e-01 |
| ASPARAGINE N LINKED GLYCOSYLATION | 281 | 8.78e-03 | 0.091000 | 1.31e-01 |
| MOLECULES ASSOCIATED WITH ELASTIC FIBRES | 32 | 3.76e-01 | -0.090500 | 7.29e-01 |
| CYTOSOLIC SENSORS OF PATHOGEN ASSOCIATED DNA | 59 | 2.31e-01 | -0.090200 | 6.19e-01 |
| MHC CLASS II ANTIGEN PRESENTATION | 103 | 1.14e-01 | 0.090200 | 4.49e-01 |
| NEGATIVE REGULATION OF FLT3 | 14 | 5.60e-01 | 0.090100 | 8.34e-01 |
| SIGNALLING TO RAS | 19 | 4.98e-01 | -0.089700 | 8.06e-01 |
| C TYPE LECTIN RECEPTORS CLRS | 112 | 1.05e-01 | -0.088800 | 4.27e-01 |
| RUNX2 REGULATES BONE DEVELOPMENT | 29 | 4.09e-01 | -0.088700 | 7.51e-01 |
| ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 | 19 | 5.04e-01 | -0.088500 | 8.07e-01 |
| NICOTINAMIDE SALVAGING | 16 | 5.40e-01 | 0.088500 | 8.27e-01 |
| NEGATIVE REGULATION OF FGFR4 SIGNALING | 22 | 4.75e-01 | 0.088000 | 7.90e-01 |
| PYRIMIDINE SALVAGE | 10 | 6.31e-01 | 0.087600 | 8.71e-01 |
| METABOLISM OF COFACTORS | 18 | 5.20e-01 | -0.087600 | 8.17e-01 |
| EXPORT OF VIRAL RIBONUCLEOPROTEINS FROM NUCLEUS | 31 | 3.99e-01 | 0.087500 | 7.51e-01 |
| DEFECTS IN VITAMIN AND COFACTOR METABOLISM | 20 | 4.99e-01 | -0.087400 | 8.06e-01 |
| RNA POLYMERASE III TRANSCRIPTION TERMINATION | 23 | 4.68e-01 | 0.087400 | 7.88e-01 |
| NUCLEAR SIGNALING BY ERBB4 | 31 | 4.00e-01 | -0.087300 | 7.51e-01 |
| SYNDECAN INTERACTIONS | 26 | 4.41e-01 | -0.087300 | 7.76e-01 |
| MUSCLE CONTRACTION | 159 | 5.86e-02 | 0.087000 | 3.28e-01 |
| KERATAN SULFATE KERATIN METABOLISM | 30 | 4.10e-01 | 0.087000 | 7.51e-01 |
| SUMOYLATION OF DNA METHYLATION PROTEINS | 15 | 5.60e-01 | 0.086900 | 8.34e-01 |
| RAC2 GTPASE CYCLE | 86 | 1.64e-01 | -0.086900 | 5.16e-01 |
| PHOSPHOLIPASE C MEDIATED CASCADE FGFR2 | 11 | 6.18e-01 | -0.086800 | 8.65e-01 |
| FCERI MEDIATED MAPK ACTIVATION | 28 | 4.27e-01 | -0.086800 | 7.67e-01 |
| NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | 59 | 2.50e-01 | 0.086700 | 6.35e-01 |
| TRANSLOCATION OF SLC2A4 GLUT4 TO THE PLASMA MEMBRANE | 63 | 2.37e-01 | 0.086200 | 6.28e-01 |
| P75NTR RECRUITS SIGNALLING COMPLEXES | 13 | 5.91e-01 | -0.086100 | 8.46e-01 |
| NEGATIVE REGULATION OF NOTCH4 SIGNALING | 54 | 2.77e-01 | 0.085600 | 6.59e-01 |
| ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K | 11 | 6.23e-01 | -0.085500 | 8.67e-01 |
| METHYLATION | 12 | 6.08e-01 | -0.085400 | 8.57e-01 |
| SIGNALING BY PTK6 | 51 | 2.92e-01 | -0.085300 | 6.76e-01 |
| ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES | 50 | 2.97e-01 | 0.085200 | 6.78e-01 |
| GROWTH HORMONE RECEPTOR SIGNALING | 21 | 5.01e-01 | -0.084800 | 8.06e-01 |
| TERMINATION OF TRANSLESION DNA SYNTHESIS | 32 | 4.07e-01 | 0.084800 | 7.51e-01 |
| PIWI INTERACTING RNA PIRNA BIOGENESIS | 22 | 4.93e-01 | 0.084500 | 8.01e-01 |
| TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE | 39 | 3.62e-01 | 0.084400 | 7.24e-01 |
| SIGNALING BY INTERLEUKINS | 349 | 6.97e-03 | -0.084300 | 1.24e-01 |
| FATTY ACYL COA BIOSYNTHESIS | 32 | 4.10e-01 | -0.084200 | 7.51e-01 |
| RHOH GTPASE CYCLE | 37 | 3.76e-01 | -0.084200 | 7.29e-01 |
| INTERLEUKIN RECEPTOR SHC SIGNALING | 20 | 5.15e-01 | -0.084100 | 8.16e-01 |
| CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | 19 | 5.28e-01 | 0.083700 | 8.22e-01 |
| NEUROTRANSMITTER RELEASE CYCLE | 48 | 3.19e-01 | 0.083200 | 6.92e-01 |
| MET RECEPTOR RECYCLING | 10 | 6.49e-01 | -0.083100 | 8.80e-01 |
| SUMOYLATION OF DNA REPLICATION PROTEINS | 43 | 3.46e-01 | 0.083000 | 7.06e-01 |
| SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS | 41 | 3.58e-01 | 0.083000 | 7.21e-01 |
| RAF ACTIVATION | 34 | 4.03e-01 | 0.082800 | 7.51e-01 |
| FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 19 | 5.33e-01 | -0.082600 | 8.23e-01 |
| PROTEIN FOLDING | 87 | 1.84e-01 | 0.082500 | 5.44e-01 |
| REGULATION OF EXPRESSION OF SLITS AND ROBOS | 162 | 7.04e-02 | -0.082500 | 3.55e-01 |
| ROS AND RNS PRODUCTION IN PHAGOCYTES | 29 | 4.44e-01 | -0.082100 | 7.76e-01 |
| RNA POLYMERASE I PROMOTER ESCAPE | 48 | 3.28e-01 | -0.081700 | 6.94e-01 |
| GLUTAMATE AND GLUTAMINE METABOLISM | 13 | 6.11e-01 | -0.081600 | 8.58e-01 |
| BILE ACID AND BILE SALT METABOLISM | 25 | 4.81e-01 | -0.081500 | 7.94e-01 |
| PROTEIN METHYLATION | 17 | 5.61e-01 | -0.081500 | 8.34e-01 |
| NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 20 | 5.29e-01 | -0.081400 | 8.22e-01 |
| TRANSLESION SYNTHESIS BY POLK | 17 | 5.62e-01 | 0.081300 | 8.34e-01 |
| REGULATION OF INSULIN LIKE GROWTH FACTOR IGF TRANSPORT AND UPTAKE BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | 90 | 1.83e-01 | -0.081200 | 5.44e-01 |
| SPHINGOLIPID METABOLISM | 79 | 2.13e-01 | -0.081000 | 5.89e-01 |
| SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS | 18 | 5.52e-01 | -0.081000 | 8.32e-01 |
| GAP JUNCTION DEGRADATION | 11 | 6.42e-01 | 0.080900 | 8.76e-01 |
| NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 23 | 5.04e-01 | -0.080500 | 8.07e-01 |
| ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | 28 | 4.62e-01 | 0.080400 | 7.88e-01 |
| O GLYCOSYLATION OF TSR DOMAIN CONTAINING PROTEINS | 33 | 4.26e-01 | -0.080100 | 7.66e-01 |
| VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS | 37 | 4.00e-01 | 0.079900 | 7.51e-01 |
| DISEASES OF GLYCOSYLATION | 122 | 1.28e-01 | 0.079800 | 4.69e-01 |
| POLYMERASE SWITCHING ON THE C STRAND OF THE TELOMERE | 25 | 4.91e-01 | 0.079600 | 8.01e-01 |
| ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS | 67 | 2.61e-01 | -0.079500 | 6.43e-01 |
| TRANSLATION | 287 | 2.09e-02 | -0.079400 | 2.06e-01 |
| TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE | 13 | 6.20e-01 | 0.079300 | 8.67e-01 |
| CELLULAR RESPONSE TO HEAT STRESS | 96 | 1.80e-01 | -0.079200 | 5.38e-01 |
| TIE2 SIGNALING | 17 | 5.72e-01 | -0.079100 | 8.38e-01 |
| TRANSCRIPTIONAL REGULATION BY E2F6 | 34 | 4.25e-01 | -0.079000 | 7.66e-01 |
| DNA STRAND ELONGATION | 32 | 4.42e-01 | 0.078500 | 7.76e-01 |
| NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 26 | 4.89e-01 | 0.078400 | 8.01e-01 |
| ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA | 15 | 6.00e-01 | 0.078300 | 8.53e-01 |
| KILLING MECHANISMS | 10 | 6.69e-01 | 0.078200 | 8.86e-01 |
| METABOLISM OF AMINO ACIDS AND DERIVATIVES | 311 | 1.87e-02 | -0.077700 | 1.99e-01 |
| HIV LIFE CYCLE | 143 | 1.10e-01 | 0.077400 | 4.37e-01 |
| SELECTIVE AUTOPHAGY | 72 | 2.59e-01 | 0.076900 | 6.43e-01 |
| GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION | 32 | 4.52e-01 | -0.076900 | 7.83e-01 |
| FORMATION OF SENESCENCE ASSOCIATED HETEROCHROMATIN FOCI SAHF | 14 | 6.19e-01 | -0.076900 | 8.65e-01 |
| PI METABOLISM | 79 | 2.40e-01 | 0.076400 | 6.29e-01 |
| ABERRANT REGULATION OF MITOTIC EXIT IN CANCER DUE TO RB1 DEFECTS | 19 | 5.67e-01 | 0.075900 | 8.36e-01 |
| TRANSPORT OF BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | 60 | 3.09e-01 | -0.075900 | 6.89e-01 |
| RHOJ GTPASE CYCLE | 54 | 3.36e-01 | -0.075700 | 6.98e-01 |
| NEGATIVE REGULATION OF TCF DEPENDENT SIGNALING BY WNT LIGAND ANTAGONISTS | 11 | 6.65e-01 | -0.075500 | 8.86e-01 |
| SIGNALING BY ERBB2 | 48 | 3.66e-01 | -0.075400 | 7.27e-01 |
| SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | 18 | 5.80e-01 | 0.075300 | 8.41e-01 |
| MYD88 INDEPENDENT TLR4 CASCADE | 93 | 2.11e-01 | -0.075100 | 5.85e-01 |
| YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | 11 | 6.67e-01 | -0.074900 | 8.86e-01 |
| TRIGLYCERIDE METABOLISM | 22 | 5.44e-01 | -0.074800 | 8.27e-01 |
| CRISTAE FORMATION | 31 | 4.71e-01 | -0.074800 | 7.88e-01 |
| ASPARTATE AND ASPARAGINE METABOLISM | 11 | 6.68e-01 | 0.074700 | 8.86e-01 |
| CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE | 49 | 3.66e-01 | -0.074700 | 7.27e-01 |
| TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | 77 | 2.57e-01 | 0.074700 | 6.43e-01 |
| CHROMOSOME MAINTENANCE | 103 | 1.91e-01 | -0.074600 | 5.51e-01 |
| SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS | 58 | 3.30e-01 | 0.074000 | 6.94e-01 |
| BRANCHED CHAIN AMINO ACID CATABOLISM | 21 | 5.60e-01 | -0.073500 | 8.34e-01 |
| TELOMERE MAINTENANCE | 79 | 2.60e-01 | -0.073300 | 6.43e-01 |
| REGULATION OF PTEN GENE TRANSCRIPTION | 59 | 3.30e-01 | 0.073300 | 6.94e-01 |
| INSULIN PROCESSING | 24 | 5.36e-01 | 0.073000 | 8.25e-01 |
| INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | 34 | 4.63e-01 | 0.072700 | 7.88e-01 |
| ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | 64 | 3.16e-01 | 0.072500 | 6.92e-01 |
| G2 M CHECKPOINTS | 135 | 1.47e-01 | -0.072400 | 4.91e-01 |
| AQUAPORIN MEDIATED TRANSPORT | 39 | 4.36e-01 | 0.072100 | 7.74e-01 |
| LYSOSPHINGOLIPID AND LPA RECEPTORS | 12 | 6.66e-01 | -0.072000 | 8.86e-01 |
| TRNA AMINOACYLATION | 42 | 4.20e-01 | 0.072000 | 7.60e-01 |
| SYNTHESIS OF PC | 26 | 5.29e-01 | -0.071400 | 8.22e-01 |
| APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | 34 | 4.72e-01 | -0.071300 | 7.88e-01 |
| KERATAN SULFATE BIOSYNTHESIS | 24 | 5.46e-01 | 0.071300 | 8.28e-01 |
| REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS | 12 | 6.69e-01 | -0.071200 | 8.86e-01 |
| DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | 26 | 5.31e-01 | -0.070900 | 8.22e-01 |
| CD28 DEPENDENT PI3K AKT SIGNALING | 20 | 5.83e-01 | 0.070900 | 8.41e-01 |
| PINK1 PRKN MEDIATED MITOPHAGY | 22 | 5.65e-01 | 0.070900 | 8.35e-01 |
| PI3K AKT SIGNALING IN CANCER | 89 | 2.49e-01 | -0.070800 | 6.35e-01 |
| RHOA GTPASE CYCLE | 143 | 1.45e-01 | -0.070600 | 4.91e-01 |
| CARGO RECOGNITION FOR CLATHRIN MEDIATED ENDOCYTOSIS | 94 | 2.37e-01 | 0.070600 | 6.28e-01 |
| TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS | 54 | 3.72e-01 | 0.070300 | 7.29e-01 |
| GAP FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG NER | 25 | 5.44e-01 | 0.070200 | 8.27e-01 |
| REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | 15 | 6.40e-01 | 0.069800 | 8.76e-01 |
| MET PROMOTES CELL MOTILITY | 39 | 4.51e-01 | -0.069800 | 7.83e-01 |
| INTRA GOLGI AND RETROGRADE GOLGI TO ER TRAFFIC | 185 | 1.02e-01 | 0.069700 | 4.27e-01 |
| BASE EXCISION REPAIR AP SITE FORMATION | 30 | 5.09e-01 | -0.069700 | 8.09e-01 |
| NICOTINATE METABOLISM | 26 | 5.42e-01 | 0.069100 | 8.27e-01 |
| INTERLEUKIN 12 SIGNALING | 37 | 4.68e-01 | -0.068900 | 7.88e-01 |
| TRANSCRIPTION OF THE HIV GENOME | 67 | 3.31e-01 | 0.068700 | 6.94e-01 |
| RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | 125 | 1.87e-01 | -0.068400 | 5.48e-01 |
| UB SPECIFIC PROCESSING PROTEASES | 168 | 1.27e-01 | -0.068300 | 4.69e-01 |
| INTERACTIONS OF REV WITH HOST CELLULAR PROTEINS | 35 | 4.86e-01 | 0.068000 | 7.98e-01 |
| FCGAMMA RECEPTOR FCGR DEPENDENT PHAGOCYTOSIS | 83 | 2.85e-01 | 0.067900 | 6.70e-01 |
| SMOOTH MUSCLE CONTRACTION | 32 | 5.07e-01 | -0.067800 | 8.08e-01 |
| TNF RECEPTOR SUPERFAMILY TNFSF MEMBERS MEDIATING NON CANONICAL NF KB PATHWAY | 12 | 6.85e-01 | -0.067600 | 8.98e-01 |
| RNA POLYMERASE III TRANSCRIPTION | 41 | 4.57e-01 | 0.067100 | 7.88e-01 |
| RRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 59 | 3.74e-01 | 0.067000 | 7.29e-01 |
| NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | 13 | 6.76e-01 | -0.066900 | 8.92e-01 |
| CELLULAR RESPONSE TO STARVATION | 146 | 1.64e-01 | -0.066900 | 5.16e-01 |
| NR1H3 NR1H2 REGULATE GENE EXPRESSION LINKED TO CHOLESTEROL TRANSPORT AND EFFLUX | 33 | 5.07e-01 | -0.066700 | 8.08e-01 |
| PCP CE PATHWAY | 89 | 2.78e-01 | 0.066600 | 6.59e-01 |
| SIGNAL AMPLIFICATION | 29 | 5.38e-01 | -0.066000 | 8.26e-01 |
| REGULATION OF TP53 EXPRESSION AND DEGRADATION | 35 | 4.99e-01 | -0.066000 | 8.06e-01 |
| DNA DOUBLE STRAND BREAK RESPONSE | 53 | 4.07e-01 | -0.065900 | 7.51e-01 |
| SIGNALING BY WNT IN CANCER | 31 | 5.27e-01 | -0.065700 | 8.22e-01 |
| ASSEMBLY OF THE HIV VIRION | 16 | 6.49e-01 | 0.065700 | 8.80e-01 |
| NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 11 | 7.06e-01 | -0.065700 | 9.09e-01 |
| OXIDATIVE STRESS INDUCED SENESCENCE | 79 | 3.13e-01 | -0.065600 | 6.92e-01 |
| SIGNALING BY TGF BETA RECEPTOR COMPLEX | 72 | 3.41e-01 | -0.064900 | 7.02e-01 |
| EPHB MEDIATED FORWARD SIGNALING | 42 | 4.67e-01 | 0.064800 | 7.88e-01 |
| CLEC7A DECTIN 1 SIGNALING | 93 | 2.80e-01 | -0.064800 | 6.65e-01 |
| MEMBRANE TRAFFICKING | 579 | 7.95e-03 | 0.064800 | 1.26e-01 |
| REGULATION OF BETA CELL DEVELOPMENT | 25 | 5.76e-01 | -0.064700 | 8.40e-01 |
| MRNA SPLICING | 188 | 1.27e-01 | 0.064600 | 4.69e-01 |
| PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | 237 | 8.79e-02 | 0.064400 | 3.97e-01 |
| GLUCAGON SIGNALING IN METABOLIC REGULATION | 29 | 5.48e-01 | 0.064400 | 8.30e-01 |
| DNA REPAIR | 295 | 5.90e-02 | 0.064000 | 3.29e-01 |
| G ALPHA I SIGNALLING EVENTS | 193 | 1.26e-01 | 0.063900 | 4.69e-01 |
| COPII MEDIATED VESICLE TRANSPORT | 65 | 3.77e-01 | 0.063400 | 7.30e-01 |
| HIV INFECTION | 222 | 1.05e-01 | 0.063200 | 4.27e-01 |
| COMPLEX I BIOGENESIS | 56 | 4.14e-01 | -0.063100 | 7.55e-01 |
| NOTCH HLH TRANSCRIPTION PATHWAY | 28 | 5.64e-01 | -0.063000 | 8.35e-01 |
| SIGNALING BY WNT | 267 | 7.82e-02 | -0.062700 | 3.69e-01 |
| REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION | 85 | 3.19e-01 | 0.062600 | 6.92e-01 |
| BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS SPMS | 11 | 7.20e-01 | -0.062500 | 9.15e-01 |
| TRANSFERRIN ENDOCYTOSIS AND RECYCLING | 26 | 5.83e-01 | 0.062200 | 8.41e-01 |
| RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | 105 | 2.73e-01 | -0.061900 | 6.55e-01 |
| RHOD GTPASE CYCLE | 49 | 4.54e-01 | 0.061800 | 7.84e-01 |
| ACTIVATION OF GENE EXPRESSION BY SREBF SREBP | 43 | 4.85e-01 | -0.061500 | 7.98e-01 |
| SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | 31 | 5.54e-01 | -0.061500 | 8.32e-01 |
| RND3 GTPASE CYCLE | 38 | 5.16e-01 | -0.060900 | 8.16e-01 |
| APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | 21 | 6.30e-01 | 0.060800 | 8.71e-01 |
| COSTIMULATION BY THE CD28 FAMILY | 49 | 4.62e-01 | -0.060800 | 7.88e-01 |
| WNT LIGAND BIOGENESIS AND TRAFFICKING | 20 | 6.40e-01 | 0.060400 | 8.76e-01 |
| EGR2 AND SOX10 MEDIATED INITIATION OF SCHWANN CELL MYELINATION | 27 | 5.89e-01 | -0.060100 | 8.46e-01 |
| COLLAGEN CHAIN TRIMERIZATION | 39 | 5.17e-01 | 0.060000 | 8.16e-01 |
| HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR | 48 | 4.72e-01 | -0.060000 | 7.88e-01 |
| SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | 11 | 7.32e-01 | 0.059700 | 9.23e-01 |
| RAB REGULATION OF TRAFFICKING | 117 | 2.66e-01 | 0.059600 | 6.48e-01 |
| REGULATION OF LIPID METABOLISM BY PPARALPHA | 109 | 2.83e-01 | 0.059600 | 6.69e-01 |
| BETA CATENIN PHOSPHORYLATION CASCADE | 16 | 6.80e-01 | 0.059600 | 8.93e-01 |
| ACYL CHAIN REMODELLING OF PE | 16 | 6.80e-01 | 0.059500 | 8.93e-01 |
| AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | 14 | 7.01e-01 | 0.059200 | 9.07e-01 |
| INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | 29 | 5.82e-01 | -0.059100 | 8.41e-01 |
| HDMS DEMETHYLATE HISTONES | 28 | 5.89e-01 | -0.059000 | 8.46e-01 |
| SIGNAL REGULATORY PROTEIN FAMILY INTERACTIONS | 11 | 7.36e-01 | 0.058800 | 9.24e-01 |
| CARGO CONCENTRATION IN THE ER | 30 | 5.78e-01 | -0.058700 | 8.41e-01 |
| ARACHIDONIC ACID METABOLISM | 38 | 5.32e-01 | -0.058600 | 8.22e-01 |
| MITOTIC G2 G2 M PHASES | 184 | 1.73e-01 | 0.058300 | 5.31e-01 |
| NEGATIVE REGULATION OF THE PI3K AKT NETWORK | 94 | 3.30e-01 | -0.058200 | 6.94e-01 |
| INTERLEUKIN 3 INTERLEUKIN 5 AND GM CSF SIGNALING | 41 | 5.19e-01 | -0.058200 | 8.17e-01 |
| FANCONI ANEMIA PATHWAY | 36 | 5.47e-01 | 0.058000 | 8.29e-01 |
| TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53 DEPENDENT APOPTOSIS REMAIN UNCERTAIN | 12 | 7.28e-01 | 0.058000 | 9.20e-01 |
| RESPIRATORY ELECTRON TRANSPORT | 102 | 3.13e-01 | -0.057900 | 6.92e-01 |
| ATF4 ACTIVATES GENES IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 23 | 6.32e-01 | 0.057600 | 8.71e-01 |
| HATS ACETYLATE HISTONES | 93 | 3.38e-01 | 0.057500 | 7.00e-01 |
| SIGNALING BY FGFR IN DISEASE | 55 | 4.62e-01 | -0.057300 | 7.88e-01 |
| COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 26 | 6.14e-01 | -0.057200 | 8.61e-01 |
| AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | 25 | 6.23e-01 | 0.056800 | 8.67e-01 |
| BETA OXIDATION OF VERY LONG CHAIN FATTY ACIDS | 11 | 7.46e-01 | 0.056400 | 9.25e-01 |
| INSULIN RECEPTOR SIGNALLING CASCADE | 42 | 5.28e-01 | -0.056400 | 8.22e-01 |
| DEUBIQUITINATION | 242 | 1.33e-01 | -0.056200 | 4.75e-01 |
| TCR SIGNALING | 100 | 3.34e-01 | -0.055900 | 6.97e-01 |
| DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN METABOLISM | 39 | 5.46e-01 | 0.055900 | 8.28e-01 |
| PLASMA LIPOPROTEIN ASSEMBLY REMODELING AND CLEARANCE | 51 | 4.93e-01 | 0.055500 | 8.01e-01 |
| ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | 37 | 5.60e-01 | 0.055400 | 8.34e-01 |
| DISEASES OF MITOTIC CELL CYCLE | 37 | 5.62e-01 | 0.055100 | 8.34e-01 |
| SIGNALING BY ERYTHROPOIETIN | 24 | 6.41e-01 | -0.055000 | 8.76e-01 |
| CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | 74 | 4.15e-01 | 0.054800 | 7.55e-01 |
| COOPERATION OF PDCL PHLP1 AND TRIC CCT IN G PROTEIN BETA FOLDING | 34 | 5.81e-01 | -0.054700 | 8.41e-01 |
| VESICLE MEDIATED TRANSPORT | 609 | 2.19e-02 | 0.054600 | 2.10e-01 |
| CITRIC ACID CYCLE TCA CYCLE | 22 | 6.58e-01 | 0.054600 | 8.86e-01 |
| NF KB IS ACTIVATED AND SIGNALS SURVIVAL | 13 | 7.34e-01 | -0.054500 | 9.24e-01 |
| GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION | 24 | 6.45e-01 | 0.054300 | 8.77e-01 |
| RHO GTPASES ACTIVATE PAKS | 21 | 6.68e-01 | 0.054100 | 8.86e-01 |
| ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE | 96 | 3.60e-01 | 0.054100 | 7.24e-01 |
| CYCLIN D ASSOCIATED EVENTS IN G1 | 45 | 5.31e-01 | -0.054100 | 8.22e-01 |
| OTHER SEMAPHORIN INTERACTIONS | 19 | 6.86e-01 | -0.053700 | 8.98e-01 |
| SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | 12 | 7.50e-01 | -0.053100 | 9.27e-01 |
| INOSITOL PHOSPHATE METABOLISM | 47 | 5.29e-01 | 0.053100 | 8.22e-01 |
| PLATELET AGGREGATION PLUG FORMATION | 33 | 5.99e-01 | -0.052900 | 8.53e-01 |
| CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER | 26 | 6.41e-01 | 0.052800 | 8.76e-01 |
| RESOLUTION OF D LOOP STRUCTURES | 31 | 6.11e-01 | -0.052800 | 8.58e-01 |
| INTERLEUKIN 1 FAMILY SIGNALING | 123 | 3.15e-01 | -0.052500 | 6.92e-01 |
| TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | 32 | 6.09e-01 | -0.052300 | 8.57e-01 |
| PKA MEDIATED PHOSPHORYLATION OF CREB | 19 | 6.94e-01 | 0.052200 | 9.04e-01 |
| SIGNALING BY GPCR | 475 | 5.25e-02 | 0.052100 | 3.09e-01 |
| SIGNALING BY ROBO RECEPTORS | 207 | 1.99e-01 | -0.051800 | 5.64e-01 |
| GLUCAGON TYPE LIGAND RECEPTORS | 24 | 6.61e-01 | 0.051700 | 8.86e-01 |
| HYALURONAN UPTAKE AND DEGRADATION | 11 | 7.67e-01 | 0.051700 | 9.39e-01 |
| TRANSCRIPTIONAL REGULATION BY RUNX3 | 94 | 3.87e-01 | -0.051600 | 7.42e-01 |
| G1 S DNA DAMAGE CHECKPOINTS | 65 | 4.72e-01 | -0.051600 | 7.88e-01 |
| INTERLEUKIN 2 FAMILY SIGNALING | 34 | 6.03e-01 | -0.051500 | 8.54e-01 |
| VISUAL PHOTOTRANSDUCTION | 61 | 4.87e-01 | -0.051500 | 7.98e-01 |
| IRON UPTAKE AND TRANSPORT | 52 | 5.22e-01 | -0.051300 | 8.19e-01 |
| CA2 PATHWAY | 55 | 5.14e-01 | -0.050900 | 8.15e-01 |
| POLYMERASE SWITCHING | 14 | 7.42e-01 | 0.050800 | 9.25e-01 |
| SUMOYLATION OF TRANSCRIPTION COFACTORS | 42 | 5.71e-01 | 0.050600 | 8.38e-01 |
| CELLULAR SENESCENCE | 143 | 2.98e-01 | -0.050500 | 6.78e-01 |
| OTHER INTERLEUKIN SIGNALING | 20 | 6.99e-01 | 0.050000 | 9.06e-01 |
| HOMOLOGY DIRECTED REPAIR | 110 | 3.69e-01 | -0.049600 | 7.29e-01 |
| RUNX1 INTERACTS WITH CO FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN | 37 | 6.02e-01 | 0.049600 | 8.54e-01 |
| ADORA2B MEDIATED ANTI INFLAMMATORY CYTOKINES PRODUCTION | 91 | 4.15e-01 | 0.049500 | 7.55e-01 |
| RMTS METHYLATE HISTONE ARGININES | 44 | 5.71e-01 | -0.049300 | 8.38e-01 |
| RAS PROCESSING | 24 | 6.77e-01 | -0.049100 | 8.92e-01 |
| HEDGEHOG ON STATE | 82 | 4.43e-01 | -0.049000 | 7.76e-01 |
| MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | 15 | 7.43e-01 | 0.048900 | 9.25e-01 |
| GLYCOSPHINGOLIPID METABOLISM | 38 | 6.02e-01 | 0.048900 | 8.54e-01 |
| THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | 172 | 2.70e-01 | -0.048800 | 6.52e-01 |
| LDL CLEARANCE | 16 | 7.37e-01 | 0.048600 | 9.24e-01 |
| STIMULI SENSING CHANNELS | 75 | 4.71e-01 | 0.048200 | 7.88e-01 |
| METABOLISM OF WATER SOLUBLE VITAMINS AND COFACTORS | 103 | 4.02e-01 | 0.047800 | 7.51e-01 |
| RAC1 GTPASE CYCLE | 177 | 2.77e-01 | -0.047400 | 6.59e-01 |
| GENE SILENCING BY RNA | 87 | 4.47e-01 | -0.047200 | 7.79e-01 |
| POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION | 26 | 6.77e-01 | 0.047200 | 8.92e-01 |
| NON INTEGRIN MEMBRANE ECM INTERACTIONS | 56 | 5.43e-01 | -0.047000 | 8.27e-01 |
| SIGNALING BY FGFR2 IN DISEASE | 36 | 6.27e-01 | -0.046800 | 8.69e-01 |
| DEGRADATION OF THE EXTRACELLULAR MATRIX | 106 | 4.05e-01 | 0.046800 | 7.51e-01 |
| SIGNALING BY NOTCH | 189 | 2.68e-01 | -0.046800 | 6.51e-01 |
| METABOLISM OF NUCLEOTIDES | 92 | 4.38e-01 | 0.046800 | 7.74e-01 |
| PHOSPHOLIPID METABOLISM | 187 | 2.71e-01 | 0.046800 | 6.52e-01 |
| BASE EXCISION REPAIR | 58 | 5.38e-01 | 0.046700 | 8.26e-01 |
| POLO LIKE KINASE MEDIATED EVENTS | 14 | 7.62e-01 | 0.046700 | 9.37e-01 |
| TRP CHANNELS | 19 | 7.26e-01 | -0.046500 | 9.18e-01 |
| REGULATION OF SIGNALING BY CBL | 22 | 7.06e-01 | -0.046500 | 9.09e-01 |
| ABC TRANSPORTERS IN LIPID HOMEOSTASIS | 13 | 7.72e-01 | 0.046500 | 9.43e-01 |
| CELLULAR RESPONSES TO EXTERNAL STIMULI | 601 | 5.38e-02 | -0.046200 | 3.10e-01 |
| ONCOGENIC MAPK SIGNALING | 77 | 4.83e-01 | 0.046200 | 7.96e-01 |
| SIGNALLING TO ERKS | 33 | 6.47e-01 | -0.046000 | 8.79e-01 |
| CILIUM ASSEMBLY | 189 | 2.76e-01 | 0.046000 | 6.59e-01 |
| TRANSCRIPTIONAL REGULATION BY RUNX1 | 177 | 2.92e-01 | -0.046000 | 6.76e-01 |
| METABOLISM OF RNA | 645 | 4.75e-02 | 0.045900 | 2.99e-01 |
| TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | 82 | 4.73e-01 | 0.045900 | 7.88e-01 |
| MITOCHONDRIAL PROTEIN IMPORT | 63 | 5.30e-01 | 0.045800 | 8.22e-01 |
| TNFR2 NON CANONICAL NF KB PATHWAY | 79 | 4.82e-01 | -0.045700 | 7.96e-01 |
| G BETA GAMMA SIGNALLING THROUGH CDC42 | 18 | 7.39e-01 | 0.045300 | 9.25e-01 |
| DEGRADATION OF DVL | 55 | 5.62e-01 | 0.045200 | 8.34e-01 |
| FC EPSILON RECEPTOR FCERI SIGNALING | 122 | 3.92e-01 | -0.044900 | 7.45e-01 |
| RAF INDEPENDENT MAPK1 3 ACTIVATION | 21 | 7.22e-01 | 0.044900 | 9.16e-01 |
| SUMOYLATION OF IMMUNE RESPONSE PROTEINS | 11 | 7.98e-01 | -0.044500 | 9.58e-01 |
| RHO GTPASE CYCLE | 426 | 1.17e-01 | -0.044400 | 4.54e-01 |
| G ALPHA 12 13 SIGNALLING EVENTS | 75 | 5.06e-01 | 0.044400 | 8.08e-01 |
| ONCOGENE INDUCED SENESCENCE | 32 | 6.64e-01 | -0.044400 | 8.86e-01 |
| TRANSCRIPTIONAL REGULATION BY TP53 | 342 | 1.62e-01 | 0.044100 | 5.15e-01 |
| NEGATIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 65 | 5.44e-01 | -0.043600 | 8.27e-01 |
| PROLONGED ERK ACTIVATION EVENTS | 14 | 7.79e-01 | 0.043400 | 9.47e-01 |
| MITOTIC METAPHASE AND ANAPHASE | 208 | 2.85e-01 | 0.043100 | 6.70e-01 |
| SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE | 86 | 4.90e-01 | 0.043100 | 8.01e-01 |
| ORGANELLE BIOGENESIS AND MAINTENANCE | 281 | 2.15e-01 | 0.043000 | 5.91e-01 |
| PROCESSIVE SYNTHESIS ON THE C STRAND OF THE TELOMERE | 19 | 7.46e-01 | -0.043000 | 9.25e-01 |
| HOST INTERACTIONS OF HIV FACTORS | 126 | 4.06e-01 | 0.042900 | 7.51e-01 |
| PLASMA LIPOPROTEIN CLEARANCE | 27 | 7.01e-01 | 0.042800 | 9.07e-01 |
| P75 NTR RECEPTOR MEDIATED SIGNALLING | 95 | 4.73e-01 | 0.042600 | 7.88e-01 |
| METABOLISM OF STEROIDS | 112 | 4.38e-01 | -0.042500 | 7.74e-01 |
| PRE NOTCH PROCESSING IN GOLGI | 17 | 7.62e-01 | 0.042400 | 9.37e-01 |
| SIGNALING BY BRAF AND RAF FUSIONS | 60 | 5.72e-01 | 0.042200 | 8.38e-01 |
| CYTOSOLIC TRNA AMINOACYLATION | 24 | 7.20e-01 | 0.042200 | 9.15e-01 |
| TRANSPORT OF SMALL MOLECULES | 566 | 8.90e-02 | 0.042000 | 3.97e-01 |
| G ALPHA Z SIGNALLING EVENTS | 45 | 6.28e-01 | 0.041800 | 8.69e-01 |
| NERVOUS SYSTEM DEVELOPMENT | 545 | 1.01e-01 | 0.041200 | 4.26e-01 |
| NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 48 | 6.23e-01 | -0.041000 | 8.67e-01 |
| DISEASES OF METABOLISM | 197 | 3.23e-01 | 0.040900 | 6.93e-01 |
| LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS | 19 | 7.58e-01 | 0.040900 | 9.35e-01 |
| REGULATION OF TP53 ACTIVITY | 151 | 3.89e-01 | 0.040700 | 7.42e-01 |
| APC C MEDIATED DEGRADATION OF CELL CYCLE PROTEINS | 82 | 5.25e-01 | 0.040600 | 8.22e-01 |
| GABA B RECEPTOR ACTIVATION | 39 | 6.61e-01 | 0.040600 | 8.86e-01 |
| ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS | 23 | 7.36e-01 | -0.040600 | 9.24e-01 |
| HDR THROUGH SINGLE STRAND ANNEALING SSA | 37 | 6.70e-01 | -0.040400 | 8.86e-01 |
| DISEASES ASSOCIATED WITH O GLYCOSYLATION OF PROTEINS | 49 | 6.25e-01 | -0.040300 | 8.68e-01 |
| DISEASES OF SIGNAL TRANSDUCTION BY GROWTH FACTOR RECEPTORS AND SECOND MESSENGERS | 366 | 1.87e-01 | -0.040300 | 5.48e-01 |
| SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER | 59 | 5.93e-01 | -0.040300 | 8.47e-01 |
| HEDGEHOG LIGAND BIOGENESIS | 61 | 5.90e-01 | -0.039900 | 8.46e-01 |
| GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | 16 | 7.85e-01 | -0.039300 | 9.51e-01 |
| SIGNALING BY KIT IN DISEASE | 20 | 7.61e-01 | -0.039200 | 9.37e-01 |
| MITOTIC PROMETAPHASE | 178 | 3.71e-01 | 0.038900 | 7.29e-01 |
| ALPHA PROTEIN KINASE 1 SIGNALING PATHWAY | 11 | 8.23e-01 | -0.038900 | 9.65e-01 |
| SIGNALING BY FGFR4 | 32 | 7.06e-01 | -0.038600 | 9.09e-01 |
| FGFR2 MUTANT RECEPTOR ACTIVATION | 26 | 7.34e-01 | 0.038400 | 9.24e-01 |
| PERK REGULATES GENE EXPRESSION | 28 | 7.26e-01 | -0.038300 | 9.18e-01 |
| ACTIVATION OF RAC1 | 13 | 8.11e-01 | -0.038300 | 9.62e-01 |
| TRANSCRIPTIONAL REGULATION BY SMALL RNAS | 62 | 6.04e-01 | -0.038100 | 8.54e-01 |
| FOXO MEDIATED TRANSCRIPTION OF OXIDATIVE STRESS METABOLIC AND NEURONAL GENES | 24 | 7.47e-01 | -0.038100 | 9.25e-01 |
| ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | 74 | 5.73e-01 | 0.037900 | 8.38e-01 |
| SLC TRANSPORTER DISORDERS | 68 | 5.92e-01 | 0.037600 | 8.47e-01 |
| SIALIC ACID METABOLISM | 32 | 7.14e-01 | 0.037500 | 9.12e-01 |
| O LINKED GLYCOSYLATION OF MUCINS | 41 | 6.78e-01 | 0.037400 | 8.92e-01 |
| PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | 16 | 7.96e-01 | 0.037400 | 9.57e-01 |
| DEVELOPMENTAL BIOLOGY | 808 | 7.78e-02 | 0.036700 | 3.68e-01 |
| M PHASE | 342 | 2.47e-01 | 0.036500 | 6.35e-01 |
| MITOCHONDRIAL BIOGENESIS | 92 | 5.51e-01 | 0.036000 | 8.32e-01 |
| SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | 16 | 8.05e-01 | 0.035600 | 9.61e-01 |
| CELL CELL JUNCTION ORGANIZATION | 48 | 6.70e-01 | -0.035600 | 8.86e-01 |
| POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 63 | 6.26e-01 | -0.035500 | 8.68e-01 |
| METABOLISM OF FOLATE AND PTERINES | 15 | 8.12e-01 | 0.035500 | 9.62e-01 |
| ABC FAMILY PROTEINS MEDIATED TRANSPORT | 94 | 5.55e-01 | 0.035300 | 8.32e-01 |
| CELL CYCLE CHECKPOINTS | 245 | 3.48e-01 | -0.034800 | 7.09e-01 |
| TRANSLATION OF SARS COV 1 STRUCTURAL PROTEINS | 28 | 7.50e-01 | 0.034800 | 9.27e-01 |
| SENSORY PERCEPTION | 151 | 4.64e-01 | -0.034500 | 7.88e-01 |
| MITOCHONDRIAL TRANSLATION | 93 | 5.65e-01 | -0.034500 | 8.35e-01 |
| GABA RECEPTOR ACTIVATION | 53 | 6.64e-01 | -0.034500 | 8.86e-01 |
| REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS | 12 | 8.36e-01 | 0.034500 | 9.70e-01 |
| DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | 13 | 8.30e-01 | -0.034300 | 9.69e-01 |
| SIGNALING BY NOTCH1 | 75 | 6.09e-01 | -0.034200 | 8.57e-01 |
| METABOLISM OF POLYAMINES | 57 | 6.62e-01 | 0.033500 | 8.86e-01 |
| TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES | 45 | 6.98e-01 | 0.033500 | 9.06e-01 |
| APOPTOSIS | 164 | 4.63e-01 | -0.033300 | 7.88e-01 |
| INTERLEUKIN 17 SIGNALING | 66 | 6.41e-01 | 0.033200 | 8.76e-01 |
| RNA POLYMERASE II TRANSCRIBES SNRNA GENES | 74 | 6.21e-01 | 0.033200 | 8.67e-01 |
| FLT3 SIGNALING IN DISEASE | 27 | 7.66e-01 | -0.033100 | 9.39e-01 |
| SARS COV INFECTIONS | 140 | 5.00e-01 | 0.033000 | 8.06e-01 |
| TP53 REGULATES METABOLIC GENES | 85 | 6.01e-01 | -0.032800 | 8.54e-01 |
| PREGNENOLONE BIOSYNTHESIS | 12 | 8.44e-01 | -0.032800 | 9.71e-01 |
| EXTRACELLULAR MATRIX ORGANIZATION | 241 | 3.88e-01 | -0.032300 | 7.42e-01 |
| GLUTATHIONE CONJUGATION | 29 | 7.64e-01 | -0.032200 | 9.38e-01 |
| THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT | 66 | 6.53e-01 | 0.032100 | 8.81e-01 |
| DISORDERS OF TRANSMEMBRANE TRANSPORTERS | 137 | 5.20e-01 | 0.031900 | 8.17e-01 |
| HCMV INFECTION | 104 | 5.75e-01 | 0.031800 | 8.40e-01 |
| CTLA4 INHIBITORY SIGNALING | 20 | 8.07e-01 | -0.031600 | 9.62e-01 |
| APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | 70 | 6.50e-01 | 0.031400 | 8.80e-01 |
| RORA ACTIVATES GENE EXPRESSION | 18 | 8.18e-01 | -0.031300 | 9.64e-01 |
| MYOGENESIS | 24 | 7.91e-01 | 0.031300 | 9.54e-01 |
| INTRINSIC PATHWAY FOR APOPTOSIS | 52 | 6.97e-01 | 0.031200 | 9.06e-01 |
| SIGNALING BY MET | 75 | 6.44e-01 | -0.030800 | 8.77e-01 |
| DEATH RECEPTOR SIGNALLING | 134 | 5.38e-01 | 0.030800 | 8.26e-01 |
| RND2 GTPASE CYCLE | 38 | 7.43e-01 | -0.030800 | 9.25e-01 |
| SIGNALING BY EGFR | 47 | 7.16e-01 | -0.030700 | 9.14e-01 |
| THE PHOTOTRANSDUCTION CASCADE | 21 | 8.08e-01 | 0.030600 | 9.62e-01 |
| ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS | 17 | 8.27e-01 | 0.030600 | 9.66e-01 |
| THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | 21 | 8.09e-01 | 0.030500 | 9.62e-01 |
| CELL CELL COMMUNICATION | 105 | 5.91e-01 | -0.030400 | 8.46e-01 |
| METABOLISM OF STEROID HORMONES | 20 | 8.14e-01 | -0.030400 | 9.62e-01 |
| STABILIZATION OF P53 | 54 | 7.03e-01 | -0.030000 | 9.08e-01 |
| UPTAKE AND FUNCTION OF ANTHRAX TOXINS | 11 | 8.63e-01 | -0.030000 | 9.76e-01 |
| DNA REPLICATION | 122 | 5.69e-01 | 0.029900 | 8.38e-01 |
| TNFR1 INDUCED NFKAPPAB SIGNALING PATHWAY | 29 | 7.83e-01 | 0.029600 | 9.49e-01 |
| HIV TRANSCRIPTION INITIATION | 45 | 7.32e-01 | 0.029500 | 9.23e-01 |
| SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | 52 | 7.13e-01 | 0.029500 | 9.12e-01 |
| MISCELLANEOUS TRANSPORT AND BINDING EVENTS | 20 | 8.23e-01 | 0.029000 | 9.65e-01 |
| TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST | 15 | 8.47e-01 | 0.028900 | 9.72e-01 |
| TICAM1 TRAF6 DEPENDENT INDUCTION OF TAK1 COMPLEX | 11 | 8.69e-01 | -0.028700 | 9.78e-01 |
| TELOMERE C STRAND SYNTHESIS INITIATION | 13 | 8.58e-01 | 0.028700 | 9.73e-01 |
| ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | 32 | 7.80e-01 | -0.028500 | 9.48e-01 |
| GAP JUNCTION ASSEMBLY | 21 | 8.22e-01 | -0.028400 | 9.65e-01 |
| POST TRANSLATIONAL PROTEIN MODIFICATION | 1210 | 9.90e-02 | 0.028400 | 4.19e-01 |
| RHO GTPASES ACTIVATE FORMINS | 119 | 5.94e-01 | 0.028300 | 8.47e-01 |
| NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | 17 | 8.40e-01 | -0.028300 | 9.70e-01 |
| SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | 59 | 7.08e-01 | 0.028300 | 9.10e-01 |
| CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION | 22 | 8.19e-01 | -0.028100 | 9.64e-01 |
| PTEN REGULATION | 134 | 5.76e-01 | 0.028000 | 8.40e-01 |
| TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST | 13 | 8.62e-01 | 0.027800 | 9.76e-01 |
| INLB MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL | 15 | 8.52e-01 | 0.027800 | 9.72e-01 |
| CD28 DEPENDENT VAV1 PATHWAY | 11 | 8.74e-01 | -0.027700 | 9.78e-01 |
| PLATELET ACTIVATION SIGNALING AND AGGREGATION | 222 | 4.78e-01 | -0.027700 | 7.92e-01 |
| PEPTIDE HORMONE METABOLISM | 59 | 7.13e-01 | -0.027700 | 9.12e-01 |
| REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | 84 | 6.63e-01 | 0.027500 | 8.86e-01 |
| METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS | 10 | 8.81e-01 | 0.027400 | 9.78e-01 |
| REGULATION OF KIT SIGNALING | 16 | 8.50e-01 | -0.027300 | 9.72e-01 |
| CIRCADIAN CLOCK | 68 | 6.98e-01 | 0.027200 | 9.06e-01 |
| PECAM1 INTERACTIONS | 12 | 8.71e-01 | -0.027100 | 9.78e-01 |
| KINESINS | 48 | 7.47e-01 | 0.026900 | 9.25e-01 |
| MAPK FAMILY SIGNALING CASCADES | 288 | 4.38e-01 | 0.026600 | 7.74e-01 |
| PROCESSING AND ACTIVATION OF SUMO | 10 | 8.85e-01 | 0.026400 | 9.78e-01 |
| INTERLEUKIN 1 SIGNALING | 95 | 6.58e-01 | -0.026300 | 8.86e-01 |
| CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | 34 | 7.91e-01 | 0.026300 | 9.54e-01 |
| GLYCEROPHOSPHOLIPID BIOSYNTHESIS | 109 | 6.36e-01 | 0.026200 | 8.76e-01 |
| HEDGEHOG OFF STATE | 106 | 6.41e-01 | 0.026200 | 8.76e-01 |
| SIGNALING BY LEPTIN | 10 | 8.86e-01 | -0.026100 | 9.78e-01 |
| ADHERENS JUNCTIONS INTERACTIONS | 30 | 8.05e-01 | 0.026100 | 9.61e-01 |
| ABC TRANSPORTER DISORDERS | 69 | 7.09e-01 | 0.026000 | 9.10e-01 |
| SIGNALING BY THE B CELL RECEPTOR BCR | 103 | 6.51e-01 | -0.025800 | 8.80e-01 |
| DNA REPLICATION PRE INITIATION | 80 | 6.91e-01 | 0.025700 | 9.03e-01 |
| O LINKED GLYCOSYLATION | 83 | 6.89e-01 | 0.025400 | 9.01e-01 |
| HCMV EARLY EVENTS | 81 | 6.94e-01 | -0.025300 | 9.04e-01 |
| SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS | 73 | 7.10e-01 | 0.025200 | 9.10e-01 |
| PLASMA LIPOPROTEIN ASSEMBLY | 13 | 8.75e-01 | -0.025200 | 9.78e-01 |
| ELASTIC FIBRE FORMATION | 37 | 7.93e-01 | -0.025000 | 9.54e-01 |
| SIGNALING BY FGFR1 | 43 | 7.82e-01 | -0.024400 | 9.49e-01 |
| LAGGING STRAND SYNTHESIS | 20 | 8.52e-01 | -0.024000 | 9.72e-01 |
| PHASE II CONJUGATION OF COMPOUNDS | 62 | 7.44e-01 | -0.024000 | 9.25e-01 |
| FERTILIZATION | 10 | 8.96e-01 | -0.023900 | 9.78e-01 |
| TRIGLYCERIDE CATABOLISM | 14 | 8.77e-01 | -0.023900 | 9.78e-01 |
| INTRACELLULAR SIGNALING BY SECOND MESSENGERS | 282 | 4.94e-01 | 0.023700 | 8.01e-01 |
| FGFR2 ALTERNATIVE SPLICING | 25 | 8.37e-01 | 0.023700 | 9.70e-01 |
| DNA DOUBLE STRAND BREAK REPAIR | 139 | 6.32e-01 | -0.023600 | 8.71e-01 |
| THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | 27 | 8.33e-01 | 0.023400 | 9.69e-01 |
| ELEVATION OF CYTOSOLIC CA2 LEVELS | 14 | 8.80e-01 | -0.023300 | 9.78e-01 |
| COLLAGEN FORMATION | 77 | 7.24e-01 | 0.023300 | 9.18e-01 |
| CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | 344 | 4.64e-01 | 0.023000 | 7.88e-01 |
| GAP JUNCTION TRAFFICKING AND REGULATION | 33 | 8.20e-01 | 0.023000 | 9.64e-01 |
| CLASS B 2 SECRETIN FAMILY RECEPTORS | 68 | 7.44e-01 | 0.022900 | 9.25e-01 |
| TRANSCRIPTIONAL REGULATION BY VENTX | 35 | 8.16e-01 | -0.022800 | 9.62e-01 |
| CYTOPROTECTION BY HMOX1 | 119 | 6.69e-01 | 0.022700 | 8.86e-01 |
| SIGNALING BY VEGF | 101 | 6.94e-01 | -0.022700 | 9.04e-01 |
| PEROXISOMAL LIPID METABOLISM | 26 | 8.42e-01 | -0.022600 | 9.71e-01 |
| PROGRAMMED CELL DEATH | 186 | 6.05e-01 | -0.022000 | 8.55e-01 |
| REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP SREBF | 56 | 7.76e-01 | -0.022000 | 9.46e-01 |
| BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION | 26 | 8.47e-01 | -0.021900 | 9.72e-01 |
| TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | 43 | 8.04e-01 | -0.021900 | 9.61e-01 |
| INFECTIOUS DISEASE | 734 | 3.17e-01 | -0.021800 | 6.92e-01 |
| CHEMOKINE RECEPTORS BIND CHEMOKINES | 13 | 8.92e-01 | 0.021700 | 9.78e-01 |
| TERMINATION OF O GLYCAN BIOSYNTHESIS | 10 | 9.06e-01 | -0.021700 | 9.81e-01 |
| UPTAKE AND ACTIONS OF BACTERIAL TOXINS | 28 | 8.43e-01 | -0.021600 | 9.71e-01 |
| MAP3K8 TPL2 DEPENDENT MAPK1 3 ACTIVATION | 16 | 8.81e-01 | 0.021600 | 9.78e-01 |
| NOTCH2 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 23 | 8.58e-01 | 0.021600 | 9.73e-01 |
| BETA CATENIN INDEPENDENT WNT SIGNALING | 137 | 6.64e-01 | 0.021500 | 8.86e-01 |
| SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL | 13 | 8.94e-01 | -0.021400 | 9.78e-01 |
| TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | 31 | 8.37e-01 | 0.021400 | 9.70e-01 |
| JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | 22 | 8.64e-01 | -0.021100 | 9.76e-01 |
| ADENYLATE CYCLASE INHIBITORY PATHWAY | 13 | 8.96e-01 | 0.020800 | 9.78e-01 |
| SIGNALING BY FGFR2 | 62 | 7.78e-01 | 0.020700 | 9.47e-01 |
| PYRUVATE METABOLISM | 27 | 8.54e-01 | -0.020400 | 9.72e-01 |
| G PROTEIN ACTIVATION | 21 | 8.73e-01 | 0.020200 | 9.78e-01 |
| CELL CYCLE MITOTIC | 477 | 4.58e-01 | 0.019900 | 7.88e-01 |
| SIGNALING BY RHO GTPASES MIRO GTPASES AND RHOBTB3 | 630 | 3.98e-01 | -0.019800 | 7.51e-01 |
| SIGNALING BY FGFR3 | 35 | 8.40e-01 | -0.019700 | 9.70e-01 |
| PLASMA LIPOPROTEIN REMODELING | 16 | 8.91e-01 | 0.019700 | 9.78e-01 |
| TOLL LIKE RECEPTOR TLR1 TLR2 CASCADE | 92 | 7.45e-01 | -0.019600 | 9.25e-01 |
| SEMAPHORIN INTERACTIONS | 64 | 7.87e-01 | -0.019500 | 9.53e-01 |
| G1 S SPECIFIC TRANSCRIPTION | 26 | 8.64e-01 | -0.019400 | 9.76e-01 |
| FCERI MEDIATED NF KB ACTIVATION | 76 | 7.71e-01 | -0.019300 | 9.42e-01 |
| MITOTIC SPINDLE CHECKPOINT | 98 | 7.42e-01 | 0.019300 | 9.25e-01 |
| MAPK6 MAPK4 SIGNALING | 83 | 7.68e-01 | -0.018700 | 9.40e-01 |
| TELOMERE C STRAND LAGGING STRAND SYNTHESIS | 33 | 8.53e-01 | 0.018700 | 9.72e-01 |
| METABOLISM OF FAT SOLUBLE VITAMINS | 33 | 8.54e-01 | -0.018600 | 9.72e-01 |
| ACTIVATION OF MATRIX METALLOPROTEINASES | 14 | 9.05e-01 | 0.018400 | 9.81e-01 |
| CHROMATIN MODIFYING ENZYMES | 219 | 6.45e-01 | 0.018100 | 8.77e-01 |
| NUCLEOBASE BIOSYNTHESIS | 15 | 9.04e-01 | -0.018000 | 9.81e-01 |
| RESPONSE OF MTB TO PHAGOCYTOSIS | 22 | 8.85e-01 | -0.017800 | 9.78e-01 |
| IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX | 10 | 9.23e-01 | -0.017700 | 9.87e-01 |
| TRANSCRIPTIONAL REGULATION BY THE AP 2 TFAP2 FAMILY OF TRANSCRIPTION FACTORS | 31 | 8.65e-01 | -0.017600 | 9.76e-01 |
| COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES | 61 | 8.12e-01 | 0.017600 | 9.62e-01 |
| CELL CYCLE | 595 | 4.68e-01 | 0.017500 | 7.88e-01 |
| TOLL LIKE RECEPTOR 9 TLR9 CASCADE | 91 | 7.74e-01 | -0.017400 | 9.44e-01 |
| CELLULAR RESPONSE TO HYPOXIA | 71 | 8.00e-01 | -0.017400 | 9.59e-01 |
| HEMOSTASIS | 474 | 5.19e-01 | -0.017400 | 8.17e-01 |
| CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT | 20 | 8.94e-01 | -0.017300 | 9.78e-01 |
| AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS | 10 | 9.26e-01 | 0.016900 | 9.87e-01 |
| PYROPTOSIS | 21 | 8.94e-01 | -0.016700 | 9.78e-01 |
| RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION | 23 | 8.90e-01 | -0.016600 | 9.78e-01 |
| UNFOLDED PROTEIN RESPONSE UPR | 85 | 7.92e-01 | -0.016600 | 9.54e-01 |
| FOXO MEDIATED TRANSCRIPTION OF CELL CYCLE GENES | 16 | 9.10e-01 | -0.016400 | 9.81e-01 |
| SUMOYLATION | 163 | 7.19e-01 | -0.016300 | 9.15e-01 |
| SEPARATION OF SISTER CHROMATIDS | 167 | 7.19e-01 | 0.016100 | 9.15e-01 |
| SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER | 15 | 9.15e-01 | 0.016000 | 9.84e-01 |
| MITOCHONDRIAL CALCIUM ION TRANSPORT | 23 | 8.95e-01 | 0.015800 | 9.78e-01 |
| PHASE I FUNCTIONALIZATION OF COMPOUNDS | 60 | 8.33e-01 | 0.015700 | 9.69e-01 |
| CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | 10 | 9.32e-01 | 0.015500 | 9.87e-01 |
| UCH PROTEINASES | 89 | 8.02e-01 | -0.015400 | 9.60e-01 |
| DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | 78 | 8.14e-01 | 0.015400 | 9.62e-01 |
| SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL | 26 | 8.94e-01 | 0.015100 | 9.78e-01 |
| RAB GERANYLGERANYLATION | 58 | 8.44e-01 | 0.014900 | 9.71e-01 |
| NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | 43 | 8.66e-01 | -0.014900 | 9.76e-01 |
| DOWNSTREAM SIGNAL TRANSDUCTION | 29 | 8.91e-01 | -0.014700 | 9.78e-01 |
| INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | 13 | 9.27e-01 | -0.014600 | 9.87e-01 |
| EPHRIN SIGNALING | 19 | 9.12e-01 | 0.014600 | 9.82e-01 |
| NEGATIVE REGULATION OF MET ACTIVITY | 21 | 9.08e-01 | -0.014600 | 9.81e-01 |
| DECTIN 1 MEDIATED NONCANONICAL NF KB SIGNALING | 58 | 8.49e-01 | 0.014500 | 9.72e-01 |
| FLT3 SIGNALING | 36 | 8.81e-01 | 0.014400 | 9.78e-01 |
| EPHA MEDIATED GROWTH CONE COLLAPSE | 27 | 8.97e-01 | -0.014400 | 9.78e-01 |
| POTENTIAL THERAPEUTICS FOR SARS | 77 | 8.30e-01 | -0.014200 | 9.69e-01 |
| PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | 12 | 9.34e-01 | -0.013900 | 9.87e-01 |
| NOTCH4 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 12 | 9.35e-01 | 0.013700 | 9.87e-01 |
| ASYMMETRIC LOCALIZATION OF PCP PROTEINS | 62 | 8.53e-01 | 0.013600 | 9.72e-01 |
| CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | 46 | 8.74e-01 | -0.013500 | 9.78e-01 |
| METABOLISM OF LIPIDS | 611 | 5.72e-01 | -0.013400 | 8.38e-01 |
| MATURATION OF SARS COV 2 SPIKE PROTEIN | 29 | 9.01e-01 | -0.013300 | 9.81e-01 |
| ORC1 REMOVAL FROM CHROMATIN | 67 | 8.54e-01 | 0.013000 | 9.72e-01 |
| SIGNALING BY INSULIN RECEPTOR | 61 | 8.63e-01 | 0.012800 | 9.76e-01 |
| FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | 119 | 8.13e-01 | 0.012600 | 9.62e-01 |
| METABOLISM OF VITAMINS AND COFACTORS | 153 | 7.89e-01 | 0.012600 | 9.53e-01 |
| G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | 23 | 9.18e-01 | -0.012400 | 9.86e-01 |
| PEPTIDE LIGAND BINDING RECEPTORS | 105 | 8.26e-01 | -0.012400 | 9.66e-01 |
| TRANSCRIPTIONAL REGULATION BY RUNX2 | 108 | 8.27e-01 | -0.012200 | 9.66e-01 |
| SIGNALING BY FLT3 ITD AND TKD MUTANTS | 15 | 9.37e-01 | 0.011800 | 9.87e-01 |
| RHOU GTPASE CYCLE | 33 | 9.08e-01 | 0.011600 | 9.81e-01 |
| SIGNALING BY NODAL | 15 | 9.39e-01 | -0.011500 | 9.87e-01 |
| SIGNALING BY NOTCH4 | 83 | 8.57e-01 | 0.011400 | 9.73e-01 |
| PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | 51 | 8.88e-01 | 0.011400 | 9.78e-01 |
| MITOTIC G1 PHASE AND G1 S TRANSITION | 142 | 8.16e-01 | -0.011300 | 9.62e-01 |
| REGULATION OF TNFR1 SIGNALING | 34 | 9.10e-01 | 0.011200 | 9.81e-01 |
| METAL ION SLC TRANSPORTERS | 24 | 9.25e-01 | -0.011200 | 9.87e-01 |
| RHO GTPASE EFFECTORS | 249 | 7.62e-01 | 0.011200 | 9.37e-01 |
| SIGNALING BY FGFR2 IIIA TM | 19 | 9.33e-01 | 0.011200 | 9.87e-01 |
| CLASS A 1 RHODOPSIN LIKE RECEPTORS | 180 | 7.97e-01 | -0.011100 | 9.58e-01 |
| IRE1ALPHA ACTIVATES CHAPERONES | 49 | 8.94e-01 | 0.011000 | 9.78e-01 |
| FOXO MEDIATED TRANSCRIPTION | 58 | 8.87e-01 | -0.010700 | 9.78e-01 |
| GLUTATHIONE SYNTHESIS AND RECYCLING | 11 | 9.52e-01 | -0.010400 | 9.87e-01 |
| SIGNALING BY HEDGEHOG | 141 | 8.32e-01 | -0.010300 | 9.69e-01 |
| ACTIVATION OF SMO | 16 | 9.44e-01 | -0.010200 | 9.87e-01 |
| REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION | 88 | 8.69e-01 | -0.010200 | 9.78e-01 |
| SLC MEDIATED TRANSMEMBRANE TRANSPORT | 180 | 8.15e-01 | 0.010100 | 9.62e-01 |
| ECM PROTEOGLYCANS | 63 | 8.90e-01 | 0.010100 | 9.78e-01 |
| REGULATION OF RUNX2 EXPRESSION AND ACTIVITY | 68 | 8.86e-01 | 0.010100 | 9.78e-01 |
| MISMATCH REPAIR | 15 | 9.47e-01 | 0.009830 | 9.87e-01 |
| DEGRADATION OF GLI1 BY THE PROTEASOME | 57 | 9.01e-01 | -0.009500 | 9.81e-01 |
| PROTEIN LOCALIZATION | 157 | 8.38e-01 | 0.009440 | 9.70e-01 |
| RHOV GTPASE CYCLE | 32 | 9.28e-01 | -0.009280 | 9.87e-01 |
| CHOLESTEROL BIOSYNTHESIS | 24 | 9.39e-01 | 0.009100 | 9.87e-01 |
| ADAPTIVE IMMUNE SYSTEM | 600 | 7.10e-01 | 0.008940 | 9.10e-01 |
| RHO GTPASES ACTIVATE CIT | 18 | 9.48e-01 | 0.008830 | 9.87e-01 |
| DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS | 59 | 9.07e-01 | -0.008810 | 9.81e-01 |
| TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE | 19 | 9.48e-01 | -0.008700 | 9.87e-01 |
| HDR THROUGH HOMOLOGOUS RECOMBINATION HRR | 64 | 9.06e-01 | -0.008550 | 9.81e-01 |
| TRANSLATION OF SARS COV 2 STRUCTURAL PROTEINS | 44 | 9.22e-01 | -0.008530 | 9.87e-01 |
| MICRORNA MIRNA BIOGENESIS | 24 | 9.44e-01 | -0.008320 | 9.87e-01 |
| ANTI INFLAMMATORY RESPONSE FAVOURING LEISHMANIA PARASITE INFECTION | 117 | 8.79e-01 | -0.008170 | 9.78e-01 |
| ENDOGENOUS STEROLS | 21 | 9.49e-01 | -0.008110 | 9.87e-01 |
| COLLAGEN DEGRADATION | 50 | 9.24e-01 | 0.007800 | 9.87e-01 |
| TNF SIGNALING | 43 | 9.32e-01 | 0.007550 | 9.87e-01 |
| GPCR LIGAND BINDING | 260 | 8.35e-01 | 0.007520 | 9.70e-01 |
| NGF STIMULATED TRANSCRIPTION | 37 | 9.43e-01 | -0.006840 | 9.87e-01 |
| ACTIVATION OF THE PRE REPLICATIVE COMPLEX | 30 | 9.49e-01 | -0.006800 | 9.87e-01 |
| P75NTR REGULATES AXONOGENESIS | 10 | 9.71e-01 | 0.006710 | 9.92e-01 |
| DEGRADATION OF CYSTEINE AND HOMOCYSTEINE | 13 | 9.69e-01 | -0.006290 | 9.92e-01 |
| GLUCAGON LIKE PEPTIDE 1 GLP1 REGULATES INSULIN SECRETION | 38 | 9.47e-01 | -0.006260 | 9.87e-01 |
| SIGNALING BY PDGF | 53 | 9.38e-01 | -0.006220 | 9.87e-01 |
| RHO GTPASES ACTIVATE ROCKS | 19 | 9.64e-01 | -0.005940 | 9.92e-01 |
| REGULATION OF PTEN STABILITY AND ACTIVITY | 66 | 9.34e-01 | -0.005880 | 9.87e-01 |
| G PROTEIN BETA GAMMA SIGNALLING | 30 | 9.56e-01 | 0.005800 | 9.90e-01 |
| TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES | 37 | 9.51e-01 | 0.005790 | 9.87e-01 |
| FOXO MEDIATED TRANSCRIPTION OF CELL DEATH GENES | 15 | 9.69e-01 | -0.005770 | 9.92e-01 |
| TRANS GOLGI NETWORK VESICLE BUDDING | 70 | 9.34e-01 | 0.005690 | 9.87e-01 |
| MET ACTIVATES PTK2 SIGNALING | 29 | 9.58e-01 | -0.005630 | 9.91e-01 |
| MITOTIC PROPHASE | 95 | 9.26e-01 | -0.005550 | 9.87e-01 |
| CD28 CO STIMULATION | 30 | 9.59e-01 | 0.005450 | 9.91e-01 |
| RRNA PROCESSING | 195 | 8.96e-01 | -0.005420 | 9.78e-01 |
| CELLULAR RESPONSE TO CHEMICAL STRESS | 149 | 9.10e-01 | -0.005350 | 9.81e-01 |
| INTERLEUKIN 15 SIGNALING | 13 | 9.74e-01 | -0.005260 | 9.92e-01 |
| EPIGENETIC REGULATION OF GENE EXPRESSION | 103 | 9.27e-01 | -0.005230 | 9.87e-01 |
| PROCESSING OF SMDT1 | 16 | 9.72e-01 | -0.005040 | 9.92e-01 |
| REGULATION OF RUNX3 EXPRESSION AND ACTIVITY | 53 | 9.51e-01 | 0.004870 | 9.87e-01 |
| SUMOYLATION OF INTRACELLULAR RECEPTORS | 26 | 9.68e-01 | -0.004530 | 9.92e-01 |
| REGULATION OF RAS BY GAPS | 66 | 9.51e-01 | 0.004420 | 9.87e-01 |
| HCMV LATE EVENTS | 66 | 9.51e-01 | -0.004390 | 9.87e-01 |
| SIGNALING BY NOTCH2 | 33 | 9.66e-01 | 0.004320 | 9.92e-01 |
| MATURATION OF NUCLEOPROTEIN | 10 | 9.81e-01 | -0.004280 | 9.92e-01 |
| CDC42 GTPASE CYCLE | 153 | 9.31e-01 | 0.004080 | 9.87e-01 |
| S PHASE | 154 | 9.32e-01 | 0.003990 | 9.87e-01 |
| BIOLOGICAL OXIDATIONS | 125 | 9.41e-01 | 0.003840 | 9.87e-01 |
| TNFR1 INDUCED PROAPOPTOTIC SIGNALING | 12 | 9.82e-01 | -0.003800 | 9.92e-01 |
| SYNTHESIS OF BILE ACIDS AND BILE SALTS | 22 | 9.76e-01 | 0.003690 | 9.92e-01 |
| SIGNALING BY NOTCH3 | 48 | 9.65e-01 | 0.003620 | 9.92e-01 |
| REGULATION OF BACH1 ACTIVITY | 11 | 9.84e-01 | 0.003570 | 9.92e-01 |
| ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING | 21 | 9.78e-01 | -0.003440 | 9.92e-01 |
| REGULATION OF HMOX1 EXPRESSION AND ACTIVITY | 63 | 9.64e-01 | -0.003270 | 9.92e-01 |
| SEMA3A PAK DEPENDENT AXON REPULSION | 16 | 9.82e-01 | -0.003240 | 9.92e-01 |
| LEISHMANIA INFECTION | 197 | 9.38e-01 | -0.003210 | 9.87e-01 |
| CYCLIN A CDK2 ASSOCIATED EVENTS AT S PHASE ENTRY | 84 | 9.63e-01 | -0.002950 | 9.92e-01 |
| RNA POLYMERASE II TRANSCRIPTION | 1088 | 8.71e-01 | -0.002950 | 9.78e-01 |
| G ALPHA Q SIGNALLING EVENTS | 154 | 9.50e-01 | 0.002940 | 9.87e-01 |
| ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1 | 22 | 9.81e-01 | -0.002920 | 9.92e-01 |
| SIGNALING BY RECEPTOR TYROSINE KINASES | 458 | 9.17e-01 | 0.002850 | 9.86e-01 |
| SIGNALING BY FGFR | 72 | 9.69e-01 | 0.002680 | 9.92e-01 |
| RAC3 GTPASE CYCLE | 88 | 9.66e-01 | 0.002620 | 9.92e-01 |
| TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN | 20 | 9.84e-01 | -0.002580 | 9.92e-01 |
| TELOMERE EXTENSION BY TELOMERASE | 22 | 9.84e-01 | 0.002470 | 9.92e-01 |
| ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | 10 | 9.90e-01 | 0.002220 | 9.93e-01 |
| DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX | 82 | 9.73e-01 | 0.002200 | 9.92e-01 |
| EXTENSION OF TELOMERES | 49 | 9.79e-01 | -0.002130 | 9.92e-01 |
| MAP2K AND MAPK ACTIVATION | 36 | 9.83e-01 | 0.002110 | 9.92e-01 |
| SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS | 15 | 9.91e-01 | 0.001680 | 9.93e-01 |
| GOLGI ASSOCIATED VESICLE BIOGENESIS | 55 | 9.83e-01 | 0.001630 | 9.92e-01 |
| SENSORY PROCESSING OF SOUND BY OUTER HAIR CELLS OF THE COCHLEA | 41 | 9.86e-01 | 0.001620 | 9.92e-01 |
| AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA | 53 | 9.85e-01 | -0.001490 | 9.92e-01 |
| CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND | 10 | 9.94e-01 | -0.001460 | 9.94e-01 |
| RHOB GTPASE CYCLE | 67 | 9.84e-01 | 0.001420 | 9.92e-01 |
| SYNTHESIS OF PA | 29 | 9.90e-01 | 0.001360 | 9.93e-01 |
| RAB GEFS EXCHANGE GTP FOR GDP ON RABS | 87 | 9.84e-01 | 0.001280 | 9.92e-01 |
| RNA POLYMERASE I TRANSCRIPTION | 68 | 9.86e-01 | -0.001240 | 9.92e-01 |
| DEGRADATION OF AXIN | 53 | 9.88e-01 | 0.001180 | 9.92e-01 |
| RESOLUTION OF SISTER CHROMATID COHESION | 103 | 9.87e-01 | -0.000917 | 9.92e-01 |
| NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | 10 | 9.98e-01 | -0.000388 | 9.98e-01 |
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO
| 784 | |
|---|---|
| set | REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO |
| setSize | 10 |
| pANOVA | 0.00196 |
| s.dist | 0.566 |
| p.adjustANOVA | 0.0528 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Nell2 | 8334 |
| Slit2 | 7715 |
| Slit3 | 7397 |
| Robo2 | 6798 |
| Ntn1 | 4776 |
| Src | 4689 |
| Robo3 | 4576 |
| Slit1 | 4244 |
| Robo1 | -190 |
| Dcc | -470 |
| GeneID | Gene Rank |
|---|---|
| Nell2 | 8334 |
| Slit2 | 7715 |
| Slit3 | 7397 |
| Robo2 | 6798 |
| Ntn1 | 4776 |
| Src | 4689 |
| Robo3 | 4576 |
| Slit1 | 4244 |
| Robo1 | -190 |
| Dcc | -470 |
TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS
| 1095 | |
|---|---|
| set | TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS |
| setSize | 17 |
| pANOVA | 7.94e-05 |
| s.dist | 0.553 |
| p.adjustANOVA | 0.00924 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Prkca | 8091 |
| Prkcg | 7934 |
| Ap2a1 | 7394 |
| Nsf | 7135 |
| Ap2b1 | 7080 |
| Prkcb | 6741 |
| Ap2a2 | 6358 |
| Gria3 | 6301 |
| Pick1 | 5747 |
| Ap2m1 | 5729 |
| Gria1 | 5278 |
| Grip1 | 4534 |
| Gria2 | 3969 |
| Ap2s1 | 2536 |
| Tspan7 | 1433 |
| Gria4 | 120 |
| Grip2 | -6880 |
| GeneID | Gene Rank |
|---|---|
| Prkca | 8091 |
| Prkcg | 7934 |
| Ap2a1 | 7394 |
| Nsf | 7135 |
| Ap2b1 | 7080 |
| Prkcb | 6741 |
| Ap2a2 | 6358 |
| Gria3 | 6301 |
| Pick1 | 5747 |
| Ap2m1 | 5729 |
| Gria1 | 5278 |
| Grip1 | 4534 |
| Gria2 | 3969 |
| Ap2s1 | 2536 |
| Tspan7 | 1433 |
| Gria4 | 120 |
| Grip2 | -6880 |
SYNAPTIC ADHESION LIKE MOLECULES
| 1022 | |
|---|---|
| set | SYNAPTIC ADHESION LIKE MOLECULES |
| setSize | 21 |
| pANOVA | 3.89e-05 |
| s.dist | 0.519 |
| p.adjustANOVA | 0.00503 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Lrfn4 | 7994 |
| Ptprs | 7795 |
| Grin1 | 7629 |
| Dlg3 | 7480 |
| Grin2c | 7110 |
| Dlg4 | 6940 |
| Gria3 | 6301 |
| Lrfn2 | 6283 |
| Grin2b | 6241 |
| Lrfn1 | 5481 |
| Gria1 | 5278 |
| Grin2a | 4615 |
| Flot1 | 3791 |
| Lrfn3 | 3175 |
| Ptprf | 2822 |
| Flot2 | 2657 |
| Rtn3 | 2122 |
| Ptprd | 278 |
| Gria4 | 120 |
| Dlg1 | 61 |
| GeneID | Gene Rank |
|---|---|
| Lrfn4 | 7994 |
| Ptprs | 7795 |
| Grin1 | 7629 |
| Dlg3 | 7480 |
| Grin2c | 7110 |
| Dlg4 | 6940 |
| Gria3 | 6301 |
| Lrfn2 | 6283 |
| Grin2b | 6241 |
| Lrfn1 | 5481 |
| Gria1 | 5278 |
| Grin2a | 4615 |
| Flot1 | 3791 |
| Lrfn3 | 3175 |
| Ptprf | 2822 |
| Flot2 | 2657 |
| Rtn3 | 2122 |
| Ptprd | 278 |
| Gria4 | 120 |
| Dlg1 | 61 |
| Grin2d | -2102 |
COMMON PATHWAY OF FIBRIN CLOT FORMATION
| 167 | |
|---|---|
| set | COMMON PATHWAY OF FIBRIN CLOT FORMATION |
| setSize | 11 |
| pANOVA | 0.00323 |
| s.dist | -0.513 |
| p.adjustANOVA | 0.0767 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Serpine2 | -7671 |
| Procr | -7567 |
| Pros1 | -6994 |
| Serpind1 | -6322 |
| F8 | -6292 |
| F2r | -5645 |
| F13a1 | -3810 |
| Serpinc1 | -3407 |
| Prtn3 | -1921 |
| F5 | 495 |
| Thbd | 974 |
| GeneID | Gene Rank |
|---|---|
| Serpine2 | -7671 |
| Procr | -7567 |
| Pros1 | -6994 |
| Serpind1 | -6322 |
| F8 | -6292 |
| F2r | -5645 |
| F13a1 | -3810 |
| Serpinc1 | -3407 |
| Prtn3 | -1921 |
| F5 | 495 |
| Thbd | 974 |
WNT5A DEPENDENT INTERNALIZATION OF FZD4
| 1161 | |
|---|---|
| set | WNT5A DEPENDENT INTERNALIZATION OF FZD4 |
| setSize | 15 |
| pANOVA | 0.000709 |
| s.dist | 0.505 |
| p.adjustANOVA | 0.0344 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Prkca | 8091 |
| Prkcg | 7934 |
| Ap2a1 | 7394 |
| Ap2b1 | 7080 |
| Prkcb | 6741 |
| Dvl2 | 6555 |
| Ap2a2 | 6358 |
| Ap2m1 | 5729 |
| Arrb2 | 4011 |
| Clta | 2910 |
| Ap2s1 | 2536 |
| Cltb | 1571 |
| Cltc | 1187 |
| Wnt5a | -1070 |
| Fzd4 | -2968 |
| GeneID | Gene Rank |
|---|---|
| Prkca | 8091 |
| Prkcg | 7934 |
| Ap2a1 | 7394 |
| Ap2b1 | 7080 |
| Prkcb | 6741 |
| Dvl2 | 6555 |
| Ap2a2 | 6358 |
| Ap2m1 | 5729 |
| Arrb2 | 4011 |
| Clta | 2910 |
| Ap2s1 | 2536 |
| Cltb | 1571 |
| Cltc | 1187 |
| Wnt5a | -1070 |
| Fzd4 | -2968 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES
| 80 | |
|---|---|
| set | ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES |
| setSize | 10 |
| pANOVA | 0.00592 |
| s.dist | -0.503 |
| p.adjustANOVA | 0.123 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Hspa5 | -8508 |
| Xbp1 | -8476 |
| Hsp90b1 | -8419 |
| Nfya | -8351 |
| Calr | -8276 |
| Ddit3 | -7358 |
| Atf4 | -3829 |
| Nfyc | -47 |
| Nfyb | 4588 |
| Atf6 | 5760 |
| GeneID | Gene Rank |
|---|---|
| Hspa5 | -8508 |
| Xbp1 | -8476 |
| Hsp90b1 | -8419 |
| Nfya | -8351 |
| Calr | -8276 |
| Ddit3 | -7358 |
| Atf4 | -3829 |
| Nfyc | -47 |
| Nfyb | 4588 |
| Atf6 | 5760 |
CAMK IV MEDIATED PHOSPHORYLATION OF CREB
| 109 | |
|---|---|
| set | CAMK IV MEDIATED PHOSPHORYLATION OF CREB |
| setSize | 10 |
| pANOVA | 0.00673 |
| s.dist | 0.495 |
| p.adjustANOVA | 0.124 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Camkk2 | 8297 |
| Camkk1 | 8221 |
| Camk2b | 8027 |
| Kpna2 | 7487 |
| Camk2a | 7008 |
| Camk4 | 4797 |
| Camk2d | 4345 |
| Camk2g | 2899 |
| Calm1 | -2523 |
| Creb1 | -6695 |
| GeneID | Gene Rank |
|---|---|
| Camkk2 | 8297 |
| Camkk1 | 8221 |
| Camk2b | 8027 |
| Kpna2 | 7487 |
| Camk2a | 7008 |
| Camk4 | 4797 |
| Camk2d | 4345 |
| Camk2g | 2899 |
| Calm1 | -2523 |
| Creb1 | -6695 |
CGMP EFFECTS
| 141 | |
|---|---|
| set | CGMP EFFECTS |
| setSize | 15 |
| pANOVA | 0.00094 |
| s.dist | 0.493 |
| p.adjustANOVA | 0.0365 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Pde1a | 8218 |
| Pde11a | 7583 |
| Kcnmb2 | 7467 |
| Pde2a | 7424 |
| Pde9a | 7242 |
| Kcnmb4 | 6993 |
| Kcnma1 | 6073 |
| Itpr1 | 5676 |
| Irag1 | 5277 |
| Pde1b | 5215 |
| Kcnmb1 | 4711 |
| Pde10a | 861 |
| Pde5a | -388 |
| Prkg1 | -2456 |
| Prkg2 | -7323 |
| GeneID | Gene Rank |
|---|---|
| Pde1a | 8218 |
| Pde11a | 7583 |
| Kcnmb2 | 7467 |
| Pde2a | 7424 |
| Pde9a | 7242 |
| Kcnmb4 | 6993 |
| Kcnma1 | 6073 |
| Itpr1 | 5676 |
| Irag1 | 5277 |
| Pde1b | 5215 |
| Kcnmb1 | 4711 |
| Pde10a | 861 |
| Pde5a | -388 |
| Prkg1 | -2456 |
| Prkg2 | -7323 |
DNA METHYLATION
| 251 | |
|---|---|
| set | DNA METHYLATION |
| setSize | 20 |
| pANOVA | 0.000442 |
| s.dist | -0.454 |
| p.adjustANOVA | 0.0245 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| H2ac18 | -8348 |
| H4c12 | -7747 |
| Uhrf1 | -7604 |
| H4c8 | -7477 |
| H2bc21 | -7459 |
| H2bc6 | -6848 |
| H2az2 | -6816 |
| H2bc4 | -6707 |
| H2bc8 | -6624 |
| H4c9 | -6415 |
| Dnmt3a | -4563 |
| H3c15 | -4019 |
| H2aj | -2603 |
| H3f3a | -2297 |
| H2az1 | -864 |
| H2ac19 | -532 |
| H3f3b | -414 |
| H4c14 | 138 |
| H2ax | 4083 |
| Dnmt1 | 5612 |
| GeneID | Gene Rank |
|---|---|
| H2ac18 | -8348 |
| H4c12 | -7747 |
| Uhrf1 | -7604 |
| H4c8 | -7477 |
| H2bc21 | -7459 |
| H2bc6 | -6848 |
| H2az2 | -6816 |
| H2bc4 | -6707 |
| H2bc8 | -6624 |
| H4c9 | -6415 |
| Dnmt3a | -4563 |
| H3c15 | -4019 |
| H2aj | -2603 |
| H3f3a | -2297 |
| H2az1 | -864 |
| H2ac19 | -532 |
| H3f3b | -414 |
| H4c14 | 138 |
| H2ax | 4083 |
| Dnmt1 | 5612 |
LGI ADAM INTERACTIONS
| 511 | |
|---|---|
| set | LGI ADAM INTERACTIONS |
| setSize | 14 |
| pANOVA | 0.00348 |
| s.dist | 0.451 |
| p.adjustANOVA | 0.081 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Stx1a | 7938 |
| Cacng3 | 7889 |
| Adam11 | 7834 |
| Cacng8 | 7549 |
| Dlg4 | 6940 |
| Stx1b | 5641 |
| Lgi3 | 5514 |
| Adam22 | 3626 |
| Adam23 | 2458 |
| Lgi1 | 1211 |
| Lgi4 | 814 |
| Lgi2 | -245 |
| Cacng4 | -372 |
| Cacng2 | -3424 |
| GeneID | Gene Rank |
|---|---|
| Stx1a | 7938 |
| Cacng3 | 7889 |
| Adam11 | 7834 |
| Cacng8 | 7549 |
| Dlg4 | 6940 |
| Stx1b | 5641 |
| Lgi3 | 5514 |
| Adam22 | 3626 |
| Adam23 | 2458 |
| Lgi1 | 1211 |
| Lgi4 | 814 |
| Lgi2 | -245 |
| Cacng4 | -372 |
| Cacng2 | -3424 |
TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX
| 1117 | |
|---|---|
| set | TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX |
| setSize | 12 |
| pANOVA | 0.00692 |
| s.dist | 0.45 |
| p.adjustANOVA | 0.124 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Chmp6 | 7060 |
| Chmp3 | 6443 |
| Pik3r4 | 6435 |
| Becn1 | 5034 |
| Pik3c3 | 4940 |
| Chmp4b | 4061 |
| Chmp7 | 3408 |
| Chmp2b | 3035 |
| Map1lc3b | 2678 |
| Chmp2a | 2450 |
| Chmp4c | 1140 |
| Uvrag | -1008 |
| GeneID | Gene Rank |
|---|---|
| Chmp6 | 7060 |
| Chmp3 | 6443 |
| Pik3r4 | 6435 |
| Becn1 | 5034 |
| Pik3c3 | 4940 |
| Chmp4b | 4061 |
| Chmp7 | 3408 |
| Chmp2b | 3035 |
| Map1lc3b | 2678 |
| Chmp2a | 2450 |
| Chmp4c | 1140 |
| Uvrag | -1008 |
SEROTONIN NEUROTRANSMITTER RELEASE CYCLE
| 913 | |
|---|---|
| set | SEROTONIN NEUROTRANSMITTER RELEASE CYCLE |
| setSize | 18 |
| pANOVA | 0.00102 |
| s.dist | 0.447 |
| p.adjustANOVA | 0.0379 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Stx1a | 7938 |
| Unc13b | 7488 |
| Syn1 | 7354 |
| Stxbp1 | 7232 |
| Ppfia3 | 7037 |
| Syt1 | 6858 |
| Rims1 | 5934 |
| Syn2 | 5671 |
| Syn3 | 4255 |
| Rab3a | 4251 |
| Vamp2 | 4007 |
| Ppfia4 | 3212 |
| Tspoap1 | 2801 |
| Snap25 | 2764 |
| Ppfia2 | 1867 |
| Cplx1 | 512 |
| Ppfia1 | -2775 |
| Slc18a2 | -8364 |
| GeneID | Gene Rank |
|---|---|
| Stx1a | 7938 |
| Unc13b | 7488 |
| Syn1 | 7354 |
| Stxbp1 | 7232 |
| Ppfia3 | 7037 |
| Syt1 | 6858 |
| Rims1 | 5934 |
| Syn2 | 5671 |
| Syn3 | 4255 |
| Rab3a | 4251 |
| Vamp2 | 4007 |
| Ppfia4 | 3212 |
| Tspoap1 | 2801 |
| Snap25 | 2764 |
| Ppfia2 | 1867 |
| Cplx1 | 512 |
| Ppfia1 | -2775 |
| Slc18a2 | -8364 |
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR
| 1093 | |
|---|---|
| set | TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR |
| setSize | 11 |
| pANOVA | 0.0112 |
| s.dist | -0.442 |
| p.adjustANOVA | 0.143 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Hsp90b1 | -8419 |
| Tlr3 | -7950 |
| Ctss | -7927 |
| Lgmn | -5222 |
| Ctsl | -4944 |
| Ctsk | -4723 |
| Unc93b1 | -3682 |
| Tlr7 | -3257 |
| Tlr9 | 101 |
| Ctsb | 727 |
| Cnpy3 | 3782 |
| GeneID | Gene Rank |
|---|---|
| Hsp90b1 | -8419 |
| Tlr3 | -7950 |
| Ctss | -7927 |
| Lgmn | -5222 |
| Ctsl | -4944 |
| Ctsk | -4723 |
| Unc93b1 | -3682 |
| Tlr7 | -3257 |
| Tlr9 | 101 |
| Ctsb | 727 |
| Cnpy3 | 3782 |
DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS
| 234 | |
|---|---|
| set | DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS |
| setSize | 18 |
| pANOVA | 0.00126 |
| s.dist | 0.439 |
| p.adjustANOVA | 0.0408 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Srd5a3 | 7833 |
| Glb1 | 7481 |
| Mpi | 7156 |
| Dolk | 6220 |
| Dpm3 | 6197 |
| Dhdds | 6188 |
| Gne | 6149 |
| Galt | 5683 |
| Gale | 4936 |
| Dpm1 | 4736 |
| Ctsa | 3765 |
| Dpm2 | 3381 |
| Neu1 | 2229 |
| Pmm2 | 2162 |
| Galk1 | 1265 |
| Pgm1 | -1727 |
| Gfpt1 | -2249 |
| Nus1 | -4630 |
| GeneID | Gene Rank |
|---|---|
| Srd5a3 | 7833 |
| Glb1 | 7481 |
| Mpi | 7156 |
| Dolk | 6220 |
| Dpm3 | 6197 |
| Dhdds | 6188 |
| Gne | 6149 |
| Galt | 5683 |
| Gale | 4936 |
| Dpm1 | 4736 |
| Ctsa | 3765 |
| Dpm2 | 3381 |
| Neu1 | 2229 |
| Pmm2 | 2162 |
| Galk1 | 1265 |
| Pgm1 | -1727 |
| Gfpt1 | -2249 |
| Nus1 | -4630 |
NUCLEOTIDE LIKE PURINERGIC RECEPTORS
| 653 | |
|---|---|
| set | NUCLEOTIDE LIKE PURINERGIC RECEPTORS |
| setSize | 12 |
| pANOVA | 0.00852 |
| s.dist | -0.439 |
| p.adjustANOVA | 0.13 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Adora3 | -8301 |
| P2ry13 | -8282 |
| Adora2b | -7728 |
| Gpr17 | -7614 |
| P2ry12 | -7476 |
| P2ry14 | -5282 |
| Lpar4 | -5063 |
| P2ry6 | -3039 |
| Lpar6 | -1656 |
| P2ry1 | 464 |
| Adora2a | 591 |
| Adora1 | 8419 |
| GeneID | Gene Rank |
|---|---|
| Adora3 | -8301 |
| P2ry13 | -8282 |
| Adora2b | -7728 |
| Gpr17 | -7614 |
| P2ry12 | -7476 |
| P2ry14 | -5282 |
| Lpar4 | -5063 |
| P2ry6 | -3039 |
| Lpar6 | -1656 |
| P2ry1 | 464 |
| Adora2a | 591 |
| Adora1 | 8419 |
MUCOPOLYSACCHARIDOSES
| 583 | |
|---|---|
| set | MUCOPOLYSACCHARIDOSES |
| setSize | 11 |
| pANOVA | 0.012 |
| s.dist | 0.437 |
| p.adjustANOVA | 0.148 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Naglu | 8479 |
| Glb1 | 7481 |
| Galns | 5932 |
| Hgsnat | 5889 |
| Sgsh | 5045 |
| Arsb | 4866 |
| Hyal1 | 4403 |
| Gns | 1421 |
| Gusb | 460 |
| Ids | -1372 |
| Idua | -1926 |
| GeneID | Gene Rank |
|---|---|
| Naglu | 8479 |
| Glb1 | 7481 |
| Galns | 5932 |
| Hgsnat | 5889 |
| Sgsh | 5045 |
| Arsb | 4866 |
| Hyal1 | 4403 |
| Gns | 1421 |
| Gusb | 460 |
| Ids | -1372 |
| Idua | -1926 |
TRAFFICKING OF AMPA RECEPTORS
| 1094 | |
|---|---|
| set | TRAFFICKING OF AMPA RECEPTORS |
| setSize | 31 |
| pANOVA | 2.84e-05 |
| s.dist | 0.434 |
| p.adjustANOVA | 0.00456 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Prkca | 8091 |
| Camk2b | 8027 |
| Prkcg | 7934 |
| Cacng3 | 7889 |
| Cacng8 | 7549 |
| Ap2a1 | 7394 |
| Nsf | 7135 |
| Ap2b1 | 7080 |
| Camk2a | 7008 |
| Dlg4 | 6940 |
| Prkcb | 6741 |
| Ap2a2 | 6358 |
| Gria3 | 6301 |
| Akap5 | 6204 |
| Pick1 | 5747 |
| Ap2m1 | 5729 |
| Gria1 | 5278 |
| Grip1 | 4534 |
| Camk2d | 4345 |
| Gria2 | 3969 |
| GeneID | Gene Rank |
|---|---|
| Prkca | 8091 |
| Camk2b | 8027 |
| Prkcg | 7934 |
| Cacng3 | 7889 |
| Cacng8 | 7549 |
| Ap2a1 | 7394 |
| Nsf | 7135 |
| Ap2b1 | 7080 |
| Camk2a | 7008 |
| Dlg4 | 6940 |
| Prkcb | 6741 |
| Ap2a2 | 6358 |
| Gria3 | 6301 |
| Akap5 | 6204 |
| Pick1 | 5747 |
| Ap2m1 | 5729 |
| Gria1 | 5278 |
| Grip1 | 4534 |
| Camk2d | 4345 |
| Gria2 | 3969 |
| Camk2g | 2899 |
| Ap2s1 | 2536 |
| Epb41l1 | 1917 |
| Tspan7 | 1433 |
| Gria4 | 120 |
| Dlg1 | 61 |
| Cacng4 | -372 |
| Cacng2 | -3424 |
| Grip2 | -6880 |
| Myo6 | -7334 |
| Mdm2 | -7509 |
SHC MEDIATED CASCADE FGFR4
| 917 | |
|---|---|
| set | SHC MEDIATED CASCADE FGFR4 |
| setSize | 11 |
| pANOVA | 0.0152 |
| s.dist | -0.423 |
| p.adjustANOVA | 0.175 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Fgf9 | -8111 |
| Nras | -8042 |
| Fgf2 | -8002 |
| Fgf18 | -7611 |
| Fgf1 | -7475 |
| Kras | -4796 |
| Sos1 | -4081 |
| Shc1 | -3374 |
| Hras | -19 |
| Grb2 | 4493 |
| Fgf16 | 7270 |
| GeneID | Gene Rank |
|---|---|
| Fgf9 | -8111 |
| Nras | -8042 |
| Fgf2 | -8002 |
| Fgf18 | -7611 |
| Fgf1 | -7475 |
| Kras | -4796 |
| Sos1 | -4081 |
| Shc1 | -3374 |
| Hras | -19 |
| Grb2 | 4493 |
| Fgf16 | 7270 |
SIGNALING BY HIPPO
| 953 | |
|---|---|
| set | SIGNALING BY HIPPO |
| setSize | 20 |
| pANOVA | 0.00124 |
| s.dist | -0.417 |
| p.adjustANOVA | 0.0408 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Tjp2 | -8083 |
| Amotl2 | -7597 |
| Sav1 | -7390 |
| Amotl1 | -7259 |
| Tjp1 | -7253 |
| Stk3 | -6856 |
| Mob1a | -6776 |
| Casp3 | -6671 |
| Wwtr1 | -5903 |
| Stk4 | -5711 |
| Lats1 | -5682 |
| Mob1b | -5515 |
| Lats2 | -4702 |
| Amot | -4025 |
| Ywhae | -970 |
| Yap1 | 1104 |
| Wwc1 | 1524 |
| Ywhab | 1545 |
| Dvl2 | 6555 |
| Nphp4 | 8375 |
| GeneID | Gene Rank |
|---|---|
| Tjp2 | -8083 |
| Amotl2 | -7597 |
| Sav1 | -7390 |
| Amotl1 | -7259 |
| Tjp1 | -7253 |
| Stk3 | -6856 |
| Mob1a | -6776 |
| Casp3 | -6671 |
| Wwtr1 | -5903 |
| Stk4 | -5711 |
| Lats1 | -5682 |
| Mob1b | -5515 |
| Lats2 | -4702 |
| Amot | -4025 |
| Ywhae | -970 |
| Yap1 | 1104 |
| Wwc1 | 1524 |
| Ywhab | 1545 |
| Dvl2 | 6555 |
| Nphp4 | 8375 |
INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION
| 483 | |
|---|---|
| set | INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION |
| setSize | 13 |
| pANOVA | 0.0101 |
| s.dist | -0.412 |
| p.adjustANOVA | 0.137 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Serpine2 | -7671 |
| Pros1 | -6994 |
| Vwf | -6657 |
| Serpind1 | -6322 |
| F8 | -6292 |
| Prcp | -5390 |
| Serping1 | -4239 |
| Serpinc1 | -3407 |
| Gp5 | -3223 |
| Gp1bb | -1929 |
| C1qbp | -1897 |
| A2m | -141 |
| Gp1ba | 8379 |
| GeneID | Gene Rank |
|---|---|
| Serpine2 | -7671 |
| Pros1 | -6994 |
| Vwf | -6657 |
| Serpind1 | -6322 |
| F8 | -6292 |
| Prcp | -5390 |
| Serping1 | -4239 |
| Serpinc1 | -3407 |
| Gp5 | -3223 |
| Gp1bb | -1929 |
| C1qbp | -1897 |
| A2m | -141 |
| Gp1ba | 8379 |
HSF1 ACTIVATION
| 426 | |
|---|---|
| set | HSF1 ACTIVATION |
| setSize | 27 |
| pANOVA | 0.00024 |
| s.dist | -0.408 |
| p.adjustANOVA | 0.0174 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Serpinh1 | -8522 |
| Hspb1 | -8520 |
| Fkbp4 | -8515 |
| Hsph1 | -8479 |
| Hspa1b | -8409 |
| Hspa1a | -8371 |
| Dnajb1 | -8303 |
| Hsp90aa1 | -7811 |
| Dedd2 | -7321 |
| Rpa1 | -6820 |
| Ptges3 | -6554 |
| Col4a6 | -5419 |
| Hsp90ab1 | -4459 |
| Rln1 | -3680 |
| Rpa2 | -2399 |
| Mrpl18 | -2116 |
| Cryba4 | -1416 |
| Dnajb6 | -1244 |
| Ywhae | -970 |
| Eef1a1 | -401 |
| GeneID | Gene Rank |
|---|---|
| Serpinh1 | -8522 |
| Hspb1 | -8520 |
| Fkbp4 | -8515 |
| Hsph1 | -8479 |
| Hspa1b | -8409 |
| Hspa1a | -8371 |
| Dnajb1 | -8303 |
| Hsp90aa1 | -7811 |
| Dedd2 | -7321 |
| Rpa1 | -6820 |
| Ptges3 | -6554 |
| Col4a6 | -5419 |
| Hsp90ab1 | -4459 |
| Rln1 | -3680 |
| Rpa2 | -2399 |
| Mrpl18 | -2116 |
| Cryba4 | -1416 |
| Dnajb6 | -1244 |
| Ywhae | -970 |
| Eef1a1 | -401 |
| Rpa3 | 478 |
| Hdac6 | 558 |
| Vcp | 799 |
| Ubb | 1348 |
| Hsf1 | 2256 |
| Hsbp1 | 3840 |
| Tnfrsf21 | 6286 |
UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION
| 1144 | |
|---|---|
| set | UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION |
| setSize | 21 |
| pANOVA | 0.00131 |
| s.dist | 0.405 |
| p.adjustANOVA | 0.0413 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Camk2b | 8027 |
| Grin1 | 7629 |
| Dlg3 | 7480 |
| Grin2c | 7110 |
| Camk2a | 7008 |
| Dlg4 | 6940 |
| Gria3 | 6301 |
| Grin2b | 6241 |
| Actn2 | 5570 |
| Gria1 | 5278 |
| Grin2a | 4615 |
| Camk2d | 4345 |
| Gria2 | 3969 |
| Camk2g | 2899 |
| Lrrc7 | 2260 |
| Gria4 | 120 |
| Dlg1 | 61 |
| Grin2d | -2102 |
| Calm1 | -2523 |
| Dlg2 | -3794 |
| GeneID | Gene Rank |
|---|---|
| Camk2b | 8027 |
| Grin1 | 7629 |
| Dlg3 | 7480 |
| Grin2c | 7110 |
| Camk2a | 7008 |
| Dlg4 | 6940 |
| Gria3 | 6301 |
| Grin2b | 6241 |
| Actn2 | 5570 |
| Gria1 | 5278 |
| Grin2a | 4615 |
| Camk2d | 4345 |
| Gria2 | 3969 |
| Camk2g | 2899 |
| Lrrc7 | 2260 |
| Gria4 | 120 |
| Dlg1 | 61 |
| Grin2d | -2102 |
| Calm1 | -2523 |
| Dlg2 | -3794 |
| Nefl | -5602 |
SIGNALING BY FGFR3 FUSIONS IN CANCER
| 946 | |
|---|---|
| set | SIGNALING BY FGFR3 FUSIONS IN CANCER |
| setSize | 10 |
| pANOVA | 0.0269 |
| s.dist | -0.404 |
| p.adjustANOVA | 0.232 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Gab1 | -8223 |
| Nras | -8042 |
| Pik3ca | -7797 |
| Kras | -4796 |
| Frs2 | -4087 |
| Sos1 | -4081 |
| Fgfr3 | -4029 |
| Hras | -19 |
| Pik3r1 | 2027 |
| Grb2 | 4493 |
| GeneID | Gene Rank |
|---|---|
| Gab1 | -8223 |
| Nras | -8042 |
| Pik3ca | -7797 |
| Kras | -4796 |
| Frs2 | -4087 |
| Sos1 | -4081 |
| Fgfr3 | -4029 |
| Hras | -19 |
| Pik3r1 | 2027 |
| Grb2 | 4493 |
PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING
| 729 | |
|---|---|
| set | PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING |
| setSize | 11 |
| pANOVA | 0.0213 |
| s.dist | 0.401 |
| p.adjustANOVA | 0.208 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Cacna1b | 7716 |
| Cacna1e | 7333 |
| Cacnb3 | 6883 |
| Cacnb1 | 6597 |
| Cacna1a | 5931 |
| Cacna2d3 | 4358 |
| Cacnb2 | 1475 |
| Cacna2d2 | 1251 |
| Cacng4 | -372 |
| Cacnb4 | -469 |
| Cacng2 | -3424 |
| GeneID | Gene Rank |
|---|---|
| Cacna1b | 7716 |
| Cacna1e | 7333 |
| Cacnb3 | 6883 |
| Cacnb1 | 6597 |
| Cacna1a | 5931 |
| Cacna2d3 | 4358 |
| Cacnb2 | 1475 |
| Cacna2d2 | 1251 |
| Cacng4 | -372 |
| Cacnb4 | -469 |
| Cacng2 | -3424 |
NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10
| 618 | |
|---|---|
| set | NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10 |
| setSize | 11 |
| pANOVA | 0.0218 |
| s.dist | -0.399 |
| p.adjustANOVA | 0.21 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ifih1 | -8330 |
| Ripk1 | -7581 |
| Casp8 | -7196 |
| Chuk | -6067 |
| Rnf135 | -4521 |
| Trim25 | -2446 |
| Ddx58 | -2254 |
| Mavs | -1764 |
| Ikbkg | -1408 |
| Ikbkb | 397 |
| Fadd | 3615 |
| GeneID | Gene Rank |
|---|---|
| Ifih1 | -8330 |
| Ripk1 | -7581 |
| Casp8 | -7196 |
| Chuk | -6067 |
| Rnf135 | -4521 |
| Trim25 | -2446 |
| Ddx58 | -2254 |
| Mavs | -1764 |
| Ikbkg | -1408 |
| Ikbkb | 397 |
| Fadd | 3615 |
CONDENSATION OF PROPHASE CHROMOSOMES
| 170 | |
|---|---|
| set | CONDENSATION OF PROPHASE CHROMOSOMES |
| setSize | 28 |
| pANOVA | 0.000297 |
| s.dist | -0.395 |
| p.adjustANOVA | 0.0182 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| H2ac18 | -8348 |
| H4c12 | -7747 |
| H4c8 | -7477 |
| H2bc21 | -7459 |
| H2bc6 | -6848 |
| H2az2 | -6816 |
| Kmt5a | -6768 |
| H2bc4 | -6707 |
| H2bc8 | -6624 |
| H4c9 | -6415 |
| Smc2 | -6023 |
| Smc4 | -5878 |
| Ncapg2 | -5514 |
| Set | -4883 |
| H3c15 | -4019 |
| Rb1 | -3454 |
| H2aj | -2603 |
| H3f3a | -2297 |
| H2az1 | -864 |
| H2ac19 | -532 |
| GeneID | Gene Rank |
|---|---|
| H2ac18 | -8348 |
| H4c12 | -7747 |
| H4c8 | -7477 |
| H2bc21 | -7459 |
| H2bc6 | -6848 |
| H2az2 | -6816 |
| Kmt5a | -6768 |
| H2bc4 | -6707 |
| H2bc8 | -6624 |
| H4c9 | -6415 |
| Smc2 | -6023 |
| Smc4 | -5878 |
| Ncapg2 | -5514 |
| Set | -4883 |
| H3c15 | -4019 |
| Rb1 | -3454 |
| H2aj | -2603 |
| H3f3a | -2297 |
| H2az1 | -864 |
| H2ac19 | -532 |
| Mcph1 | -454 |
| H3f3b | -414 |
| Ncapd3 | -249 |
| H4c14 | 138 |
| Plk1 | 1976 |
| Phf8 | 2818 |
| H2ax | 4083 |
| Ncaph2 | 4911 |
CROSSLINKING OF COLLAGEN FIBRILS
| 189 | |
|---|---|
| set | CROSSLINKING OF COLLAGEN FIBRILS |
| setSize | 14 |
| pANOVA | 0.0112 |
| s.dist | 0.391 |
| p.adjustANOVA | 0.143 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Pcolce | 7956 |
| Col4a2 | 7647 |
| Pxdn | 6822 |
| Bmp1 | 6796 |
| Col1a1 | 6512 |
| Tll1 | 6180 |
| Col4a1 | 5625 |
| Loxl1 | 4862 |
| Loxl2 | 4292 |
| Col4a5 | 1455 |
| Loxl3 | -1273 |
| Tll2 | -2579 |
| Col1a2 | -2588 |
| Col4a6 | -5419 |
| GeneID | Gene Rank |
|---|---|
| Pcolce | 7956 |
| Col4a2 | 7647 |
| Pxdn | 6822 |
| Bmp1 | 6796 |
| Col1a1 | 6512 |
| Tll1 | 6180 |
| Col4a1 | 5625 |
| Loxl1 | 4862 |
| Loxl2 | 4292 |
| Col4a5 | 1455 |
| Loxl3 | -1273 |
| Tll2 | -2579 |
| Col1a2 | -2588 |
| Col4a6 | -5419 |
NEUROTOXICITY OF CLOSTRIDIUM TOXINS
| 614 | |
|---|---|
| set | NEUROTOXICITY OF CLOSTRIDIUM TOXINS |
| setSize | 10 |
| pANOVA | 0.0324 |
| s.dist | 0.391 |
| p.adjustANOVA | 0.248 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Sv2b | 8281 |
| Stx1a | 7938 |
| Syt1 | 6858 |
| Stx1b | 5641 |
| Sv2a | 4695 |
| Vamp2 | 4007 |
| Snap25 | 2764 |
| Sv2c | 1325 |
| Syt2 | -4028 |
| Vamp1 | -4481 |
| GeneID | Gene Rank |
|---|---|
| Sv2b | 8281 |
| Stx1a | 7938 |
| Syt1 | 6858 |
| Stx1b | 5641 |
| Sv2a | 4695 |
| Vamp2 | 4007 |
| Snap25 | 2764 |
| Sv2c | 1325 |
| Syt2 | -4028 |
| Vamp1 | -4481 |
CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND
| 116 | |
|---|---|
| set | CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND |
| setSize | 13 |
| pANOVA | 0.0152 |
| s.dist | -0.389 |
| p.adjustANOVA | 0.175 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Tnfsf10 | -8485 |
| Cd14 | -8329 |
| Ripk1 | -7581 |
| Tlr4 | -7369 |
| Casp8 | -7196 |
| Tnfrsf10b | -5896 |
| Ticam2 | -5065 |
| Cflar | -2954 |
| Traf2 | -2620 |
| Tradd | 990 |
| Fas | 3329 |
| Fadd | 3615 |
| Ticam1 | 4321 |
| GeneID | Gene Rank |
|---|---|
| Tnfsf10 | -8485 |
| Cd14 | -8329 |
| Ripk1 | -7581 |
| Tlr4 | -7369 |
| Casp8 | -7196 |
| Tnfrsf10b | -5896 |
| Ticam2 | -5065 |
| Cflar | -2954 |
| Traf2 | -2620 |
| Tradd | 990 |
| Fas | 3329 |
| Fadd | 3615 |
| Ticam1 | 4321 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONES
| 81 | |
|---|---|
| set | ATF6 ATF6 ALPHA ACTIVATES CHAPERONES |
| setSize | 12 |
| pANOVA | 0.0199 |
| s.dist | -0.388 |
| p.adjustANOVA | 0.202 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Hspa5 | -8508 |
| Xbp1 | -8476 |
| Hsp90b1 | -8419 |
| Nfya | -8351 |
| Calr | -8276 |
| Ddit3 | -7358 |
| Atf4 | -3829 |
| Mbtps2 | -3818 |
| Nfyc | -47 |
| Nfyb | 4588 |
| Atf6 | 5760 |
| Mbtps1 | 6915 |
| GeneID | Gene Rank |
|---|---|
| Hspa5 | -8508 |
| Xbp1 | -8476 |
| Hsp90b1 | -8419 |
| Nfya | -8351 |
| Calr | -8276 |
| Ddit3 | -7358 |
| Atf4 | -3829 |
| Mbtps2 | -3818 |
| Nfyc | -47 |
| Nfyb | 4588 |
| Atf6 | 5760 |
| Mbtps1 | 6915 |
RETROGRADE NEUROTROPHIN SIGNALLING
| 834 | |
|---|---|
| set | RETROGRADE NEUROTROPHIN SIGNALLING |
| setSize | 14 |
| pANOVA | 0.0121 |
| s.dist | 0.387 |
| p.adjustANOVA | 0.148 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Dnm1 | 7420 |
| Ap2a1 | 7394 |
| Ap2b1 | 7080 |
| Ap2a2 | 6358 |
| Sh3gl2 | 6061 |
| Ap2m1 | 5729 |
| Dnal4 | 3744 |
| Clta | 2910 |
| Ap2s1 | 2536 |
| Ngf | 2217 |
| Cltc | 1187 |
| Dnm2 | -552 |
| Ntrk1 | -1523 |
| Dnm3 | -4756 |
| GeneID | Gene Rank |
|---|---|
| Dnm1 | 7420 |
| Ap2a1 | 7394 |
| Ap2b1 | 7080 |
| Ap2a2 | 6358 |
| Sh3gl2 | 6061 |
| Ap2m1 | 5729 |
| Dnal4 | 3744 |
| Clta | 2910 |
| Ap2s1 | 2536 |
| Ngf | 2217 |
| Cltc | 1187 |
| Dnm2 | -552 |
| Ntrk1 | -1523 |
| Dnm3 | -4756 |
TRAF6 MEDIATED IRF7 ACTIVATION
| 1090 | |
|---|---|
| set | TRAF6 MEDIATED IRF7 ACTIVATION |
| setSize | 15 |
| pANOVA | 0.0102 |
| s.dist | -0.383 |
| p.adjustANOVA | 0.137 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ifih1 | -8330 |
| Irf7 | -8101 |
| Traf6 | -7783 |
| Tank | -5965 |
| Tbk1 | -5931 |
| Rnf135 | -4521 |
| Sike1 | -3450 |
| Traf2 | -2620 |
| Trim25 | -2446 |
| Ep300 | -2267 |
| Ddx58 | -2254 |
| Mavs | -1764 |
| Irf3 | -1173 |
| Crebbp | 2884 |
| Ikbke | 4612 |
| GeneID | Gene Rank |
|---|---|
| Ifih1 | -8330 |
| Irf7 | -8101 |
| Traf6 | -7783 |
| Tank | -5965 |
| Tbk1 | -5931 |
| Rnf135 | -4521 |
| Sike1 | -3450 |
| Traf2 | -2620 |
| Trim25 | -2446 |
| Ep300 | -2267 |
| Ddx58 | -2254 |
| Mavs | -1764 |
| Irf3 | -1173 |
| Crebbp | 2884 |
| Ikbke | 4612 |
ATTENUATION PHASE
| 82 | |
|---|---|
| set | ATTENUATION PHASE |
| setSize | 25 |
| pANOVA | 0.000934 |
| s.dist | -0.382 |
| p.adjustANOVA | 0.0365 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Serpinh1 | -8522 |
| Hspb1 | -8520 |
| Fkbp4 | -8515 |
| Hsph1 | -8479 |
| Hspa1b | -8409 |
| Hspa1a | -8371 |
| Dnajb1 | -8303 |
| Hsp90aa1 | -7811 |
| Hspa8 | -7724 |
| Dedd2 | -7321 |
| Ptges3 | -6554 |
| Col4a6 | -5419 |
| Hsp90ab1 | -4459 |
| Rln1 | -3680 |
| Ep300 | -2267 |
| Mrpl18 | -2116 |
| Cryba4 | -1416 |
| Dnajb6 | -1244 |
| Ubb | 1348 |
| Hsf1 | 2256 |
| GeneID | Gene Rank |
|---|---|
| Serpinh1 | -8522 |
| Hspb1 | -8520 |
| Fkbp4 | -8515 |
| Hsph1 | -8479 |
| Hspa1b | -8409 |
| Hspa1a | -8371 |
| Dnajb1 | -8303 |
| Hsp90aa1 | -7811 |
| Hspa8 | -7724 |
| Dedd2 | -7321 |
| Ptges3 | -6554 |
| Col4a6 | -5419 |
| Hsp90ab1 | -4459 |
| Rln1 | -3680 |
| Ep300 | -2267 |
| Mrpl18 | -2116 |
| Cryba4 | -1416 |
| Dnajb6 | -1244 |
| Ubb | 1348 |
| Hsf1 | 2256 |
| Crebbp | 2884 |
| Hspa1l | 3116 |
| Hsbp1 | 3840 |
| Tnfrsf21 | 6286 |
| Hspa2 | 7713 |
PI 3K CASCADE FGFR4
| 696 | |
|---|---|
| set | PI 3K CASCADE FGFR4 |
| setSize | 11 |
| pANOVA | 0.0304 |
| s.dist | -0.377 |
| p.adjustANOVA | 0.242 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Gab1 | -8223 |
| Fgf9 | -8111 |
| Fgf2 | -8002 |
| Pik3ca | -7797 |
| Fgf18 | -7611 |
| Fgf1 | -7475 |
| Frs2 | -4087 |
| Pik3r1 | 2027 |
| Ptpn11 | 2062 |
| Grb2 | 4493 |
| Fgf16 | 7270 |
| GeneID | Gene Rank |
|---|---|
| Gab1 | -8223 |
| Fgf9 | -8111 |
| Fgf2 | -8002 |
| Pik3ca | -7797 |
| Fgf18 | -7611 |
| Fgf1 | -7475 |
| Frs2 | -4087 |
| Pik3r1 | 2027 |
| Ptpn11 | 2062 |
| Grb2 | 4493 |
| Fgf16 | 7270 |
DOPAMINE NEUROTRANSMITTER RELEASE CYCLE
| 256 | |
|---|---|
| set | DOPAMINE NEUROTRANSMITTER RELEASE CYCLE |
| setSize | 23 |
| pANOVA | 0.00182 |
| s.dist | 0.376 |
| p.adjustANOVA | 0.0505 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Stx1a | 7938 |
| Unc13b | 7488 |
| Syn1 | 7354 |
| Stxbp1 | 7232 |
| Ppfia3 | 7037 |
| Syt1 | 6858 |
| Rims1 | 5934 |
| Syn2 | 5671 |
| Syn3 | 4255 |
| Rab3a | 4251 |
| Vamp2 | 4007 |
| Lin7b | 3533 |
| Ppfia4 | 3212 |
| Tspoap1 | 2801 |
| Snap25 | 2764 |
| Ppfia2 | 1867 |
| Cask | 1508 |
| Lin7a | 1004 |
| Cplx1 | 512 |
| Apba1 | 127 |
| GeneID | Gene Rank |
|---|---|
| Stx1a | 7938 |
| Unc13b | 7488 |
| Syn1 | 7354 |
| Stxbp1 | 7232 |
| Ppfia3 | 7037 |
| Syt1 | 6858 |
| Rims1 | 5934 |
| Syn2 | 5671 |
| Syn3 | 4255 |
| Rab3a | 4251 |
| Vamp2 | 4007 |
| Lin7b | 3533 |
| Ppfia4 | 3212 |
| Tspoap1 | 2801 |
| Snap25 | 2764 |
| Ppfia2 | 1867 |
| Cask | 1508 |
| Lin7a | 1004 |
| Cplx1 | 512 |
| Apba1 | 127 |
| Lin7c | -1316 |
| Ppfia1 | -2775 |
| Slc18a2 | -8364 |
DEFECTS IN COBALAMIN B12 METABOLISM
| 217 | |
|---|---|
| set | DEFECTS IN COBALAMIN B12 METABOLISM |
| setSize | 12 |
| pANOVA | 0.0277 |
| s.dist | -0.367 |
| p.adjustANOVA | 0.235 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Mmut | -7915 |
| Mtrr | -7591 |
| Abcd4 | -6939 |
| Mmaa | -6321 |
| Mmadhc | -5236 |
| Mmachc | -4429 |
| Lmbrd1 | -4231 |
| Tcn2 | -3809 |
| Cd320 | -2432 |
| Mtr | -2248 |
| Amn | 5929 |
| Mmab | 7539 |
| GeneID | Gene Rank |
|---|---|
| Mmut | -7915 |
| Mtrr | -7591 |
| Abcd4 | -6939 |
| Mmaa | -6321 |
| Mmadhc | -5236 |
| Mmachc | -4429 |
| Lmbrd1 | -4231 |
| Tcn2 | -3809 |
| Cd320 | -2432 |
| Mtr | -2248 |
| Amn | 5929 |
| Mmab | 7539 |
SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION
| 990 | |
|---|---|
| set | SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION |
| setSize | 25 |
| pANOVA | 0.00182 |
| s.dist | -0.36 |
| p.adjustANOVA | 0.0505 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| H2ac18 | -8348 |
| H4c12 | -7747 |
| H4c8 | -7477 |
| H2bc21 | -7459 |
| H2bc6 | -6848 |
| H2az2 | -6816 |
| H2bc4 | -6707 |
| H2bc8 | -6624 |
| H4c9 | -6415 |
| Taf1a | -6340 |
| Sirt1 | -4712 |
| H3c15 | -4019 |
| Suv39h1 | -3076 |
| Taf1d | -2841 |
| H2aj | -2603 |
| H3f3a | -2297 |
| H2az1 | -864 |
| H2ac19 | -532 |
| H3f3b | -414 |
| Taf1c | -36 |
| GeneID | Gene Rank |
|---|---|
| H2ac18 | -8348 |
| H4c12 | -7747 |
| H4c8 | -7477 |
| H2bc21 | -7459 |
| H2bc6 | -6848 |
| H2az2 | -6816 |
| H2bc4 | -6707 |
| H2bc8 | -6624 |
| H4c9 | -6415 |
| Taf1a | -6340 |
| Sirt1 | -4712 |
| H3c15 | -4019 |
| Suv39h1 | -3076 |
| Taf1d | -2841 |
| H2aj | -2603 |
| H3f3a | -2297 |
| H2az1 | -864 |
| H2ac19 | -532 |
| H3f3b | -414 |
| Taf1c | -36 |
| H4c14 | 138 |
| Rrp8 | 585 |
| Taf1b | 3775 |
| H2ax | 4083 |
| Tbp | 6609 |
ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE
| 8 | |
|---|---|
| set | ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE |
| setSize | 17 |
| pANOVA | 0.0102 |
| s.dist | 0.36 |
| p.adjustANOVA | 0.137 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Stx1a | 7938 |
| Unc13b | 7488 |
| Stxbp1 | 7232 |
| Ppfia3 | 7037 |
| Syt1 | 6858 |
| Rims1 | 5934 |
| Rab3a | 4251 |
| Vamp2 | 4007 |
| Ppfia4 | 3212 |
| Tspoap1 | 2801 |
| Snap25 | 2764 |
| Ppfia2 | 1867 |
| Cplx1 | 512 |
| Chat | 444 |
| Slc18a3 | -2007 |
| Ppfia1 | -2775 |
| Slc5a7 | -5917 |
| GeneID | Gene Rank |
|---|---|
| Stx1a | 7938 |
| Unc13b | 7488 |
| Stxbp1 | 7232 |
| Ppfia3 | 7037 |
| Syt1 | 6858 |
| Rims1 | 5934 |
| Rab3a | 4251 |
| Vamp2 | 4007 |
| Ppfia4 | 3212 |
| Tspoap1 | 2801 |
| Snap25 | 2764 |
| Ppfia2 | 1867 |
| Cplx1 | 512 |
| Chat | 444 |
| Slc18a3 | -2007 |
| Ppfia1 | -2775 |
| Slc5a7 | -5917 |
CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2
| 175 | |
|---|---|
| set | CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2 |
| setSize | 11 |
| pANOVA | 0.0388 |
| s.dist | -0.36 |
| p.adjustANOVA | 0.275 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ptpn12 | -8331 |
| Nras | -8042 |
| Hsp90aa1 | -7811 |
| Erbin | -7214 |
| Kras | -4796 |
| Sos1 | -4081 |
| Shc1 | -3374 |
| Hras | -19 |
| Erbb2 | 1862 |
| Cdc37 | 3453 |
| Grb2 | 4493 |
| GeneID | Gene Rank |
|---|---|
| Ptpn12 | -8331 |
| Nras | -8042 |
| Hsp90aa1 | -7811 |
| Erbin | -7214 |
| Kras | -4796 |
| Sos1 | -4081 |
| Shc1 | -3374 |
| Hras | -19 |
| Erbb2 | 1862 |
| Cdc37 | 3453 |
| Grb2 | 4493 |
RRNA PROCESSING IN THE MITOCHONDRION
| 887 | |
|---|---|
| set | RRNA PROCESSING IN THE MITOCHONDRION |
| setSize | 10 |
| pANOVA | 0.0494 |
| s.dist | 0.359 |
| p.adjustANOVA | 0.306 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Elac2 | 8075 |
| Prorp | 6607 |
| Tfb1m | 5112 |
| Mterf4 | 4202 |
| Nsun4 | 3758 |
| Trmt10c | 3705 |
| Mrm1 | 3236 |
| Mrm2 | 678 |
| Hsd17b10 | -1176 |
| Mrm3 | -3897 |
| GeneID | Gene Rank |
|---|---|
| Elac2 | 8075 |
| Prorp | 6607 |
| Tfb1m | 5112 |
| Mterf4 | 4202 |
| Nsun4 | 3758 |
| Trmt10c | 3705 |
| Mrm1 | 3236 |
| Mrm2 | 678 |
| Hsd17b10 | -1176 |
| Mrm3 | -3897 |
INTERLEUKIN 10 SIGNALING
| 464 | |
|---|---|
| set | INTERLEUKIN 10 SIGNALING |
| setSize | 19 |
| pANOVA | 0.00748 |
| s.dist | -0.354 |
| p.adjustANOVA | 0.126 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Icam1 | -8494 |
| Ccr5 | -8441 |
| Cd86 | -8220 |
| Il10rb | -8095 |
| Il1a | -7481 |
| Tnfrsf1b | -7043 |
| Lif | -6639 |
| Csf1 | -5356 |
| Il10ra | -4188 |
| Ptafr | -3803 |
| Il18 | -3795 |
| Cd80 | -1872 |
| Tnfrsf1a | -1298 |
| Il1r1 | -1016 |
| Stat3 | -801 |
| Tyk2 | 1654 |
| Jak1 | 3233 |
| Ptgs2 | 6479 |
| Fcer2a | 7586 |
| GeneID | Gene Rank |
|---|---|
| Icam1 | -8494 |
| Ccr5 | -8441 |
| Cd86 | -8220 |
| Il10rb | -8095 |
| Il1a | -7481 |
| Tnfrsf1b | -7043 |
| Lif | -6639 |
| Csf1 | -5356 |
| Il10ra | -4188 |
| Ptafr | -3803 |
| Il18 | -3795 |
| Cd80 | -1872 |
| Tnfrsf1a | -1298 |
| Il1r1 | -1016 |
| Stat3 | -801 |
| Tyk2 | 1654 |
| Jak1 | 3233 |
| Ptgs2 | 6479 |
| Fcer2a | 7586 |
INTERACTION BETWEEN L1 AND ANKYRINS
| 455 | |
|---|---|
| set | INTERACTION BETWEEN L1 AND ANKYRINS |
| setSize | 29 |
| pANOVA | 0.00104 |
| s.dist | 0.352 |
| p.adjustANOVA | 0.0379 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Scn10a | 8402 |
| Sptbn5 | 8340 |
| Sptbn2 | 7435 |
| Scn8a | 7173 |
| Actb | 6914 |
| Scn1b | 6803 |
| Nrcam | 6783 |
| L1cam | 6521 |
| Sptan1 | 6269 |
| Kcnq2 | 5969 |
| Scn2a | 5523 |
| Scn3b | 5281 |
| Sptb | 4723 |
| Actg1 | 4415 |
| Sptbn4 | 4260 |
| Scn2b | 2738 |
| Scn4b | 2575 |
| Sptbn1 | 2521 |
| Nfasc | 2313 |
| Ank2 | 2029 |
| GeneID | Gene Rank |
|---|---|
| Scn10a | 8402 |
| Sptbn5 | 8340 |
| Sptbn2 | 7435 |
| Scn8a | 7173 |
| Actb | 6914 |
| Scn1b | 6803 |
| Nrcam | 6783 |
| L1cam | 6521 |
| Sptan1 | 6269 |
| Kcnq2 | 5969 |
| Scn2a | 5523 |
| Scn3b | 5281 |
| Sptb | 4723 |
| Actg1 | 4415 |
| Sptbn4 | 4260 |
| Scn2b | 2738 |
| Scn4b | 2575 |
| Sptbn1 | 2521 |
| Nfasc | 2313 |
| Ank2 | 2029 |
| Kcnq3 | 1196 |
| Ank3 | -102 |
| Ank1 | -1579 |
| Scn3a | -1671 |
| Scn5a | -1798 |
| Scn7a | -2293 |
| Scn1a | -2963 |
| Scn11a | -5321 |
| Scn9a | -6412 |
GLYCOGEN BREAKDOWN GLYCOGENOLYSIS
| 383 | |
|---|---|
| set | GLYCOGEN BREAKDOWN GLYCOGENOLYSIS |
| setSize | 14 |
| pANOVA | 0.0227 |
| s.dist | -0.352 |
| p.adjustANOVA | 0.214 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Phka1 | -7315 |
| Gyg | -6772 |
| Pygb | -5821 |
| Pgm2 | -5358 |
| Phkg2 | -4838 |
| Phkb | -4393 |
| Pygm | -4296 |
| Agl | -4222 |
| Pygl | -3764 |
| Phkg1 | -3017 |
| Calm1 | -2523 |
| Gaa | 1653 |
| Pgm2l1 | 1810 |
| Phka2 | 6738 |
| GeneID | Gene Rank |
|---|---|
| Phka1 | -7315 |
| Gyg | -6772 |
| Pygb | -5821 |
| Pgm2 | -5358 |
| Phkg2 | -4838 |
| Phkb | -4393 |
| Pygm | -4296 |
| Agl | -4222 |
| Pygl | -3764 |
| Phkg1 | -3017 |
| Calm1 | -2523 |
| Gaa | 1653 |
| Pgm2l1 | 1810 |
| Phka2 | 6738 |
FORMATION OF THE CORNIFIED ENVELOPE
| 333 | |
|---|---|
| set | FORMATION OF THE CORNIFIED ENVELOPE |
| setSize | 26 |
| pANOVA | 0.00204 |
| s.dist | 0.349 |
| p.adjustANOVA | 0.0528 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Krt9 | 8412 |
| St14 | 8252 |
| Pkp2 | 8139 |
| Evpl | 8122 |
| Capn1 | 7941 |
| Tchh | 7887 |
| Krt20 | 7338 |
| Krt77 | 7044 |
| Ppl | 6106 |
| Perp | 5493 |
| Krt73 | 4161 |
| Klk8 | 3646 |
| Dsc3 | 3280 |
| Krt10 | 2444 |
| Capns1 | 2360 |
| Lor | 2297 |
| Furin | 1847 |
| Jup | 1021 |
| Krt18 | 888 |
| Dsp | 735 |
| GeneID | Gene Rank |
|---|---|
| Krt9 | 8412 |
| St14 | 8252 |
| Pkp2 | 8139 |
| Evpl | 8122 |
| Capn1 | 7941 |
| Tchh | 7887 |
| Krt20 | 7338 |
| Krt77 | 7044 |
| Ppl | 6106 |
| Perp | 5493 |
| Krt73 | 4161 |
| Klk8 | 3646 |
| Dsc3 | 3280 |
| Krt10 | 2444 |
| Capns1 | 2360 |
| Lor | 2297 |
| Furin | 1847 |
| Jup | 1021 |
| Krt18 | 888 |
| Dsp | 735 |
| Krt12 | -969 |
| Kazn | -1202 |
| Dsg2 | -1722 |
| Pcsk6 | -4950 |
| Pkp4 | -5313 |
| Krt1 | -6628 |
KERATINIZATION
| 501 | |
|---|---|
| set | KERATINIZATION |
| setSize | 26 |
| pANOVA | 0.00204 |
| s.dist | 0.349 |
| p.adjustANOVA | 0.0528 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Krt9 | 8412 |
| St14 | 8252 |
| Pkp2 | 8139 |
| Evpl | 8122 |
| Capn1 | 7941 |
| Tchh | 7887 |
| Krt20 | 7338 |
| Krt77 | 7044 |
| Ppl | 6106 |
| Perp | 5493 |
| Krt73 | 4161 |
| Klk8 | 3646 |
| Dsc3 | 3280 |
| Krt10 | 2444 |
| Capns1 | 2360 |
| Lor | 2297 |
| Furin | 1847 |
| Jup | 1021 |
| Krt18 | 888 |
| Dsp | 735 |
| GeneID | Gene Rank |
|---|---|
| Krt9 | 8412 |
| St14 | 8252 |
| Pkp2 | 8139 |
| Evpl | 8122 |
| Capn1 | 7941 |
| Tchh | 7887 |
| Krt20 | 7338 |
| Krt77 | 7044 |
| Ppl | 6106 |
| Perp | 5493 |
| Krt73 | 4161 |
| Klk8 | 3646 |
| Dsc3 | 3280 |
| Krt10 | 2444 |
| Capns1 | 2360 |
| Lor | 2297 |
| Furin | 1847 |
| Jup | 1021 |
| Krt18 | 888 |
| Dsp | 735 |
| Krt12 | -969 |
| Kazn | -1202 |
| Dsg2 | -1722 |
| Pcsk6 | -4950 |
| Pkp4 | -5313 |
| Krt1 | -6628 |
FRS MEDIATED FGFR4 SIGNALING
| 343 | |
|---|---|
| set | FRS MEDIATED FGFR4 SIGNALING |
| setSize | 13 |
| pANOVA | 0.0297 |
| s.dist | -0.348 |
| p.adjustANOVA | 0.242 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Fgf9 | -8111 |
| Nras | -8042 |
| Fgf2 | -8002 |
| Fgf18 | -7611 |
| Fgf1 | -7475 |
| Kras | -4796 |
| Frs2 | -4087 |
| Sos1 | -4081 |
| Frs3 | -338 |
| Hras | -19 |
| Ptpn11 | 2062 |
| Grb2 | 4493 |
| Fgf16 | 7270 |
| GeneID | Gene Rank |
|---|---|
| Fgf9 | -8111 |
| Nras | -8042 |
| Fgf2 | -8002 |
| Fgf18 | -7611 |
| Fgf1 | -7475 |
| Kras | -4796 |
| Frs2 | -4087 |
| Sos1 | -4081 |
| Frs3 | -338 |
| Hras | -19 |
| Ptpn11 | 2062 |
| Grb2 | 4493 |
| Fgf16 | 7270 |
SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE
| 1035 | |
|---|---|
| set | SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE |
| setSize | 15 |
| pANOVA | 0.0196 |
| s.dist | 0.348 |
| p.adjustANOVA | 0.202 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Arf3 | 8239 |
| Fig4 | 7690 |
| Pi4ka | 7462 |
| Arf1 | 6982 |
| Pik3r4 | 6435 |
| Vac14 | 5967 |
| Inpp5e | 5242 |
| Pik3c3 | 4940 |
| Pi4k2a | 4042 |
| Pi4kb | 633 |
| Pi4k2b | 371 |
| Pikfyve | -700 |
| Ocrl | -1264 |
| Pik3c2a | -4493 |
| Sacm1l | -7466 |
| GeneID | Gene Rank |
|---|---|
| Arf3 | 8239 |
| Fig4 | 7690 |
| Pi4ka | 7462 |
| Arf1 | 6982 |
| Pik3r4 | 6435 |
| Vac14 | 5967 |
| Inpp5e | 5242 |
| Pik3c3 | 4940 |
| Pi4k2a | 4042 |
| Pi4kb | 633 |
| Pi4k2b | 371 |
| Pikfyve | -700 |
| Ocrl | -1264 |
| Pik3c2a | -4493 |
| Sacm1l | -7466 |
TRAF3 DEPENDENT IRF ACTIVATION PATHWAY
| 1088 | |
|---|---|
| set | TRAF3 DEPENDENT IRF ACTIVATION PATHWAY |
| setSize | 13 |
| pANOVA | 0.0312 |
| s.dist | -0.345 |
| p.adjustANOVA | 0.242 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ifih1 | -8330 |
| Irf7 | -8101 |
| Tbk1 | -5931 |
| Traf3 | -5653 |
| Rnf135 | -4521 |
| Sike1 | -3450 |
| Trim25 | -2446 |
| Ep300 | -2267 |
| Ddx58 | -2254 |
| Mavs | -1764 |
| Irf3 | -1173 |
| Crebbp | 2884 |
| Ikbke | 4612 |
| GeneID | Gene Rank |
|---|---|
| Ifih1 | -8330 |
| Irf7 | -8101 |
| Tbk1 | -5931 |
| Traf3 | -5653 |
| Rnf135 | -4521 |
| Sike1 | -3450 |
| Trim25 | -2446 |
| Ep300 | -2267 |
| Ddx58 | -2254 |
| Mavs | -1764 |
| Irf3 | -1173 |
| Crebbp | 2884 |
| Ikbke | 4612 |
PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION
| 753 | |
|---|---|
| set | PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION |
| setSize | 23 |
| pANOVA | 0.00441 |
| s.dist | -0.343 |
| p.adjustANOVA | 0.0968 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Nfkb2 | -7543 |
| Il1a | -7481 |
| C3ar1 | -7353 |
| Pycard | -7241 |
| Entpd1 | -6854 |
| Sugt1 | -6360 |
| Casp1 | -5869 |
| Rela | -5667 |
| Nlrp3 | -5663 |
| Nfkb1 | -5333 |
| Entpd5 | -5215 |
| Txnip | -4663 |
| Hsp90ab1 | -4459 |
| Il18 | -3795 |
| P2rx7 | -1704 |
| P2rx4 | -723 |
| C3 | -711 |
| Hmox1 | -613 |
| Pstpip1 | 447 |
| Txn1 | 2081 |
| GeneID | Gene Rank |
|---|---|
| Nfkb2 | -7543 |
| Il1a | -7481 |
| C3ar1 | -7353 |
| Pycard | -7241 |
| Entpd1 | -6854 |
| Sugt1 | -6360 |
| Casp1 | -5869 |
| Rela | -5667 |
| Nlrp3 | -5663 |
| Nfkb1 | -5333 |
| Entpd5 | -5215 |
| Txnip | -4663 |
| Hsp90ab1 | -4459 |
| Il18 | -3795 |
| P2rx7 | -1704 |
| P2rx4 | -723 |
| C3 | -711 |
| Hmox1 | -613 |
| Pstpip1 | 447 |
| Txn1 | 2081 |
| Nt5e | 3971 |
| App | 6496 |
| Gsdmd | 6789 |
DSCAM INTERACTIONS
| 267 | |
|---|---|
| set | DSCAM INTERACTIONS |
| setSize | 10 |
| pANOVA | 0.0607 |
| s.dist | 0.343 |
| p.adjustANOVA | 0.334 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Pak1 | 7075 |
| Mapk11 | 6893 |
| Dscaml1 | 5224 |
| Ntn1 | 4776 |
| Dscam | 3786 |
| Mapk8 | 3304 |
| Mapk14 | 100 |
| Dcc | -470 |
| Mapk12 | -499 |
| Rac1 | -1278 |
| GeneID | Gene Rank |
|---|---|
| Pak1 | 7075 |
| Mapk11 | 6893 |
| Dscaml1 | 5224 |
| Ntn1 | 4776 |
| Dscam | 3786 |
| Mapk8 | 3304 |
| Mapk14 | 100 |
| Dcc | -470 |
| Mapk12 | -499 |
| Rac1 | -1278 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.2.1 (2022-06-23)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 22.04.1 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3
## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] stats4 stats graphics grDevices utils datasets methods
## [8] base
##
## other attached packages:
## [1] pkgload_1.3.0 GGally_2.1.2
## [3] gtools_3.9.3 echarts4r_0.4.4
## [5] beeswarm_0.4.0 vioplot_0.3.7
## [7] sm_2.2-5.7.1 kableExtra_1.3.4
## [9] topconfects_1.12.0 limma_3.52.4
## [11] eulerr_6.1.1 mitch_1.8.0
## [13] MASS_7.3-58.1 fgsea_1.22.0
## [15] gplots_3.1.3 DESeq2_1.36.0
## [17] SummarizedExperiment_1.26.1 Biobase_2.56.0
## [19] MatrixGenerics_1.8.1 matrixStats_0.62.0
## [21] GenomicRanges_1.48.0 GenomeInfoDb_1.32.4
## [23] IRanges_2.30.1 S4Vectors_0.34.0
## [25] BiocGenerics_0.42.0 reshape2_1.4.4
## [27] forcats_0.5.2 stringr_1.4.1
## [29] dplyr_1.0.10 purrr_0.3.5
## [31] readr_2.1.3 tidyr_1.2.1
## [33] tibble_3.1.8 ggplot2_3.3.6
## [35] tidyverse_1.3.2 zoo_1.8-11
##
## loaded via a namespace (and not attached):
## [1] googledrive_2.0.0 colorspace_2.0-3 ellipsis_0.3.2
## [4] XVector_0.36.0 fs_1.5.2 rstudioapi_0.14
## [7] bit64_4.0.5 AnnotationDbi_1.58.0 fansi_1.0.3
## [10] lubridate_1.8.0 xml2_1.3.3 codetools_0.2-18
## [13] splines_4.2.1 cachem_1.0.6 knitr_1.40
## [16] geneplotter_1.74.0 jsonlite_1.8.2 broom_1.0.1
## [19] annotate_1.74.0 dbplyr_2.2.1 png_0.1-7
## [22] shiny_1.7.2 compiler_4.2.1 httr_1.4.4
## [25] backports_1.4.1 assertthat_0.2.1 Matrix_1.5-1
## [28] fastmap_1.1.0 gargle_1.2.1 cli_3.4.1
## [31] later_1.3.0 htmltools_0.5.3 tools_4.2.1
## [34] gtable_0.3.1 glue_1.6.2 GenomeInfoDbData_1.2.8
## [37] fastmatch_1.1-3 Rcpp_1.0.9 jquerylib_0.1.4
## [40] cellranger_1.1.0 vctrs_0.4.2 Biostrings_2.64.1
## [43] svglite_2.1.0 xfun_0.33 rvest_1.0.3
## [46] mime_0.12 lifecycle_1.0.3 XML_3.99-0.11
## [49] googlesheets4_1.0.1 zlibbioc_1.42.0 scales_1.2.1
## [52] hms_1.1.2 promises_1.2.0.1 parallel_4.2.1
## [55] RColorBrewer_1.1-3 yaml_2.3.5 memoise_2.0.1
## [58] gridExtra_2.3 sass_0.4.2 reshape_0.8.9
## [61] stringi_1.7.8 RSQLite_2.2.18 highr_0.9
## [64] genefilter_1.78.0 caTools_1.18.2 BiocParallel_1.30.3
## [67] systemfonts_1.0.4 rlang_1.0.6 pkgconfig_2.0.3
## [70] bitops_1.0-7 evaluate_0.17 lattice_0.20-45
## [73] htmlwidgets_1.5.4 bit_4.0.4 tidyselect_1.2.0
## [76] plyr_1.8.7 magrittr_2.0.3 R6_2.5.1
## [79] generics_0.1.3 DelayedArray_0.22.0 DBI_1.1.3
## [82] pillar_1.8.1 haven_2.5.1 withr_2.5.0
## [85] survival_3.4-0 KEGGREST_1.36.3 RCurl_1.98-1.9
## [88] modelr_0.1.9 crayon_1.5.2 KernSmooth_2.23-20
## [91] utf8_1.2.2 rmarkdown_2.17 tzdb_0.3.0
## [94] locfit_1.5-9.6 grid_4.2.1 readxl_1.4.1
## [97] data.table_1.14.2 blob_1.2.3 webshot_0.5.4
## [100] reprex_2.0.2 digest_0.6.29 xtable_1.8-4
## [103] httpuv_1.6.6 munsell_0.5.0 viridisLite_0.4.1
## [106] bslib_0.4.0
END of report